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A b s t r a c t
The aim of this project was to study the stability characteristics of the serine protease 
dipeptidyl peptidase IV (DPP IV) and recombinant Fasciola hepatica cysteine protease 
cathepsin LI (rFheCLl), with a view to using them in peptide synthesis.
DPP IV was purified from bovine serum. The chromatographic techniques used were 
phenyl-Sepharose hydrophobic interaction, Sephacryl S-300-HR gel filtration and 
quaternary-Sepharose anion exchange, producing an overall purification factor of 35. 
The enzyme was shown to have a subunit molecular weight of 77,224 Da, by SDS- 
PAGE; native weight was not determined. DPP IV activity remained stable up to 62°C 
and over a broad pH range, with a preference for neutral pH. The estimated T5o was 
71°C. With regard to solvent tolerance DPP IV was most stable in acetonitrile, at all 
concentrations tested. THF was the most deleterious solvent with little or no activity 
exhibited above 40% (v/v) concentration. Michaelis-Menten kinetics of DPP IV were 
determined at different pH values, pK  values were observed at pH 6.5 and 9.5. The 
lower pK  value is likely due to the ionisation of the active site histidine side chain of 
soluble DPP IV; however, the upper pK  value possibly belongs to the a-amino group of 
the Gly moiety of the Gly-Pro-AMC substrate.
rFheCLl was characterised and compared with the enzyme purified from liver fluke 
(Fasciola hepatica). rFheCLl was also stabilised by the reaction of the enzyme with 
ethylene glycol-bis(succinic acid N-hydroxy-succinimide ester) (EG-NHS). The 
enhanced stability of the modified enzyme is likely due to an intramolecular crosslink(s) 
being formed in the enzyme. The estimated T5o of modified rFheCLl was 87°C as 
compared to native rFheCLl, which had an estimated T50 of 78°C. At 70°C modified 
rFheCLl retained 100% amidase activity for up to 60 minutes compared to native 
rFheCLl, which showed an 80% loss in activity under the same assay conditions. 
Modified rFheCLl also demonstrated enhanced stability in the solvents acetone and 
acetonitrile; however, modification did not enhance stability in THF. Kinetic studies 
indicate that the active site of the enzyme has not been affected by cross-linking and 
that stability gain has not been at a cost of poorer catalysis. Native rFheCLl was used 
to catalyse the synthesis of the model tripeptide Z-Phe-Arg-SerNH2. LC-MS analysis 
indicated that formation of the new tripeptide occurred within ten minutes.
C h a pter  1 
In tr o d u c tio n
Chemical synthesis involves joining together optically active amino acids in chains of 
known length and predetermined sequence. The side chain group, designated R, defines 
different structures of amino acids. These side chains may contain certain functional 
groups that can interfere with the formation of the peptide bond; therefore, it is important 
that functional groups other than those involved in peptide bond formation (i.e. amino side 
chains containing thiol, imidazole, amino, carboxylic and hydroxyl functional groups) be 
blocked by protecting groups. However, this protection must be reversible and not damage 
the assembled peptide chain. Typical protecting groups for the amino function include 
tertiary-Butoxycarbonyl, or t-Boc and 9-fluorenylmethoxycarbonyl or Fmoc (FIGURE 1.1.). 
Each protecting group has its own conditions for application to, and removal from, the 
amino acid.
The main types of chemical synthesis are solution-phase peptide synthesis and solid-phase 
peptide synthesis (Andersen et al., 1991; Murphy & Ô’Fâgâin, 1996a).
1.1. Chemical Peptide Synthesis
(a) tBoc-CI
CH,
H3C C •
O
A
■o Cl
CH,
F i g u r e  1.1. S t r u c t u r e s  o f  p r o t e c t i n g  g r o u p s  c o m m o n ly  u s e d  in  c h e m i c a l  p e p t id e  
s y n t h e s i s  (Murphy & Ô ’F â g â in , 1996a).
(b) Fmoc-CI
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This method involves classical wet chemistry and the assembly of peptides in solution 
( F i g u r e  1.2.). It consists of two steps: the first step requires the activation of a carboxyl 
group on an Na-protected amino acid with an appropriate agent. The second step involves 
coupling this activated carboxyl group to the free amino group of a Ca-protected amino 
acid via a dehydration reaction promoted by an appropriate coupling reagent (e.g. DCC) 
leading to peptide bond formation (Andersen et al., 1991; Murphy & O’Fagain, 1996a).
1.1.1. Solution-phase peptide synthesis
Single amino acid residues in solution
V v
V V V
Formation of peptide intermediates
V V
V
Peptide formation
F ig u r e  1 .2. Sc h e m a t ic  d ia g r a m  o f  f r a g m e n t  c o n d e n s a t io n  in  s o l u t io n
(Kent, 1988).
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Robert Bruce Merrifield developed this method in 1963. It involves the assembly of a 
peptide chain, starting with the carboxyl-group of an amino acid attached to a solid support. 
In a series of defined steps Na-protected amino acids are deprotected and coupled to the 
attached amino acid until the desired peptide or polymer has been obtained ( F ig u r e  1.3.).
1.1.2. Solid-phase peptide synthesis (SPPS)
Polymer Support
Introduction of suitable anchor groups
Attachment of 1st N-protected amino acid
,-k ...o.
N - il
H n
Deprotection of N-protected amino acid
R2
' Acti vati ng G ro up ---------
H O
H O R (
X" T  'N "  V "  #
R 2 H o
Addition of next N-protected amino acid 
Peptide Coupling Reaction
■,n+1
N ’
H O pH
n-fold repetition of step 3 -4
R<
H ^  i  5n o
Cleavage and deprotection
Free peptide and polymer
F ig u r e  1.3. G e n e r a l  s c h e m e  f o r  s o l id -p h a s e  p e p t id e  s y n t h e s is
X = temporary protecting group, R1, R2, Rn & Rn+1, amino acid side chains 
(Sewald & Jakubke, 2002b).
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1.2. Recombinant DNA Techniques
This is a preparative technique for ribosomal synthesis of polypeptides and proteins based 
on the principle of gene technology. Expression of peptides and proteins in organisms such 
as bacteria e.g. Escherichia coli is possible. This technique relies on the recombination of 
the microorganism’s genetic material with the DNA fragment encoding for the desired 
protein and consists of a number of steps (Sewald & Jakubke, 2002c):
(1) Isolation of the encoding DNA fragment from the donor organism.
(2) Insertion of the DNA into a vector.
(3) Transfection of the vector into the host organism.
(4) Cultivation of host organism, leading to gene amplification, mRNA and protein 
synthesis.
(5) Isolation of the recombinant protein.
Lueking et al. (2000) used this technology to successfully develop a novel Pichia 
pastoris/Escherichia coli dual expression vector for the production of recombinant protein 
in both host systems.
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1.3. Proteases and Enzymatic Peptide Synthesis
Proteolytic enzymes, or proteases, catalyse a single reaction, the hydrolysis of a peptide 
bond. This reaction is one of the most frequent and important enzymatic modifications of 
proteins. They can, however catalyse the reverse reaction, i.e. formation of the peptide 
bond leading to oligopeptide synthesis. Enzymatic peptide synthesis has been used to 
produce a number of peptides. Oyama et al. (1981) used the enzyme thermolysin to 
catalyse the condensation between L-phenylalanine methyl ester and N-CBZ-L-aspartic 
acid, to produce the well-known sweetener aspartame. There are a number of advantages 
associated with enzymatic peptide synthesis as opposed to chemical methods. These are:
(1) Enzymes catalyse reactions with high regiospecificity reducing the need for side 
chain protection of reactants
(2) Owing to the stereospecificity of enzymes, no racemization is observed
(3) Reactions take place under mild conditions
(4) No requirement of protection/deprotection steps; this simplifies the process (Gill, et 
a l, 1996; Sears & Wong, 1996).
Proteases are divided into two categories on the basis of where they cleave the protein 
exopeptidases and endopeptidases (F ig u r e  1.4.). Exopeptidases require the presence of an 
unsubstituted N- or C- terminus in the substrate and remove a single amino acid, di- or 
tripeptides from one or other terminus, producing small peptides or amino acids. This mode 
of action is the basis for the classification of the exopeptidases. The same consideration of 
specificity cannot be applied to the endopeptidases, as they cleave within the protein chain, 
producing large peptides. Therefore, the classification of these peptidases is dependent on 
the catalytic mechanism of their active sites to yield four main classes: serine, cysteine, 
aspartic and metallo-endopeptidases. The same catalytic mechanisms are functional among
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the exopeptidases; hence, some can be further subdivided on the same basis (Creighton, 
1993b; Kenny, 1999; Barrett, 2001).
1.3.1. Serine proteases
Two distinct families are present in this group: the mammalian serine proteases e.g. Trypsin 
EC 3.4.21,4 and the bacterial serine proteases e.g. Subtilisin EC 3.4.21.14. They are 
characterized by the presence of a highly reactive serine residue. This is included in the 
active site arrangement of their catalytic triad Ser-His-Asp. Catalysis proceeds by covalent 
attack of polarised serine side-chain and the formation of an acyl-enzyme intermediate. 
The same type of mechanism underlies the action of all serine protease (Creighton, 1993b; 
Dunn, 2001).
1.3.2. Cysteine proteases
Included in this group are several mammalian lysosomal cathepsins and the plant proteases 
papain and actinidin. Cysteine proteases are the most comparable to the serine proteases, 
with a cysteine side chain playing the role of the serine. Catalysis proceeds by covalent 
attack of the polarised cysteine side chain and the formation of a thiol ester intermediate. 
The active site arrangement is Cys-His charge transfer (Creighton, 1993b; Dunn, 2001).
1.3.3. Aspartic proteases
Bacterial penicillopepsin EC 3.4.23.6. mammalian pepsin EC 3.4.23.1., chymosin EC
3.4.23.4. and certain fungal proteases belong to this family. The active site is composed of 
two aspartic acid residues, which lie in close proximity to each other. Catalysis proceeds 
via water molecule attack polarised by the enzyme’s aspartic acid side chains. In the
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enzymatically active pH range 2-3, one of these is ionised, the other unionised (Dunn, 
2001).
1.3.4. Metalloproteases
Metalloproteases use bound metal in their active sites. Included in this family are the 
carboxypeptidases A and B, thermolysin and medically important enzymes such as 
angiotensin-converting enzyme. Catalysis proceeds via water molecule attack polarised by 
the enzyme’s co-ordinated zinc. The active site components include zinc, with its three 
ligands of two glutamic acids and one histidine (Dunn, 2001).
Peptidases 
peptide bond hydrolases
N-teimmns C-terminus
E xo peptidas e s
cut from the ends 
of pep tide chains
opep tidases
cut internal sites 
in peptide chains
A m i nopeptidases
one at a time from 
the N-terminus
Di pe ptidyl peptidases
one dipeptide at a time 
from the N-terminus
Tri pep tidyl peptidases
one tripeptide at a time 
from the N-terminus
Carboxypeptida s e s
one at a time from 
the C-terminus
Peptidyl dipeptid as es
one dipeptide at a time 
from the C-terminus
F ig u r e  1.4. S c h e m a t ic  r e p r e s e n t a t io n  il l u s t r a t in g  c l e a v a g e  s it e s  o f  e n d o - a n d  
e x o p e p t id a s e s . (W e b s it e : b u m h a m .o rg /la b s /s a lv e se n /c la s s if ic a tio n )
1.4. Strategies for Enzymatic Peptide Synthesis
Two basic strategies exist for protease-catalysed peptide bond formation; (1) equilibrium- 
controlled synthesis and (2) kinetically-synthesis. The type of synthesis is dependent on 
the type of carboxyl component used in the reaction. In equilibrium-controlled synthesis 
the carboxyl component is free (RCOOH), whereas in kinetically-controlled synthesis the 
carboxyl component is used in an activated form (RCOOX) ( F i g u r e  1 .5.). These strategies 
are fundamentally different because of the energy requirements for the conversion of the 
substrates into peptide products (Sewald & Jakubke, 2002d).
(B) O
/
O o
H H
F i g u r e  1.5. S c h e m a t i c  d i a g r a m  t o  c o m p a r e  e q u i l i b r i u m  (A ) a n d  k i n e t i c a l l y  (B) 
c o n t r o l l e d  p e p t id e  s y n t h e s i s .  R'-COOH = free carboxyl component, R1- 
COX = activated carboxyl component (Sewald & Jakubke, 2002d).
1.4.1. Equilibrium-controlled peptide synthesis
This type of synthesis involves direct reversal of protease-catalyzed hydrolysis. It involves 
a condensation reaction between the free terminal a-carboxyl component and an unblocked 
nucleophilic a-amino component ( F i g u r e  1 .6.). A ll mechanistic classes of proteases i.e. 
cysteine, serine, aspartic and metallo, can be used for this type of synthesis, as it is 
independent of their catalytic mechanisms. The enzyme is used to accelerate the rate with 
which equilibrium is reached and cannot influence this equilibrium (Jakubke, 1987; 
Kasche, 1989; Sewald & Jakubke, 2 0 0 2 ).
K  w
RCOOH + H2NR' ---------  RCONHR' + H20
F ig u r e  1.6. E q u il ib r iu m -c o n t r o l l e d  p e p t id e  s y n t h e s is . Direct reversal o f  peptide 
hydrolysis (Barbas et al., 1988).
1.4.2. Kinetically-controlled peptide synthesis
The rate of product formation relative to peptide hydrolysis is important in kinetically- 
controlled peptide synthesis. In this type of synthesis (F ig u r e  1.7.), the enzyme rapidly 
reacts with the ester substrate forming an acyl-enzyme intermediate, with the loss of an 
amino acid or peptide fragment (HX). There is partitioning of the intermediate between 
aminolysis (k4) and hydrolysis (h). Nucleophilic attack of the intermediate by water results 
in hydrolysis of the peptide. The resulting hydrolytic products possess very low acylation 
potential and are therefore, not available for formation of the desired product. Hence, the 
ratio between aminolysis and hydrolysis of the acyl-enzyme ester is of the utmost 
importance for successful peptide synthesis and, for maximum peptide synthesis, k$ should 
be greater than ks. Thus, if a more powerful nucleophile (H2NR') than water is present then
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the desired product will be preferentially formed (R-CO-NH-R1). Formation of the desired 
product is a function of time. After complete consumption of the substrate, the possibility 
of product hydrolysis is high; therefore, the reaction should be stopped at the kinetic 
optimum. Organic cosolvents may be included in the reaction, thereby limiting the 
concentration of water available and decreasing the potential for hydrolytic reactions.
In contrast to equilibrium-controlled synthesis, the kinetic approach requires an acyl donor 
ester (R-CO-X) as the carboxyl component and is limited to those enzymes forming acyl- 
enzyme intermediates i.e. serine and cysteine proteases. Ester substrates are conveniently 
used as the carboxyl components, allowing rapid formation of the acyl-enzyme 
intermediate: hence, a lower enzyme concentration can be used (Jakubke, 1987; Morihara, 
1987; Sears & Wong, 1996; Sewald & Jakubke, 2001).
K.
R CO X +  H E
r
R- X *  H-
O
R CO NH R' +  H E
H2NR'
F R— CO— E intermediate
HX H20
RCOOH +  H E
F ig u r e  1.7. K in e t ic a l l y -c o n t r o l l e d  p e p t id e  s y n t h e s is  c a t a l y s e d  b y  s e r in e  a n d  
c y s t e in e  p r o t e a s e s  (H-E). R-CO-X is carboxyl component, X is OAlk, R-CO-E is the 
acyl-enzyme complex, H2NR' is amino component, R-CO-NH-RN' is peptide product and 
RCOOH is hydrolysis product. Ks is the equilibrium constant for E-S complex formation. 
&2 is the rate constant for formation of the acyl-enzyme intermediate. £3 and Æ4 are the rate 
constants for hydrolysis of the acyl-enzyme intermediate and synthesis of the peptide 
product, respectively (Jakubke, 1987).
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Haensler et al. (1999) used a-Chymotrypsin and papain to catalyse peptide synthesis in 
frozen aqueous systems. They successfully synthesised a number of dipeptides, using 
different nucleophiles, achieving yields up to 90%.
Getun et al. (2001) catalysed the synthesis of tetra-peptides containing multifunctional 
amino acid residues in ethanol using subtilisin. They obtained yields of up to 92%; this 
was dependent on the duration of assay and the acyl donor structure.
Zhou et al. (2003) succeeded in synthesizing the tripeptide Bz-RGD-OEt in a two step 
procedure, utilizing a chemo-enzymatic method, obtaining a 72.5% yield. The first step 
involved chemical synthesis of the Gly-Asp-diethyl ester (OEt)2. Linkage of the third 
amino acid Bz-Arg-OEt to the previously synthesized dipeptide was completed by the 
enzymatic method in organic solvents. This formed tripeptide can act as both an acyl donor 
and as a nucleophile for peptide chain extension directly (without deprotection/activation).
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1.5. Enzyme Catalysis in Aqueous and Non-Aqueous Systems
In previous years, conventional notions assumed that enzymes were active only in water. 
Indeed, it was more or less accepted that organic solvents destabilized protein molecules; 
however, this notion is fast becoming obsolete and in more recent years many solvent 
systems have been employed for non-aqueous enzymatic reactions. These may be divided 
into the following categories: (1) water:water-miscible (hydrophilic) organic cosolvents (2 ) 
water:water-immiscible (hydrophobic, biphasic) organic solvent systems and (3) nearly 
non-aqueous or anhydrous organic solvents (Krishna, 2002). There are a number of 
advantages to using enzymes in organic media, some of which are highlighted in TABLE
1. The catalysis of reactions unfavourable in water, e.g. reversal of hydrolysis reactions 
in favour of synthesis.
2. Solubilization of hydrophobic substrates.
3. Ease of recovery for some products.
4. Enhanced biocatalyst thermostability.
5. Suppression of water-induced side reactions.
T a b l e  1.1. A d v a n t a g e s  o f  u s i n g  e n z y m e s  in  o r g a n i c  a s  o p p o s e d  t o  a q u e o u s  m e d ia  
(Bell et al., 1995)
13
In the natural environment, enzymes function in aqueous solutions and exhibit their 
catalytic properties to the full extent when they have a strictly defined conformation. In 
solution, a network of interactions determines the conformation of an enzyme e.g. hydrogen 
bonding, ionic interactions, van der Waals and hydrophobic forces. Water mediates all of 
the above non-covalent interactions and also acts as a lubricant, allowing the 
conformational mobility required for catalysis. Therefore, in order to maintain these 
interactions, the enzyme molecule requires a definite hydration shell and, thus, removal of 
this hydration shell will result in distortion of the enzyme structure and denaturation 
(Khmelnitsky et al., 1988; Klibanov, 1997; Krishna, 2002). Numerous studies have 
investigated the use of enzymes in organic solvents and the effects of these solvents on 
conformation and function.
Gorman and Dordick (1992) demonstrated that organic solvents had the ability to strip 
water from enzymes (Subtilisin Carlsberg, a-chymotrypsin, HRP) a phenomenon known as 
“water stripping”. In their study, the enzyme bound water exchanged with tritiated water 
(T2O) and they monitored its desoiption into the solvent system under study. Exposure to 
polar solvents resulted in the highest degree of T2O desorption i.e. methanol desorbed 56- 
62% of the bound T2O, whereas exposure to nonpolar solvents resulted in the lowest degree 
of desorption i.e. hexane desorbed 0.4-2% of the bound T2O. They also concluded that at 
least two fractions of enzyme-bound water must exist, as methanol (most polar solvent used 
in this study) managed only to desorb 62% of T2O. Indeed, in lyzozyme four distinct 
hydration levels have been shown to exist (T a b l e  1.2.).
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L e v e l s P r o p e r t ie s
1. 0 - 0.07g H 20 /g  protein H ydration  o f  ionisable (charged) groups
2. 0.07 - 0 .25g H 20 /g  protein Shift in  w ater d istribution on protein  surface from  purely 
ionic sites to polar regions, enzym e becom es m ore mobile.
3. 0.25 -  0.38g H 20 /g  protein E nzym e activity  is observed: w ater approaches m onolayer 
coverage, polar sites hydrated first, follow ed by  nonpolar 
regions.
4. A bove 0 .38g Protein  fully  hydrated. («  300 m olecules o f H 20  per 
enzym e m olecule)
T a b l e  1.2. E n z y m e  h y d r a t io n  l e v e l s  (Reference: Dordick, 1991; Gupta, 1992)
As is clearly seen in the above table, very little water is required for native enzyme 
structure and function to be realised; even so, this bound water is crucial (Dordick, 1991). 
However, the amount of water required to retain activity in organic solvent systems is 
enzyme dependent e.g. a-chymotrypsin needs only 50 molecules of water per enzyme 
molecule to remain active, whilst polyphenol oxidase requires 3.5 x 107 molecules of water. 
Therefore, enzymes should be investigated at various levels of hydration in organic 
solvents, as it may be possible that an enzyme deemed previously to be inactive in an 
organic solvent may have been used at non-optimal levels of hydration (Krishna, 2002). 
Fitzpatrick et al. (1993) compared the crystal structures of subtilisin Carlsberg in water and 
anhydrous acetonitrile. Subtilisin Carlsberg had an identical three-dimensional structure in 
either solvent. They concluded that out of the 119 enzyme-bound water molecules, 99 have 
such affinity to the subtilisin molecule that they are not displaced in anhydrous acetonitrile. 
They also observed that 12 acetonitrile molecules bound to the enzyme surface, displacing 
only 4 water-bound molecules and 8 binding where no water was observed before. 
Klibanov (1997 & 2001) suggested that enzyme stability and retention of catalytic activity
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in anhydrous solvents is in part due to (1) the ability of the enzyme to strongly bind and 
retain some “essential water” and (2 ) the absence of bulk water (which acts as a molecular 
lubricant), thereby leading to a rigid enzyme structure. Thus, even though the drive to 
unfold in these solvents may be great, the pliability and conformational flexibility 
necessary to proceed is lacking.
All solvents are not the same and will exhibit differences in properties such as 
hydrophobicity, hydrogen-bonding capacity and miscibility in water; these in turn will have 
an effect on the enzyme's structural integrity and catalytic activity (Mattos & Ringe, 2001). 
A number of attempts have been made to establish the ideal parameter for the selection of 
organic cosolvents for use in enzymatic reactions. Log P  (P  is the partition coefficient of a 
solvent in a water/octanol biphasic system) is a common parameter used to correlate the 
denaturing efficiency of organic solvents with their hydrophobicity. This parameter 
revealed good correlation with denaturing strength: the higher the log P value, the stronger 
the denaturing effect. However, this parameter is only valid when applied to solvents of the 
same functionality e.g. alcohols. When solvents of a different functionality are included, 
the correlation breaks down (Mozhaev et al., 1989). Khmelnitsky et al. (1991a) developed 
the thermodynamic model of protein denaturation by organic solvents in solution (F ig u r e
1.8.). This model explained the molecular mechanism of the denaturation process, 
establishing a quantitative relationship between the physicochemical properties of organic 
solvents and their denaturing effect, allowing construction of the denaturation capacity 
scale (DC) of organic solvents. Organic solvents are arranged in accordance with their DC 
value, thus forming the scale. This scale can then be used to quantitatively predict the 
threshold concentration (C50) of various organic solvents at which half-inactivation of the 
enzyme is observed.
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Desolvation of hydrated native protein.
2. \
v i  ,  Dehydration of desolvated native
*  protein'wm
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A fftë-éh s.: s.- Solvation of water molecules removed from protein
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■ o y s m -::y
V
Desolvation of organic cosolvent
6.
A
V
Binding of organic cosolvent by 
partially dehydrated protein
Solvation of protein-cosolvent complex
7.
A
V
Dénaturation
F ig u r e  1.8. A s c h e m a t ic  r e p r e s e n t a t io n  o f  t h e  m o l e c u l a r  s t e p s  in v o l v e d  in  t h e
PROCESS OF REVERSIBLE PROTEIN DENATURATION BY ORGANIC SOLVENTS 
(Khmelnitsky et al., 1991a).
1 water molecule, ® organic cosolvent molecule, surrounding solvent.
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There are many advantages to employing enzymes as catalysts in organic as opposed to 
aqueous media ( T a b l e  1.1.) and the stability of certain enzymes is greater in the presence 
of organic media than aqueous media, e.g. the half-life of LST-03 lipase from Pseusomonas 
aeruginosa in «-decane was > 1 0 0  days; in the absence of organic solvent the half-life 
decreased to 12.5 days. However, most enzymes are denatured and inactivated in the 
presence of organic media. Because of this several methods have been devised for 
enhancing the stability of enzymes e.g. immobilization and chemical modification, which 
will be discussed in the next section (Ogino & Ishikawa, 2001).
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1.6. Stability of Proteases
The increasing use of proteins and their stability in-vitro remains a critical issue in 
biotechnology. In particular, the stabilization of enzymes without diminishing and diluting 
their activity is crucial for their use as industrial biocatalysts (Govardhan, 1999).
The complicated structure of proteins renders them subject to chemical and physical 
instability. Chemical instability refers to covalent modifications of the protein molecules 
resulting in the formation of a new chemical entity that can have different biological 
activities. Chemical instability occurs at high temperatures or at extreme pH values. The 
main degradation processes are hydrolysis, oxidation, racemization, elimination of Cys-Cys 
bridges and disulfide exchange. Chemical degradation processes may be controlled by 
adjusting environmental conditions or by adding stabilizers such as sugars or polyols.
The native structure of a protein is usually regarded as the conformation that is exhibited by 
proteins within the cellular environment or by isolated proteins at their maximum biological 
activity. Physical instability is mainly associated with processes that change the local 
spatial arrangement of (1) the protein backbone (2) subunits or (3) three-dimensional 
structures. These spatial changes can lead to dénaturation, aggregation or precipitation; 
however, they do not involve covalent bond breakage, except in disulfide exchange. These 
processes may eventually lead to a loss of biological activity or inactivation (Gianfreda & 
Scarfi, 1991; Sowdhamini & Balaram, 1993; Wong & Parasrampuria, 1997).
Mozhaev (1993) described the reversible and irreversible inactivation of enzymes as:
N  t; D -> I
Where N, D and I represent the native, reversibly denatured and irreversibly inactivated 
forms of the protein, respectively. Reversible dénaturation is a two state-transition unlike 
irreversible inactivation, which is a multi-step process. Reversible dénaturation, also
referred to as thermodynamic stability, is concerned with the resistance of the folded
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protein conformation to dénaturation, while irreversible inactivation measures the protein’s 
long-term stability (O’Fâgâin, 1997a).
Dénaturation studies generally involve exposing the protein of interest to a variation of 
temperature (e.g. heat/cold dénaturation) or the addition of chaotropic agents (e.g. urea, 
guanidine) as a means of inducing unfolding. Once the protein has unfolded, numerous 
factors may lead to irreversible damage to the protein, thereby rendering the protein 
inactive (Sowdhamini & Balaram, 1993).
By definition, stabilization of protein molecules means preventing these changes and 
preserving the native structure of the protein. Assuming that unfolding of the protein is the 
initial and essential step leading to inactivation, extensive research and experimental studies 
have been carried out on different chemical modification methods to approach the problem 
of enzyme stabilization (Gianfreda & Scarfi, 1991).
Chemical modification refers to any chemical alteration of the protein structure, with or 
without changes in biological function (Tyagi & Gupta, 1993). It is a valuable tool for 
altering and extending the activities of enzymes in-vitro. Chemically modifying specific 
functional groups of the protein can lead to an increase in the protein’s stability, improve its 
solubility, alter patterns of inhibition and activation, and change its pH optimum or 
substrate specificity (Hilvert, 1991). A number of chemical modification techniques exist 
which will be discussed in detail including the following: modification with 
monofunctional reagents, cross-linking with bi- or multifunctional reagents,
hydrophilization, immobilisation, coupling to polyethylene glycol (PEG) and aggregation.
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1.6.1. Chemical modification with mono functional reagents
These modifications occur when the free functional groups of the protein react with
monofunctional (small molecular weight) reagents (Tyagi & Gupta, 1993).
Eisner et al. (2000) modified trypsin by succinylation of its lysine residues. This process
did not influence the catalytic behaviour of trypsin; however, succinyl-trypsin displayed
high stability against autodigestion. In particular, modified trypsin retained 100% amidase
activity over a 5-hour period, while native trypsin showed a 95% loss in activity over the 5-
h o u r  p e r io d . T ry p s in  h y d ro ly se s  L -a rg in in y l a n d  L -ly sy l b o n d s  o f  p o ly p e p tid e s . It
undergoes rapid autolytic inactivation at neutral pH due to hydrolysis of these bonds.
However, autolysis may be prevented by chemically modifying the s-amino group of lysine
residues and the guanidine group of arginine residues (Nureddin & Inagami, 1975; &
O’Fagain, 1996b). Succinylation of trypsin results in a change in the surface charge of the
protein. In native trypsin, the ratio of positively charged and negatively charged amino acid
residues is 15/10, in succinyl-trypsin 2/23. Hence, Eisner et al. (2000) hypothesised that
the high stability of succinyl-trypsin was as a consequence of the negatively charged
protein surface. A negative electrostatic field exists in the substrate-binding pocket of
trypsin. This negative field attracts the solvated arginine and lysine substrate side chains
and helps to stabilize their postive charges in the enzyme-substrate complex. Therefore,
changing the charge on the lysine residue by modification will prevent lysine binding in the
negative substrate-binding pocket and hence, prevent autolysis (Briand et al., 1999).
Khajeh et al. (2001) chemically modified lysine residues in two bacterial a-amylases, a
mesophilic enzyme from Bacillus amyloliquefaciens (BAA) and a thermophilic enzyme
from Bacillus licheniformis (BLA) using citraconic anhydride. They observed an
enhancement in the thermostability of the modified mesophilic BAA. In particular, at
80°C, this modified enzyme retained 40% activity over a 10-minute assay period compared
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with native BAA, of which activity fell to less than 5% over the same assay time. A 
dramatic enhancement of activity at 37°C was observed for the modified thermophilic 
BLA, resulting in a 3-fold increase in the kcJ K m (1523 mM/sec) when compared to native 
BLA (486mM/sec).
1.6.2. Chemical cross-linking with bi- or multifunctional reagents
Intermole cular Cross-liiiks
F ig u r e  1..9. Sc h e m a t ic  r e p r e s e n t a t io n  o f  in t e r m o l e c u l a r  c r o s s -l in k in g  
(Katchalski-Katzir, 1993).
This is a support-free method involving covalent bond formation between proteins (same or 
different), or subunits of protein, by means of a bi- or multifunctional reagent (Bickerstaff, 
1997). Bifunctional cross-linking reagents contain two reactive groups (Han et al., 1984). 
They are classified into three categories: homobifimctional, heterobifunctional and zero- 
length (Ji, 1983). Homobifunctional reagents carry two identical functional groups. They 
have been shown to induce cross-linking between identical functional groups e.g. two 
thiols, two amines, two acids or two alcohols, and are predominantly used to form
intramolecular cross-links. However, they have been used to conjugate two different
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biomolecules e.g. an enzyme to an antibody (Ji, 1983). Examples of these reagents include: 
glutaraldehyde, succinimidyl esters, imidoesters, dianhydrides and diisocyanates (Gleich et 
al., 1992). Heterobifunctional reagents contain two dissimilar functional groups e.g. 
photosensitive azide and conventional imidate, allowing the formation of cross-links 
between unlike functional groups (Ji, 1983). The zerolength reagents form a chemical bond 
between two chemical groups without being incorporated themselves into the product. A 
feature of their reaction is a shortening of the distance between the two reacted groups upon 
cross-linking. An example of this type of reagent/reaction is the water-soluble 
carbodiimide 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC). This 
reagent couples a carboxylic acid to a primary amino group, forming an amide bond (Ji, 
1983).
Cross-linking reagents can be used to introduce both intra- and intermolecular bridges into 
proteins. Intramolecular bridges are principally used to stabilize the tertiary structure of 
proteins and are useful in determining the intramolecular distances between groups. 
Intermolecular cross-links may join similar molecules (homopolymers) or dissimilar 
(heteropolymers) together. The products can then be used as models for the study of 
protein interactions e.g. antibody-antigen interactions or hormone-receptor interactions (Ji, 
1983: Han et al., 1984). Ryan et al. (1994) chemically modified horseradish peroxidase 
(HRP) with the homobifunctional cross-linking reagents, suberic acid N- 
hydroxysuccinimide ester (SA-NHS) and ethylene glycol bis-succinimidyl succinate (EG- 
NHS). They observed a 6 - to 23-fold increase in the thermostability of modified HRP 
(depending on the NHS ester used) as compared to native HRP. Native and succinimide 
derivatives of HRP were also studied by Miland et al. (1996). They investigated the 
stability properties of both native and modified HRP in various water/organic solvent
mixtures. In each of the systems tested, increasing the solvent concentration resulted in a
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loss of activity for native HRP; however, modification of HRP resulted in improved 
tolerance in these cosolvent systems, e.g. in a 50% (v/v) THF cosolvent system at 25°C, 
SA-NHS HRP retained 50% of its original activity in comparison to native HRP, where 
activity fell to less than 20%. Both modified peroxidases also exhibited improved 
resistance to the denaturant guanidine hydrochloride.
Cheon et al. (2000) observed from previous work that the homotetramer enzyme D- 
hydantoinase from B. stearothermophilus dissociated to a monomer under operational 
conditions and that the dissociated monomer was very unstable. They hypothesized that 
intersubunit cross-linking of tetrameric D-hydantoinase would reduce the dissociation of 
subunits, and hence stabilise the enzyme. Cross-linking was performed using EDC (1- 
ethyl-3-(3-di-methylaminopropyl) carbodiimide hydrochloride). The cross-linked enzyme 
was shown to exhibit maximum activity at 70°C, considerably higher than the native 
enzyme, where maximal activity was determined at 60°C. They investigated the stability of 
the cross-linked and native enzyme at 55°C, where the calculated half-life was 37 and 9.5 
hours, respectively.
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1.6.3. Hvdrophilization
Structural analysis of proteins by X-ray crystallography suggests that about one half of the 
surface area of a protein is occupied by non-polar amino acids. These residues are very 
often organized as hydrophobic surface clusters, which play an important role in-vivo, 
enabling the protein to bind via hydrophobic interactions to other proteins forming multi­
enzyme complexes, to lipids in biological membranes and to polysaccharides in cell walls. 
However, the contact of these non-polar residues with water is thermodynamically 
unfavourable and can affect protein stability in-vitro. Therefore, reducing the non-polar 
surface area should stabilize the protein (Mozhaev et al., 1988). The process of 
hydrophilization can achieve this. It involves the preferential modification by alkylation or 
acylation of -NH 2 groups on the protein surface, e.g. transformation of protein -NH2 
groups into -NHCH2COOH groups, giving rise to an artificial hydrophilization of the 
surface area of the protein globule and resulting in increased enzyme stability. This effect 
can be explained by a decrease of non-polar clusters located on the protein surface, contact 
of which with water is thought to destabilize the enzyme (Gianfreda & Scarfi, 1991).
T h e  m o d if ic a t io n  c a n  b e  p e rfo rm e d  in  tw o  w ay s: (1 ) h y d ro p h o b ic  a m in o  a c id  re s id u es  are  
d ire c t ly  m o d if ie d  b y  th e  h y d ro p h ilic  re a g e n t  o r  (2 ) a n y  re s id u e  lo c a te d  n e a r  a  n o n p o la r  
su rfa c e  c lu s te r  is  m o d if ie d  b y  th e  h y d ro p h ilic  re a g e n t, o b ta in in g  sh ie ld in g  o f  th e  c lu s te r  
f ro m  th e  a q u e o u s  m e d iu m  ( F i g u r e  1.10.).
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Hydrophilic 
Modifier
Hydrophilic 
M o difier
F i g u r e  1 .10. S c h e m a t i c  r e p r e s e n t a t i o n  o f  a p p r o a c h  t o  h y d r o p h i l i z a t i o n  o f  n o n ­
p o l a r  s u r f a c e  a r e a s  in  A p r o t e i n  (Mozhaev et al., 1988).
Mozhaev et al. (1 9 8 8 ) successfully used this method to artificially hydrophilize trypsin and 
a-chymotrypsin. In a two-step procedure the hydrophilic reagent directly modified the 
surface hydrophobic tyrosine residues of trypsin (F ig u r e  1 .11 .). They determined that 
modified trypsin became up to 100  times more stable to the effects of thermoinactivation. 
In particular, at 56°C, modified trypsin showed 50% residual activity over a 2-hour period. 
In comparison, native trypsin was shown to have less than 10% residual activity over the 
same period. However, Mozhaev et al. (1 9 8 8 ) concluded that the extent of stabilization 
depended exclusively on the number of aminotyrosines introduced; hence, the stabilizing 
effect increased with the number of aminotyrosine residues in trypsin. From spectral 
investigations it was deduced that only four tyrosines are entirely exposed to the solvent 
and can therefore undergo modification more readily than the other tyrosine residues in 
trypsin.
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F ig u r e  1.11. In t r o d u c t io n  o f  a m in o  g r o u p  in t o  t h e  t y r o s in e  r e s id u e s  o f  t r y p s in  
(Mozhaev et al., 1988).
The same report also described the acylation of the amino groups of a-chymotrypsin by 
cyclic anhydrides of trimellitic, pyromellitic and mellitic acids. This allowed a variable 
number of carboxylic groups (up to 5) to be introduced into each lysine residue altered, 
hence bringing about considerable hydrophilization. Mozhaev et al. (1988) observed a 
1 0 0 -1 0 0 0  fold increase in stability against thermoinactivation in modified a-chymotrypsin. 
Khmelnitsky et al. (1991b) hypothesized that hydrophilized enzymes had the ability to hold 
their hydration shell, resisting the denaturing stripping of water from the enzyme surface by 
organic solvents and consequently enhancing their stability in these solvents. They 
modified a-chymotrypsin with pyromellitic dianyhydride and determined that 
hydrophilized a-chymotrypsin could endure much higher concentrations of organic 
solvents without loss of catalytic activity as compared to the native.
Fernández et al. (2002) chemically modified trypsin with monoamino derivatives of a-, p-, 
y-, cyclodextrin (CD) using EDC as a coupling agent. These cyclodextrin-enzyme 
complexes were found to be more stable against thermal incubation at temperatures ranging 
from 45 °C to 60°C when compared to native trypsin; e.g. at 50°C the half-life of trypsin- 
yCD was 108 minutes, whilst native trypsin had a half-life of 16 minutes. These complexes 
were also more resistant to autolytic degradation at pH 9.0. Fernández et al. (2002) 
suggested that this could be associated with steric hindrance of residues to the cleavage
sites in trypsin caused by the bulky cyclodextrin.
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1.6.4. Immobilization
The term “immobilized enzyme” is used to denote a protein that is localized or physically 
confined in a defined region of space, with retention of catalytic activity and which can be 
used repeatedly and continuously. The immobilization of an enzyme closely resembles the 
state of the enzyme within the intracellular microenvironment of living cells and hence, 
provides a model system to study and solve basic problems in enzymology (Gianfreda & 
Scarfi, 1991; Katchalski-Katzir, 1993). Immobilization by multipoint attachment to a 
support may enhance stability and prevent inactivation of the enzyme. The support 
rigidities the protein conformation, thus preventing unfolding and may also stabilize the 
protein by means of steric hindrance and diffusion restrictions (Wong & Parasrampuria, 
1997). Enzymes can be immobilized by a number of methods, which result in: (1) enzyme- 
carrier conjugates, in which the enzyme is adsorbed or covalently bound to its carrier, (2 ) 
entrapment of the enzyme in gels, fibres or beads and (3) chemical aggregation, (Gianfreda 
& Scarfi, 1991; Katchalski-Katzir, 1993).
The chosen immobilization technique should allow retention of enzyme catalytic activity 
while diminishing processes that are detrimental to the enzyme, such as autolysis (Diaz & 
Balkus, 1996). There are a number of advantages associated with this technique. Because 
the enzyme is immobilized, contamination of the product with the immobilized enzyme can 
be avoided, permitting an easier recovery of the product. Better quality products are also 
obtained. Once the product has been recovered the biocatalyst can be re-used. Under 
optimum assay conditions both thermal and storage stability of an enzyme can be increased 
by this method, provided the tertiary and/or quaternary structure of the protein can be 
stabilized (Huckel et al., 1996).
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1 .6 .4 .1 . E n z y m e  im m o b il iz a t io n  b y  c a r r ie r  b in d in g
Solid Support
F i g u r e  1.12. D i a g r a m  s h o w in g  im m o b i l i z a t i o n  b y  c a r r i e r  b in d in g  
(Katchalski-Katzir, 1993).
Yodoya et al. (2003) described the immobilisation of bromelain onto porous copoly (y- 
methyl-L-glutamate/L-leucine) beads. They determined that immobilized bromelain is 
more stable than free bromelain at temperatures of between 60-80°C. Immobilized 
bromelain treated at 65°C for 60 minutes exhibited residual activity 3-4 times that of free 
bromelain. The storage stability of bromelain increased significantly upon immobilisation. 
Yodoya et al. (2003) observed that storage of immobilized bromelain at 4°C for 6 months
resulted in no significant loss of activity, whereas free bromelain lost more than 50% of its
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initial activity under the same conditions. They concluded that the increase in stability of 
immobilized bromelain could be attributed to the prevention of autolysis and thermal 
denaturation by covalent immobilisation of bromelain molecules on the surface of the 
beads.
Danisman et al. (2004) used this method to immobilise invertase onto a poly (2- 
hydroxyethyl methacrylate-glycidyl methacrylate) (pHEMA-GMA) membrane. The effect 
of immobilisation on thermal and pH stability was investigated. Differences were observed 
in the optimum temperature for immobilized and free invertase at 55°C and 45°C, 
respectively. Immobilized invertase incubated at 50°C for 90 minutes remained stable with 
no observed loss in activity; however, free invertase, lost 10% of its initial activity under 
the same assay conditions. Half-lives of the free and immobilized enzyme were 11 and 38 
minutes at 70°C, respectively. The optimum pH value for free invertase was obtained at 
pH 5.0, whilst the optimum pH for immobilized invertase was shifted 1.5 pH units to the 
alkaline region.
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1.6 .4 .2 . E n z y m e  e n t r a p m e n t
Enzyme entrapment differs from adsorption and covalent binding in that the enzyme 
molecules are free in solution but are restricted in movement by the lattice structure of the 
gel (Bickerstaff, 1997). The entrapment of an enzyme may be achieved by one of two 
methods, either a cross-linked polymeric network must be formed around the enzyme 
molecule or the enzyme is placed inside a polymeric material and then cross-linking of the 
polymer chains is performed ( F ig u r e  1.13.) (O’Driscoll, 1976).
Enzyme 
Matrix 
Entrapped in Matrix
F i g u r e  1.13. D i a g r a m  s h o w in g  e n z y m e  e n t r a p m e n t  in  s e m i- p e r m e a b le  p o ly m e r  
m e m b r a n e  (fCatchalski-Katzir, 1993).
Munjal and Sawhney (2002) used this method to immobilise mushroom tyrosinase in
alginate, gelatin and polyacrylamide gels. The effect of immobilisation on thermal and pH
stability was investigated. Differences were observed in the optimum temperature for
immobilized and free tyrosinase. The maximum activity of the alginate- and gelatin-
entrapped preparations was obtained at 35 and 40°C, respectively, as compared to 20°C for
free enzyme. At 40°C, gelatine-entrapped tyrosinase retained 83% of its initial activity
after 1 hour, while the free form retained only 58% of its initial activity during the same
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period. The enzyme entrapped in polyacrylamide and alginate gels exhibited broader pH 
activity profiles, while a shift of pH optima toward the alkaline side was observed in the 
case of gelatin-entrapped tyrosinase.
Cetinus and Oztop (2003), immobilized catalase into chitosan beads prepared in a cross- 
linking solution. The formation of a cross-linked network decreases the enzyme’s mobility. 
Various characteristics of immobilized catalase were evaluated including kinetic 
parameters. The value of Km for free and immobilized catalase was found to be 35mM and 
77.5mM, respectively, while the Vmax was calculated as 32,000(J.mol (min mg protein)'1 and 
122|nmol (min mg protein)'1, respectively, for the free and immobilized enzyme. Qetinus 
and Oztop (2003) noted that the significant differences observed with these kinetic 
parameters before and after immobilisation of the enzyme could be attributed to a number 
of factors, namely, structural changes in the enzyme upon immobilisation and lower 
accessibility of the substrate to the active site due to steric hindrance by the support. Both 
enzymes showed an optimum pH of 7.0 at 35°C; however, immobilized catalase had a 
broader pH-activity range.
Chen and Lin (2003) investigated the effects of immobilization of lipase in a sol-gel matrix. 
The thermal stability of lipase increased 5 5-fold upon entrapment when compared to free 
lipase, the half-life (t/2) also increased from 49.9 to 2740 hours, at 35°C after 
immobilisation.
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1 .6 .4 .3 . C h e m ic a l  a g g r e g a t io n
The aggregation method involves using high concentrations of cross-linking agents to 
produce an insoluble aggregate of enzymes. The formation of this aggregate is attributed to 
both intramolecular and intermolecular cross-links in the protein molecule. This method 
has also been used to retain proteins on the surface of porous materials, thereby anchoring 
the protein onto its matrix. It has also been used together with inclusion to increase the 
mean size of enzyme molecules entrapped in a gel or microcell, allowing the use of lager 
gel pore sizes and reducing diffusion constraints (Broun, 1976; Khare et al., 1991; Tyagi et 
al., 1999).
Tyagi et al. (1999) used glutaraldehyde to prepare chemical aggregates of three enzymes, 
i.e. acid phosphatase, (3-glucosidase and polyphenol oxidase. They investigated the thermal 
and solvent stability of the native and modified forms. An enhancement in thermal stability 
was observed for the modified forms. They also determined increased C50 values 
(concentration of organic cosolvent required to inactivate the enzyme by 50%) for the 
modified enzymes in the co-solvent systems tested (acetonitrile, DMF & THF), each at 
50% (v/v).
A more recent technique known as cross-linked enzyme crystal technology (CLEC®), 
involves the cross-linking of enzymes in their crystalline state to produce particles which 
are insoluble in both water and organic solvents. This process consists of two major steps: 
first, the crystallization of the enzyme followed by the chemical cross-linking of the 
crystals with a suitable cross-linking reagent (e.g. glutaraldehyde) in such a manner that 
protein activity is maintained and the crystalline lattice is not disrupted. This process 
results in both stabilisation and immobilisation of the enzyme without dilution of activity. 
Channels formed within the CLEC® allow for easy diffusion of substrates and products.
(Govardhan, 1999; Kim et al., 2003; O’Fagain, 2003).
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Kim et al. (2003) used this method to synthesise CLECs of cyclodextrin glucanotransferase 
(CGTase). They studied the effect of temperature on the stability of CGTase-CLECs and 
soluble CGTase. At 70°C CGTase-CLECs retained more than 70% of its original activity 
as compared to soluble CGTase, where an 85% loss in activity was exhibited at the same 
temperature. Soluble CGTase exhibited no activity at 80°C whilst CGTase-CLECs 
retained 48% of its original activity at the same assay temperature. They also investigated 
the activity of both enzymes in 15% (v/v) solutions of water miscible organic solvents. The 
cross-linked enzyme was found to be stable in all of the tested solvents (2-butanol, DMSO, 
formamide, isopropanol) retaining more than 80% of its original activity, whereas soluble 
CGTase lost more than 50% of activity in the same solvents.
1 .6 .4 .4 . P E G y l a t io n  o f  b n y z m e s
Enzymes are becoming the main tools for specific bioconversion in organic synthesis; 
however, they suffer from insolubility in most organic solvents (Veronese, 2001). Linking 
an enzyme to the amphipathic compound polyethylene glycol (PEG) has led to solubility in 
both aqueous solutions and organic solvents. The solubility of enzymes in organic solvents 
is due to the strongly hydrated PEG chains creating an aqueous shell around the enzyme 
molecule thus protecting it from denaturation by the organic solvent (Ogino & Ishikawa, 
2001). It has been found that PEG-modified enzymes are also generally more stable 
against temperature that their native counterparts (Zhang et al., 1999). Attachment of the 
long-chain PEG molecule to an enzyme molecule surface may make the protein less 
flexible, thus minimizing unfolding and thereby enhancing the stability of the enzyme at 
high temperatures (Yang et al., 1996).
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F ig u r e  1.14. E n z y m e  [E ] m o d if ic a t io n  w it h  c y a n u r ic  c h l o r id e  a c t iv a t e d  PEG 
(Yang et al., 1996).
Zhang et al. (1999) used four activated methoxypolyethylene glycols (MPEG, molecular 
masses 350, 750, 2000 and 5000), to modify trypsin. They investigated the thermal 
stability of native and modified trypsin over the temperature range of 30°C to 70°C and 
found that all four MPEG-modified enzymes showed enhanced thermal stability as 
compared with the native enzyme. Thermal stability of the modified enzyme was found to 
increase with increasing molecular mass of the MPEG moiety. T50 (temperature required to 
inactivate enzyme by 50%) values were determined and ranged from 47°C for native 
trypsin up to 6 6 °C for MPEGsooo-trypsin. A decrease in the rate of autolysis was observed 
for modified trypsin. While native trypsin retained only 20% of its initial activity at 60°C 
after 90 minutes, modified trypsin retained 28, 36, 57 and 63% of its initial activity for all 
four MPEG-trypsin, respectively.
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1.7. Protein Engineering
Protein engineering involves using genetic manipulation techniques to alter the protein of 
interest in specific ways. This can be accomplished by site-directed mutagenesis, random 
mutagensis and directed evolution. Site directed mutagenesis allows the introduction of 
one or more defined changes at a time. Random mutagenesis is a broader method of 
introducing changes into the enzyme and involves the introduction of random mutations 
followed by screening the resultant mutants. These methods have been used to improve 
enzyme stability, substrate specificity and to create novel and efficient catalysts (Sears & 
Wong, 1996; O’Fagain, 1997c). Sears and Wong (1996), Van Den Burg and Eijsink (2002) 
and Torrez et al. (2003) have all written reviews dealing with this area.
1.8. Application of Proteases
Enzymes have been used in the industrial field for many applications e.g. brewing, animal 
feeds and detergents. The composition of dirt and stains on most clothes includes lipids, 
carbohydrates, proteins, dyes, soil and small inert particles. Normal detergents do not 
remove proteinaceous stains. However, the addition of enzymes such as bacterial alkaline 
proteases e.g. subtilisins from Bacillus licheniformis and Bacillus amyloliquifaceins has led 
to better cleansing power of these detergents by hydrolytic degradation of difficult protein- 
containing solids, e.g. blood, egg-yolk and chocolate (Khaparde & Singhal, 2001). 
Developments in molecular biology have led to the application of proteolytic enzymes as 
therapeutic agents. Proteases have been used as an alternative to mechanical debridement, 
to aid in the removal of dead skin in bums patients. Success of this treatment was variable, 
possibly due to the poor stability of the enzymes used. However, recombinant vibriolysin, 
a proteolytic enzyme from Vibrio proteolyticus, a marine micoorganism, was assessed
topically in phase 1 clinical trials, for use as a debridement agent. Tolerability and
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effectiveness of this topically applied enzyme for the debridement of bums has shown 
encouraging results (Vellard, 2003).
As industrialization of the planet has grown, so too has concern for the environment. 
Hence, finding more benign methods for the production and provision of services has led to 
further interest in enzymes. A number of examples exist where the use of enzymes has 
made a significant difference environmentally: laundry detergents where phosphates have 
been replaced with enzymes (proteases) and breadmaking where lipases have replaced 
chemical emulsifiers. This list is evergrowing and will continue to bring with it significant 
medical, social and environmental benefits (Cherry & Fidantsef, 2003).
This research describes the investigation and possible applications of two interesting 
candidate proteases, a proline-specific serine protease dipeptidyl peptidase IV (DPP IV) 
and a recombinant parasite cysteine protease cathepsin LI (rFheCLl), neither of which 
undergo autolysis.
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1.9. Mammalian Dipeptidyl Peptidase IV (DPP IV)
Dipeptidyl peptidase IV [DPP IV, EC 3.4.14.5] was first discovered by Hopsu-Havu and 
Glenner (1966) in rat homogenates and in commercial enzyme preparations as an activity 
liberating naphthylamine from Gly-Pro-2-naphthylamide and was initially termed 
glycylproline naphthamidase (Mentlein, 1999). It has also been known under different 
names such as "dipeptidyl aminopeptidase IV", "post-proline dipeptidyl aminopeptidase 
IV", "X-Pro dipeptidyl aminopeptidase" and "Gly-Pro naphthylamidase" (Sentandreu & 
Toldra, 2001).
Since the amino acid sequence Gly-Pro is frequently found in collagens, a possible
metabolic significance in collagen metabolism was proposed. However, the enzyme is
unable to cleave Pro-Pro or Pro-Hyp bonds which mostly follow the Gly-Pro sequence in
collagens and hence the physiological functions of dipeptidyl peptidase IV remained
obscure for many years (Mentlein, 1999). Dipeptidyl peptidase IV has been isolated from
various mammalian species and is present in most vertebrate tissues and body fluids;
however, their activities often vary (Mentlein, 1999). The enzyme fulfils a variety of
functions including the activation and inactivation of a number of bioactive peptides, e.g. P-
casomoiphin and substance P (Lambeir et al., 2003). Inhibition of DPP IV activity
increases insulin secretion, improving glucose control in diabetics. Thus, inhibition of DPP
IV is a promising new strategy for treating type 2 diabetes (Rasmussen et al., 2003)
The entire amino acid sequence of DPP IV for human, rat and mouse have been determined
by cDNA cloning and sequencing. CD 26, a surface marker of T lymphocytes was found to
be identical to DPP IV. DPP IV is a homodimeric type II transmembrane glycoprotein
located on the surface of tissues. The enzyme is anchored to the membrane by a single
hydrophobic helix with a short N-terminal cytoplasmic tail. The extracellular domain
consists of a flexible stalk linking the membrane anchor to a highly glycosylated region
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mostly in the N-terminal half, a cysteine rich region within the C-terminal half and the C- 
terminal catalytic domain (F ig u r e  1.15.).
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F ig u r e  1 .15. S c h e m a t ic  r e p r e s e n t a t io n  o f  DPP IV/CD 26
This picture shows the main structural features along with the vertical bar, which highlights 
the primary structure and shows the positions of the active site residues as well as the 
borders of the extracellular domains. For the catalytic domain, an a/p protein fold is 
hypothesized (top): a core a/p-sheet comprising eight strands (arrows), linked by helices 
(cylinders) and loops (lines). The dotted lines indicate possible insertions and catalytic 
residues are situated on loops. Figure reproduced from DeMeester et al., 1999.
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Proteolytic cleavage of the membrane bound DPP IV results in a soluble protein migrating 
as a homodimer with a molecular weight range of 210-290kDa. Both membrane-bound and 
the soluble forms show identical enzymatic activity (Lambeir et al., 1997; Engel et al., 
2003; Lambeir et al., 2003; Rasmussen et al., 2003).
The fully glycosylated crystal structure of human DPP IV has been solved and reported by 
Rasmussen et al. (2003). The subunits of the DPP IV homodimer consist of two domains; 
(1) a/p-hydrolase domain and (2) (3-propeller domain. Between these two domains is a 
large cavity of » 30-45 A  in width where the active site is situated. Accessibility to the 
active site is possible via two openings: (1) from the top of a central tunnel (4 A) in the 
centre of the propeller domain and (2) from a large “cave” (more than 20 A) located on the 
side between the hydrolase and propeller domain (Engel et al., 2003; Hiramatsu et al., 
2003; Rasmussen et al., 2003). Hiramatsu et al. (2003) hypothesised that substrates gain 
access to the catalytic site cavity via the large “cave”. They consider that this is more 
probable due to its large size and also because the catalytic site centre is more exposed to 
the centre of the large “cave” than to entry via the central tunnel (F ig u r e  1.16.). However, 
further experiments are needed to verify this.
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F ig u r e  1.16. R ib b o n  D ia g r a m  o f  DPP IV
DPP IV forms a homodimer, (subunit A shown in green and subunit B in blue). Each 
subunit consists of two domains: an a/(3-hydrolase domain and a P-propeller domain. The 
a/p-hydrolase domain located closest to the membrane contains the active site triad. N = 
amino termini and C = carboxyl termini. Figure reproduced from Rasmussen et al., 2003; 
Thoma et al., 2003).
Investigations into the structure of the active site have revealed how substrate specificity is 
achieved. DPP IV preferentially cleaves dipeptides with a penultimate Pro or Ala from the 
N-terminus of oligopeptides (F ig u r e  1.17.). The hydrophobic pocket (Si) is situated next 
to the active serine, as a consequence only amino acids with smaller side chains (proline, 
alanine and glycine) will be accommodated into this narrow pocket, limiting the possible 
residues at the Pj position in substrates (Rasmussen et al., 2003). This pocket is formed by 
a number of amino acids, which give a well-defined shape, and is better filled by proline 
than by alanine residues. Glycine is also accepted but with very low kcJ K m values.
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Therefore, this is a feature in the determining the preference of DPP IV for a proline 
preceding the scissile bond. Side chains of the residues situated at P2 and Pi' point into the 
large cavity and no specific interactions with DPP IV occur. This explains why DPP IV 
has no specific substrate requirements for amino acids in these positions; hence a large 
diversity of amino acids is possible at these positions (Engel et al., 2003; Rasmussen et al., 
2003; Thoma et al., 2003). Knowing the substrate preference of DPP IV enables one to 
choose the most suitable ester substrates and nucleophiles for peptide synthesis utilising 
this enzyme.
N-terminal Substrate C-terminal
F ig u r e  1 .17. S c h e m a t ic  R e p r e s e n t a t io n  o f  a n  En z y m e -S u b s t r a t e  C o m p l e x  
S c h e c h te r -B e rg e r  n o ta tio n  fo r  b in d in g  s ite s  in  se rin e  p ro te a se s . S u b s tra te  re s id u e s  a re  
d e n o te d  a c c o rd in g  to  th e ir  d is ta n c e  f ro m  th e  sc iss ile  b o n d  a n d  th e ir  lo c a tio n  o n  th e  N - 
te rm in a l o r  C -te rm in a l s id e  o f  th e  sc is s ile  b o n d  (P), P]', re sp e c tiv e ly ) , th e  su b s ite s  o n  th e  
e n z y m e  a re  s im ila r ly  d e s ig n a te d  (S i ,  S i ') .  T h e  sc iss ile  b o n d  is  lo c a te d  b e tw e e n  th e  P] an d  
P i' (F e rsh t, 2 0 0 2 b ).
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1.10. Fluke (Fasciola hepatica) Cathepsin LI
The helminth parasite Fasciola hepatica is the causative agent of liver fluke disease in 
cattle and sheep and has recently emerged as an important pathogen of humans. This 
infection causes a loss of millions to the agricultural sector worldwide. The protease 
cathepsin L [3.4.22.15] a lysosomal cysteine protease belonging to the papain superfamily 
is secreted by this parasite. It plays an important role in many aspects of its pathogenicity, 
such as nutrient acquisition by catabolizing host proteins to absorbable peptides. Cathepsin 
L also cleaves matrix proteins such as fibronectin and collagen thereby facilitating the 
migration of this parasite through host tissue e.g. liver and intestine and has been implicated 
in the inactivation of host immune defences by cleaving immunoglobulins. (Dowd et al., 
1994; Dowd et al., 2000; Dalton et al., 2003; Collins et al., 2004). Cathepsin L has been 
isolated from mammalian tissues such as rabbit, human and rat liver (Mason et al., 1984; 
Mason et al., 1985; Bromme et al., 1993). The enzyme is also present in vertebrate tissues 
(fish) such as Carp hepatopancreas (Aranishi et al., 1997).
Cathepsin L has only endopeptidase activity and preferentially cleaves peptide bonds with 
hydrophobic amino acid residues in P2 and P3 sites (Mort, 1998). It is synthesised as 
procathepsin L, and requires activation to the active monomer. Activation involves 
regeneration of the reactive thiol fuction (blocked as disulfide or metal complex) by 
addition of activators such as DTT together with chelate forming reagents e.g. EDTA 
(Creighton, 1993b). The crystal structure of human cathepsin L reveals that it contains two 
domains, (1) a-helical domain and (2) (3-barrel domain. The domains separate on the top in 
a “V”-shaped active site cleft. The catalytic cysteine residue is situated at the top of the 
central a-helix and faces the catalytic histidine residue, forming the active site (FIGURE 
1.18.) (Guncar et al., 1999; Turk et al., 2002).
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Active site cleft of cathepsin L
barrel domain
a -  helical domain
V
F ig u r e  1 .18 . R ib b o n -d ia g r  a m  o f  h u m a n  c a t h e p s in  L
The picture shows the a-helical domain on the left side, the (3-barrel domain on the right 
side of the picture and the active site opening at the top between the two domains. N = 
amino terminus and C = carboxyl terminus. Figure reproduced from Turk et al., 2002.
Substrates bind along the active site cleft in an extended conformation. The S2, Si and ST 
binding sites are well defined, whereas S3 and S2' ones are less well defined. The ST and 
S2 binding sites are largely responsible for the specificity of the enzyme, with the S2 site 
being the major determinant. This subsite is a deep hydrophobic pocket, which 
accommodates large hydrophobic residues at the P2 position (Fujishima et al., 1997; Turk 
et al., 2002). Cathepsin L favours substrates with small amino acid side chains (Ala, Ser) 
or long but non-branched (Asn, Gin, Lys) at the P i' position (Menard et al., 1993). 
Specificity of the enzyme for amino acids at this position is an important and deciding 
factor when considering suitable nucleophiles for use in peptide synthesis.
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1.11. DPP IV and rFheCLl as candidates for study
Considering the cheap and ample supply of the crude materials from which both dipeptidyl 
peptidase IV (DPP IV) and cathepsin L enzymes are sourced, investigation of their stability 
characteristics and classic enzyme kinetics in-vitro has been neglected to date. Due to the 
high selectivity of many proteases and their inability to cleave peptide bonds involving 
proline, it is not surprising that specific enzymes are involved in the cleavage of proline- 
containing peptide bonds, although they are few in number. Therefore, it was deemed a 
worthwhile project to investigate these stability and kinetic parameters for DPP IV, owing 
to its substrate specificity towards proline-containing bonds. This enzyme can also be 
considered as a suitable candidate to catalyse peptide synthesis, as the active site of many 
enzymes may not fit the bulky amino acid proline residue.
The development of a potential liver fluke vaccine targeting the fluke {Fasciola hepatica) 
cathepsin LI protease is being undertaken at present. Yeast systems have been successfully 
employed for high-level expression of recombinant Fasciola hepatica cathepsin LI 
(rFheCLl) with a view to targeting vaccines against the recombinant enzyme (rFheCLl). 
Therefore, elucidating the stability characteristics (pH, temperature, solvent) of this 
recombinant enzyme is essential for comparison to fluke (Fasciola hepatica) cathepsin LI 
and also ascertaining its shelf-life as stability is a key attribute of any vaccine. The notable 
stability of fluke {Fasciola hepatica) cathepsin LI makes rFheCLl a useful candidate for 
chemical modification and peptide synthesis. Also, a review of the literature has indicated 
that very few cysteine proteases have been used for enzymatic peptide synthesis when 
compared with serine proteases, again making this enzyme a suitable candidate for 
enzymatic peptide synthesis.
The aims of the research described in this thesis involve exploring and elucidating the
stability of bovine serum dipeptidyl peptidase IV (DPP IV) and recombinant Fasciola
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hepatica cathepsin LI (rFheCLl). DPP IV was fully investigated with regards to the 
stability of the enzyme at elevated temperatures (Results; section 4.1.2.), and in the 
presence of organic solvents commonly used in peptide synthesis (Results; section 4.1.3.). 
The effect of pH on the enzyme’s stability and kinetic parameters was also determined at 
acidic, neutral and alkaline pH (Results; section 4.1.4.). The stability characteristics of both 
native and chemically modified rFheCLl were studied. The effect of exposing both forms 
of the enzyme to increasing temperatures (Results; section 5.2.4 & 6.2.4., respectively) and 
organic solvents (Results; section 5.2.5. & 6.2.5., respectively) was fully elucidated and a 
comparison made. Hence, the direct effect of chemical modification upon the enzyme was 
determined. Chapter seven clearly outlines the usefulness of rFheCLl with regards to 
enzymatic peptide synthesis.
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C ha pter  2 
Material  a n d  M e th o d s
2 .1 . E q u i p m e n t
Centrifugations were performed using an ALC Multispeed PK 121 bench centrifuge 
(modification studies) and Beckman J2-MC high-speed centrifuge (serum isolation). Gel 
electrophoresis was performed using a Biorad Mini Gel Box with ATTO vertical 
electrophoresis system and power pac 1000. Images of gels were taken with Plustek 
OpticPro 482p scan maker (DPP IV) or Pharmacia Biotech Imagemaster® Video 
Documentation System for gel electrophoresis (rFheCLl). Enzyme and protein assays 
were performed using a Perkin Elmer LS-50 Luminescence Spectrometer, Unicam2 
UV/Vis spectrophotomer and Labsystems Multiskan MS microplate reader. A Coming pH 
Meter 240 determined pH of buffers and solutions. LC-MS analysis utilised a Bruker Mass 
Spectrometer with electrospray ionisation and ion-trap detector linked to a Hewlett-Packard 
Esquire Liquid chromatograph 1100 with photo diode array detector.
2 .2 . M a t e r i a l s
Suppliers of key chemicals used in these studies are listed below.
Amersham Biosciences UK Ltd., Bucks, England.
Sephadex™ G-25 Superfine
Bachem Feinchemikalein AG (Bebendorf, Switzerland)
Gly-Pro-AMC-HBr, Z-Lys-ONp HCl, Z-Phe-Arg-AMC-HCl, Z-Phe-Arg-OMe-HCl, H- 
SerNHrHCl
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Sodium sulphite
Fisher Scientific UK Ltd., Loughborough, England.
Acetic acid glacial, acetone, acetonitrile HPLC grade, dimethylformamide HPLC grade 
(DMF), diaminoethanetetra-acetic acid (EDTA), ethanol 100% (v/v), glycerol, hydrochloric 
acid (HC1 37%, (v/v)), sodium acetate anhydrous, sodium chloride (NaCl), sodium 
hydroxide (NaOH), tetrahydrofuran HPLC Grade (THF), Tris-(hydroxymethyl) 
aminomethane (Tris).
Kepak Meats (Clonee, Co. Meath, Ireland)
Bovine Whole Blood
Pierce Chemical Company, Illinois, USA.
BCA (Bicinchoninic acid) Protein Assay Kit, GelCode®, Blue Stain Reagent.
Riedel-de-Haen, Laborchemikalien, GmbH.
Acetonitrile CHROMASOLV®, water CHROMASOLV®.
Sigma Chemical Company (Poole, Dorset, England)
2-Mercaptoethanol, 7-amino-4-methylcoumarin (AMC), Acrylamide/bis-Acrylamide 30%
(w/v) solution, Na-Acetyl-L-Lysine, albumin bovine serum (BSA), ammonium acetate,
ammonium persulfate, ammonium sulfate, borax, Bradford reagent, brilliant blue R,
bromophenol blue, cellulose membrane dialysis tubing (33mm x 21mm), 2-[N-
Cyclohexylamino] ethane-sulfonic acid (CHES), dimethylsulfoxide HPLC grade (DMSO),
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BDH Limited Ltd., Poole, Dorset, England
DL-dithothreitol (dl-DTT), iran,s-epoxysuccmyl-L-leucylamido-(4-Guanidino)-butane (E- 
64), ethylene glycol-bis(succinic acid N-hydroxysuccinimide ester) (EG-NHS), glycine, N- 
[2-Hydroxyethyl]piperazine-N'-[2-ethane-sulfonic acid] (HEPES), 2-[N-Morpholino] 
ethanesulfonic acid (MES), 3-[N-Morpholino] propanesulfonie acid (MOPS), 
pierylsulfonic acid (2,4,6-Trinitrobenzenesulfonic acid; TNBS), phenyl-Sepharose® CL- 
4B, polyethylene glycol (m.w 10,000), potassium phophate monobasic (KH2PO4), 
potassium phosphate dibasic (K2HPO4), quaternary-Sepharose fast flow anion exchanger, 
Sephacryl S-300-HR, sodium bicarbonate, sodium dodecyl sulfate (SDS), sodium 
phosphate monobasic (NaH2P0 4 ), SigmaMarker™ low range (m.w. 6,500- 66,000), 
SigmaMarker™ wide range (m.w. 6,500-205,000), total protein reagent, trypsin (Bovine), 
N,N,N',N' -tetramethylene-ethylenediamine (TEMED).
All reagents were analytical reagent grade unless otherwise stated.
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2.3.1. P u r i f i c a t i o n  o f  B o v i n e  S e r u m  D i p e p t i d y l  P e p t i d a s e  IV (DPP IV)
2.3. P u r i f i c a t i o n  a n d  A c t i v a t i o n
The purification of dipeptidyl peptidase IV (DPP IV) was based on the method of Buckley 
et al., (2004) and includes the following steps in sections 2.3.1.1, 2.3.1.2, 2.3.1.3 and
2.3.1.4.
2.3.1.1. Serum Preparation
Bovine whole blood was collected from a freshly slaughtered animal and transported to a 
4°C cold room. A clot was allowed to form and shrink over 24 hours. The remaining 
unclotted whole blood was then decanted and centrifuged at 6000 rpm for 1 hour using a 
Beckman J2-MC refrigerated centrifuge fitted with a JL-10.5 rotor (radius 10cm). The 
supernatant and loose cellular debris was decanted and re-centrifuged at 2 0 ,0 0 0  rpm for 15 
minutes at 4°C using a JL-20 rotor (radius 6cm). The serum thus produced was collected, 
pooled and stored in 20ml aliquots at -20°C.
2.3.1.2 Phenyl Sepharose Hydrophobic Interaction Chromatography (HIC)
A 30ml phenyl-Sepharose® CL-4B hydrophobic interaction column (2.5cm x 13cm) was 
equilibrated with 100ml 50mM HEPES, pH 8.0, containing 5mM EDTA and 1M 
ammonium sulphate at a flow rate of 2ml/min. A 20ml aliquot of crude serum was thawed 
at 37°C and solid ammonium sulphate was added to give a final ammonium sulphate 
concentration of 0.5M. Salted serum (20ml) was applied to the equilibrated column 
followed by a 100ml wash of the equilibration buffer to elute any unbound protein. Bound 
protein was eluted using a 50ml linear gradient of 50mM HEPES, pH 8.0, containing 5mM
EDTA and 1M ammonium sulphate to 50mM HEPES, pH 8.0, containing 5mM EDTA. A 
further 50ml wash of 50mM HEPES, pH 8.0, containing 5mM EDTA ensured all bound 
protein was eluted. Fractions (4ml) were collected throughout the run. Loading, washing 
and elution steps were earned out at a flow rate of 1.5ml/min. Fractions were assayed for 
DPP IV activity as described in section 2.4.3. Protein was determined using the Biuret 
assay as described in section 2.4.2.1. Fractions containing Gly-Pro-AMC degrading 
activity were combined and the volume recorded to yield post-phenyl Sepharose DPP IV. 
The phenyl-Sepharose resin was regenerated with a 100% ethanol (v/v) wash and then re­
equilibrated with 100ml 50mM HEPES, pH 8.0, containing 5mM EDTA and 1M 
ammonium sulphate at a flow rate of 2ml/min.
2.3.1.3. Sephacryl S-300 High Resolution (HR) Gel Filtration Chromatography
The post-phenyl-Sepharose DPP IV (typically 35ml) was dialysed against 50mM HEPES, 
pH 8.0, containing 5mM EDTA (2 litres) for a minimum of 3 hours at 4°C to remove 
interfering salts. The dialysed sample was then concentrated via osmosis using solid 
polyethylene glycol. Glycerol was added to the concentrated sample to give a final 
glycerol concentration of 10% (v/v). The 100ml Sephacryl S-300-HR gel filtration column 
was equilibrated with 200ml 50mM HEPES, pH 8.0, containing 5mM EDTA at a flow rate 
of 2ml/min. The concentrated sample was loaded under the buffer head and the column 
washed with 150ml equilibration buffer at a flow rate of 1.5ml/min. Fractions of 5ml were 
collected and assayed for DPP IV activity as described in section 2.4.3. Protein was 
determined using the standard BCA assay as described in section 2.4.2.2. Fractions 
containing Gly-Pro-AMC degrading activity were combined and the volume recorded to 
yield post-Sephacryl S-300 DPP IV and stored at 4°C.
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2.3.1.4. Quaternary (Q) Sepharose Strong Anion Exchange Chromatography
The post-Sephaeryl S-300 DPP IV was concentrated via osmosis using solid polyethylene 
glycol. A 30ml Q-Sepharose strong anion exchange column (2.5cm x 13cm) was 
equilibrated with 100ml 50mM HEPES, pH 8.0, containing 5mM EDTA. The concentrated 
sample was applied onto the column followed by a 100ml wash with equilibration buffer. 
Bound protein was eluted using a 50ml linear gradient of 50mM HEPES, pH 8.0, 
containing 5mM EDTA to 50mM HEPES, pH 8.0, containing 5mM EDTA and 0.5M NaCl. 
A further 50ml wash of 50mM HEPES, pH 8.0, containing 5mM EDTA and 0.5M NaCl 
ensured all bound protein was eluted. Fractions (4ml) were collected throughout the run. 
Loading, washing and elution steps were carried out at a flow rate of 1.5ml/min. Fractions 
were assayed for DPP IV activity as described in section 2.4.3. Protein was determined 
using the standard BCA assay as described in section 2.4.2.2. Fractions containing Gly- 
Pro-AMC degrading activity were combined and the volume recorded. The post-Q- 
Sepharose DPP IV pooled fractions (typically 50ml) were dialysed against 50mM HEPES, 
pH 8.0, containing 5mM EDTA (2 litres) for a minimum of 3 hours at 4°C to remove 
interfering salts and stored at -20°C until required. The Q-Sepharose resin was regenerated 
with 2M NaCl and re-equilibrated with equilibration buffer. Future reference to purified 
DPP IV indicates post-Q-Sepharose DPP IV.
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2.3.2. A c t i v a t i o n  o f  rFasciota hepatica Cathepsin LI (rFheCLl)
Mr Peter Collins, Parasitology Research Group, formerly based at Dublin City University 
performed the purification step and generously supplied purified unactivated recombinant 
Fasciola hepatica Cathepsin LI (rFheCLl) as a gift. rFheCLl was activated to a protein 
concentration of 0.1 mg/nil preparation based on a method by . Example of activation 
procedure:
Composition
rFheCLl (0.5mg/ml) 
DTT(lOOmM) 
EDTA (500mM)
Volume
0 .1ml 
0.04ml 
0 .0 1 ml
These solutions were combined and made up to total volume of 0.5ml with 0.1M sodium 
acetate, pH 5.0. The solution was then incubated at 37°C for 2 hours, when the preparation 
was stored at -20°C until use.
Final Concentration
0.1 mg/ml 
8m M 
lOmM
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2 .4 .1 . F l u o r e s c e n c e  Q u a n t i f ic a t io n  o f  7 -A m i n o -4 - M e t h y l - C o u m a r in
2.4.1.1. AMC Standard Curves
AMC (lOmM in 100% DMSO (w/v)) was diluted to 100/xM using 50mM HEPES, pH 8.0, 
containing 5mM EDTA when analysing dipeptidyl peptidase IV (DPP IV) or 0.1M sodium 
acetate, pH 5.0 containing 2mM DTT and 2.5mM EDTA when analysing recombinant 
Fasciola hepatica cathepsin LI (rFheCLl). Stock solutions were stored in brown glass 
containers at 4°C to minimise any fluorescence. To form standard curves of 0-15/xM, lower 
AMC concentrations were prepared using 50mM HEPES, pH 8.0, containing 5mM EDTA 
or 0.1M sodium acetate, pH 5.0, containing 2mM DTT and 2.5mM EDTA. All curves were 
prepared in a 96-well microplate in triplicate as follows:
• 25^1 Buffer (HEPES or sodium acetate as above)
• lOOjul appropriate AMC concentration
• 175/xl 1.7.M acetic acid
Fluorometric analysis of these samples was achieved using a Perkin Elmer LS-50 
Luminescence Spectrometer at excitation and emission wavelengths of 370nm and 440nm, 
respectively. The excitation slit width was maintained at lOnm while the emission slit 
width was adjusted according to the fluorescence intensity observed.
2.4 . G e n e r a l  A ssa y s
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2.4.1.2. Inner Filter Effect
The inner filter effect or ‘quenching5 was determined as in section 2.4.1.1; however, 25fil 
buffer was substituted by 25^1 crude bovine serum/enzyme sample. These samples were 
also prepared and assayed in triplicate.
2.4.1.3. AMC Excitation and Emission Wavelengths
The optimum AMC excitation and emission wavelengths were determined using the scan 
function option of the fluorimeter. A 5j.lM AMC solution was prepared by 1:20 dilution of 
the 1 OOpM stock solution using 50mM HEPES, pH 8.0, containing 5mM EDTA or 0.1M 
sodium acetate, pH 5.0 containing 2mM DTT and 2.5mM EDTA. A pre-scan was 
performed on 1.5ml of 5|J.M AMC placed in a glass cuvette. The excitation wavelength 
obtained from the pre-scan was set and an emission scan was performed from 400-600nm 
at 5nm increments. Similarly an excitation scan was performed between 300nm and 500nm 
using the previously determined optimum emission wavelength. Optimum wavelengths 
were taken to be those at which fluorescence was at a maximum.
2.4.2. P r o t e i n  D e t e r m i n a t i o n
2.4.2.1. Biuret Assay
The Biuret assay was used to quantify the protein concentration in samples of 2-10mg/ml.
These samples include bovine serum and post-phenyl Sepharose pooled samples (DPP IV
purification). Samples (typically 20-35ml) were dialysed against 50mM HEPES, pH 8.0
containing 5mM EDTA (2 litres) for a minimum of 3 hours at 4°C to remove possible
interfering substances such as incompatible buffers or salts. This assay was also used to
determine the protein concentration of rFheCLl samples. Samples with a protein
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concentration higher than lOmg/ml were diluted with the appropriate buffer to achieve a 
suitable protein concentration with respect to the assay limits. To quantify the protein 
concentration, a BSA standard curve was included from O-lOmg/ml in triplicate. The assay 
was performed on a 96 well microplate as follows:
• 50pl Sample/BSA standard
• 200fil Biuret Reagent
• Incubation at 37°C for 30 minutes
The absorbance of each well at 560nm was determined using a Labsystems Multiskan MS 
microplate reader. Where necessary a standard curve was constructed and the protein 
concentration of the unknown samples was estimated.
2.4.2.2. Standard BCA Assay
The standard BCA assay protocol, based on the method of Smith et al. (1985), was used to 
quantify protein concentrations of samples that could not be determined accurately using 
the less sensitive Biuret assay. To determine the amount of protein present in samples, 
BSA standard curves in the range 0-2mg/ml were prepared. The assay was performed on a 
96 well microplate in triplicate as follows:
• 50|il Sample/BSA standard
• 200^1 BCA Reagent
• Incubation at 37°C for 30 minutes
The absorbance of each well was recorded as described in previous section and standard 
curves were plotted.
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2.4.3. E n z y m e  A s s a y s
Quantitative and non-quantitative enzyme assays were performed based on a method by 
Buckley et al. (2004).
2.4.3.1. Quantitative Measurement of Dipeptidyl Peptidase IV (DPP IV) Activity
Dipeptidyl peptidase IV activity was determined by the degradation of Gly-Pro-AMC. A 
lOmM Gly-Pro-AMC stock solution was prepared in 100% ethanol (w/v). This stock 
solution was diluted 1:100 to O.lmM with 50mM HEPES, pH 8.0, containing 5mM EDTA 
with a final ethanol concentration of 1% (v/v). One hundred microlitres of this solution 
was added to 25fil enzyme sample in triplicate and incubated at 37°C for 1 hour. Both 
enzyme sample and substrate were pre-incubated separately at 37°C for 15 minutes to allow 
them to reach thermal equilibrium. The reaction was terminated by the addition of 175(0.1 
1.7 M acetic acid. Negative controls were prepared by adding 175|xl 1.7M acetic acid to 
the substrate prior to the addition of the sample. The controls were also incubated at 37°C 
for 1 hour. Liberated AMC was determined fluorometrically from standard plots prepared 
as described in section 2.4.1.1. Enzyme units (defined as nanomoles of AMC released per 
minute at 37°C) were calculated using the relevant quenched AMC standard curve (section
2.4.1.2.).
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2.4.3.2. Non-Quantitative Measurement of Dipeptidyl Peptidase IV (DPP IV) Activity
Gly-Pro-AMC degrading activity in post column chromatography fractions was detected 
using a non-quantitative assay. A 200(il solution of O.lmM Gly-Pro-AMC in 50mM 
HEPES, pH 8.0, containing 5mM EDTA, was added to lOOpl of sample in each well on a 
microplate. The plate was then incubated at 37°C for 1 hour. AMC released was 
determined fluorometrically as outlined in section 2.4.1.1 using the Perkin-Elmer LS-50 
Luminescence Spectrometer.
2.4.3.3. Measurement of rFasciola hepatica Cathepsin LI (rFheCLl) Activity
rFheCLl activity was determined by the degradation of Z-Phe-Arg-AMC. A ImM Z-Phe- 
Arg-AMC stock solution was prepared in 100% DMSO (w/v). This stock solution was 
diluted 1:100 to O.OlmM with 0.1M sodium acetate, pH 5.0, containing 2mM DTT and 
2.5mM EDTA with a final DMSO concentration of 1% (v/v). This solution (lOOfil) was 
added to 25(j,l enzyme sample in triplicate and incubated at 37°C for 30 minutes. Both 
enzyme sample and substrate were pre-incubated separately at 37°C for 15 minutes to allow 
them to reach thermal equilibrium. The reaction was terminated by the addition of 175pl 
1.7M acetic acid. Negative controls were prepared by adding 175(xl 1.7M acetic acid to the 
substrate prior to the addition of the sample. The controls were also incubated at 37°C for 
30 minutes. Liberated AMC was determined fluorometrically as described in section
2.4.1.1. Fluorometric intensities observed were converted to nanomoles of AMC released 
per minute per ml using the relevant quenched AMC standard curve (section 2.4.1.2.). 
Enzyme units were defined as nanomoles of AMC released per minute at 37°C.
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2.4.3.4. Esterase Activity of rFasciola hepatica Cathepsin LI (rFheCLl)
rFheCLl esterase activity was determined by the degradation of Z-Lys-ONp, procedure 
taken from Shaw and Green (1981). A lOmM Z-Lys-ONp stock solution was prepared in 
100% DMSO (w/v). Assays were performed in 0 .1M sodium acetate, pH 5.0 (buffer). On 
a 96-well microtitre plate 12.5pl of substrate stock solution was combined with 250jal 
buffer. The reaction was initiated by the addition of 25pl activated rFheCLl (0.1 mg/ml). 
Immediately after initiation, the plate was placed on a Labsystems Multiskan MS 
microplate reader, programmed in kinetic mode, and read every minute for a period of 20 
minutes at 405nm. Blank controls were prepared, where 0 .1M sodium acetate, pH 5.0, 
containing 8mM DTT and lOmM EDTA was substituted for rFheCLl. All assays were 
carried out in triplicate.
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2 .5 . A s s a y  D e v e l o p m e n t
2 .5 .1 . A u t o d ig e s t io n  A s s a y
The rate of autolysis was determined based on the method of Bickerstaff and Zhou (1993). 
Purified DPP IV (1ml) in 50mM HEPES, pH 8.0, containing 5mM EDTA was incubated in 
a test tube at 37°C. At set time intervals, a 10|U.l sample was removed and transferred to a 
96 well microtitre plate. This sample was immediately mixed with 250jal Bradford dye 
reagent. After 15 minutes incubation at room temperature, the absorbance at 620nm was 
measured. Activated rFheCLl was assayed similarly. Blank controls were prepared, where 
50mM HEPES, pH 8.0, containing 5mM EDTA was substituted for DPP IV, while 0.1M 
sodium acetate, pH 5.0, containing 8mM DTT and lOmM EDTA was substituted for 
rFheCLl. Trypsin (O.lmg/ml) prepared in 0.2M sodium phosphate, pH 7.0, was used as a 
positive control. Controls were assayed as described above for enzyme-containing samples.
2.5.2. L i n e a r i t y  o f  E n z y m e  A s s a y  w i t h  R e s p e c t  t o  T im e
2.5.2.1. Dipeptidyl Peptidase IV (DPP IV)
Purified DPP IV (400/al) and O.lmM Gly-Pro-AMC (1600fxl) substrate were pre-incubated 
separately in a waterbath at 37°C for 15 minutes prior to assay to ensure that solutions had 
reached thermal equilibrium. Enzyme and substrate were then combined in a test tube held 
at 37°C to begin the reaction (t = 0). At appropriate time intervals, 125|_il of the combined 
enzyme/substrate solution was removed and added to 175pl acetic acid (1.7M) on a 96 well
microplate to terminate the reaction. Blank controls were prepared, where 400|j,1 50mM
HEPES, pH 8.0, containing 5mM EDTA was substituted for enzyme. Fluorescence
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intensity was measured as described in section 2.4.3.1. All assays were carried out in 
triplicate. A plot of fluorescence intensity versus time was constructed.
2.5.2.2. rFasciola hepatica Cathepsin LI (rFheCLl)
Activated rFheCLl was diluted 1/50 with 0.1M sodium acetate, pH 5.0, and gently stirred 
to ensure equilibrium. This solution (700pl) and 2800|ul O.OlmM Z-Phe-Arg-AMC 
substrate were pre-incubated separately in a waterbath at 37°C for 15 minutes prior to assay 
to ensure that solutions had reached thermal equilibrium. Enzyme and substrate were then 
combined in a test tube held at 37°C to begin the reaction (t = 0). At appropriate time 
intervals, 125|j.l of the combined enzyme/substrate solution was removed and added to 
175 ,^1 1.7M acetic acid on a 96 well microplate to terminate the reaction. Blank controls 
were prepared, where 0.1M sodium acetate, pH 5.0 containing 8mM DTT and lOmM 
EDTA was substituted for enzyme. Fluorescence intensity was measured as described in 
section 2.4.3.3. All assays were carried out in triplicate. A plot of fluorescence intensity 
versus time was constructed.
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2.5.3. L i n e a r i t y  o f  A s s a y  w i t h  R e s p e c t  t o  E n z y m e  C o n c e n t r a t i o n
2.5.3.1. Dipeptidyl Peptidase IV (DPP IV)
Purified DPP IV was diluted with 50mM HEPES, pH 8.0, containing 5mM EDTA to 
achieve enzyme concentrations ranging from 0-100% of initial stock solution. The enzyme 
at these different concentrations was assayed in triplicate with O.lmM Gly-Pro-AMC as 
described in section 2.4.3.1. All assays were carried out in triplicate. A plot of 
fluorescenec intensity versus enzyme concentration (%) was constructed.
2.5.3.2. rFasciola hepatica Cathepsin LI (rFheCLl)
Activated rFheCLl was diluted 1/50 with 0.1M sodium acetate, pH 5.0, and gently stirred 
to ensure equilibrium. From this 1/50 stock solution a range of concentrations (0-100%) 
was prepared in 0.1M sodium acetate, pH 5.0. The enzyme at these different 
concentrations was assayed in triplicate with O.OlmM Z-Phe-Arg-AMC as described in 
section 2.4.3.3. All assays were carried out in triplicate. A plot of fluorescence intensity 
versus enzyme concentration (%) was constructed.
62
2 .6 . K in e t ic  A n a l y s is
2.6.1. Km and Fmax determination for Gly-Pro-AMC
Gly-Pro-AMC (lOmM in 100% ethanol (w/v)) was diluted to 0.5mM with 0.1M HEPES, 
pH 8.0, containing 5mM EDTA. This solution was further diluted in buffer to a range of 
Gly-Pro-AMC concentrations. Purified DPP IV was assayed at each substrate 
concentration as described in section 2.4.3.1. The Michaelis-Menten constant (Km) and 
maximum velocity value (Fmax) were determined using Michaelis-Menten plot analysis 
(Enzfitter Programme, Biosoft, Cambridge, UK).
2.6.2. Km and Vm!lx determination for Z-Phe-Arg-AMC
Z-Phe-Arg-AMC (lOmM in 100% DMSO (w/v)) was diluted to 100/iM Z-Phe-Arg-AMC 
with 0.1M sodium acetate, pH 5.0, containing 2mM DTT and 2.5mM EDTA. This solution 
was further diluted in buffer to a range of Z-Phe-Arg-AMC concentrations. Activated 
rFheCLl (native and chemically modified; section 2.11.) was assayed at each substrate 
concentration, as described in section 2.4.3.3. The Michaelis-Menten constant (Km) and 
maximum velocity value (Fmax) were determined using Michaelis-Menten plot analysis 
(Enzfitter Programme, Biosoft, Cambridge, UK).
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2 .7 . T e m p e r a t u r e  S t u d i e s
2.7.1. T e m p e r a t u r e  P r o f i l e
2.7.1.1. Dipeptidyl Peptidase IV (DPP IV)
Aliquots of purified DPP IV were incubated for ten minutes at temperatures ranging 
between 37-90°C. The samples were cooled rapidly on ice and residual activity was 
assayed as described in section 2.4.3.1. Blank controls were prepared, where 50mM 
HEPES, pH 8.0, containing 5mM EDTA was substituted for enzyme. All assays were 
earned out in triplicate. A plot of % residual activity versus temperature (°C) was 
constructed and the temperature of half-inactivation (T50) determined by inspection.
2.7.1.2. rFasciola hepatica Cathepsin LI (rFheCLl)
Activated rFheCLl was diluted 1/50 with 0.1M sodium acetate, pH 5.0 and gently stirred to 
ensure equilibrium. Aliquots of this 1/50 dilution were incubated for ten minutes at 
temperatures ranging between 37-90°C. The samples were cooled rapidly on ice and 
residual activity was assayed as described in section 2.4.3.3. Blank controls were prepared, 
where 0.1M sodium acetate, pH 5.0, containing 8mM DTT and lOmM EDTA was 
substituted for enzyme. All assays were carried out in triplicate. A plot of % residual 
activity versus temperature (°C) was constructed and the T50 determined by inspection.
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2 .7 .2 . T h e r m o i n a c t iv a t i o n
2.7.2.1. Dipeptidyl Peptidase IV (DPP IV)
Purified DPP IV was maintained at a constant temperature in a heated waterbath 
(temperature-dependent on assay). At appropriate time intervals, aliquots were removed 
from the incubating solution and their activities assayed as described in section 2.4.3.1. 
Blank controls were prepared, where 50mM HEPES, pH 8.0, containing 5mM EDTA was 
substituted for enzyme. A plot of % residual activity versus time (minutes) was 
constructed. Data were fitted to a first-order exponential decay using the Enzfitter 
programme (Biosofit, Cambridge, UK) in order to estimate the rate constant (k) and, hence, 
the half-life (t/2).
2.1.2.2. rFasciola hepatica Cathepsin LI (rFheCLl)
Activated rFheCLl was diluted 1/50 with 0.1M sodium acetate, pH 5.0 and gently stirred to 
ensure equilibrium. The enzyme was then maintained at a constant temperature in a heated 
waterbath (temperature dependent on assay). At appropriate time intervals, aliquots were 
removed from the incubating solution and their activities assayed as described in section
2.4.3.3. Blank controls were prepared, where 0.1M sodium acetate, pH 5, containing 8mM 
DTT and lOmM EDTA was substituted for activated enzyme. A plot of % residual activity 
versus time (minutes) was constructed. Data were fitted to a first-order exponential decay 
using the Enzfitter programme (Biosoft, Cambridge, UK) in order to estimate the rate 
constant (k) and, hence, the half-life (ty2).
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2 .8 . O r g a n o t o l e r a n c e  S t u d i e s
2.8.1. S o l v e n t  S t a b i l i t y  S t u d ie s
2.8.1.1. Dipeptidyl Peptidase IV (DPP IV)
Aliquots of purified DPP IV were incubated for 1 hour at room temperature with a range of 
solvents (acetonitrile, DMF, DMSO, THF) to achieve final solvent concentrations ranging 
from 0-90% (T a b l e  2.1). The enzyme/solvent solution was adjusted to a final volume of 
0.5 ml with 50mM HEPES pH 8.0, containing 5mM EDTA. Blanks containing no enzyme 
were included for each solvent, at each solvent concentration. Enzyme activity was 
assayed as described in section 2.4.3.1. All assays were carried out in triplicate. A plot of 
% residual activity versus solvent concentration (%) was constructed and the C50 
determined by inspection. A temperature profile was performed as described in section
2.7.1.1. on each solvent at 50% (v/v) concentration. Thermoinactivation at 37°C was 
performed as detailed in section 2.7.2.1. on each solvent, also at 50% (v/v) concentration.
T a b l e  2.1 P r e p a r a t io n  o f  e n z y m e / s o l v e n t  s o l u t io n  (v /v )
Solvent Concentration (%) 0 10 20 30 40 50 60 70 80 90
Volume of Enzyme (pi) 50 50 50 50 50 50 50 50 50 50
Volume of Buffer (pi) 450 400 350 300 250 2 0 0 150 100 50 ——
Volume of Solvent (pi) 50 100 150 20 0 250 300 350 400 450
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2.8.1.2. rFasciola hepatica Cathepsin LI (rFheCLl)
Activated rFheCLl (native and chemically modified; section 2.11.) was diluted 1/5 with 
0.1M sodium acetate, pH 5.0 and gently stirred to ensure equilibrium. Aliquots of this 
stock solution were incubated for 1 hour at room temperature with a range of solvents 
(acetone, acetonitrile, DMF, DMSO, THF) to achieve final solvent concentrations ranging 
from 0-90% (T a b l e  2.1). The enzyme/solvent solution was adjusted to a final volume of 
0.5ml with 0.1M sodium acetate, pH 5.0. Blank controls containing no enzyme were 
included for each solvent, at each solvent concentration (%). Enzyme activity was assayed 
as described in section 2.4.3.3. All assays were carried out in triplicate. A plot of % 
residual activity versus solvent concentration (%) was constructed and the C50 determined 
by inspection. Thermoinactivation of rFheCLl (chemically modified; section 2.11.) at 
37°C and 50°C was performed as detailed in section 2.1.22. on acetonitrile and DMF, each 
at 50% (v/v) concentration.
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2.9. pH Studies on D ipeptidyl Peptidase IV (DPP IV)
2.9.1. Effect of pH on Activity and Kinetics
Purified DPP IV (5ml) was dialysed for 12 hours against ultra-pure water (2 litres). A 
500(j,l volume of dialysate was then further dialysed overnight into each of the buffers 
listed in T a b l e  2 .2 . with buffer changes at 2 and 6 hours. The effect o f  pH and buffer 
system on enzyme activity was assayed in triplicate as described in section 2 .4 .3 .1. at 
different pH values and in the different buffers to determine the pKa of DPP IV. Liberated 
AMC was determined fluorometrically as described in section 2 .4 .1.1. Graphs of Log 
V/Km (min'1) versus pH, log V (^M/min) versus pH and log Km (|jM) versus pH were 
plotted.
T a b l e  2.2. B u f f e r  sy st e m s  u s e d  in d e t e r m in in g  effect  of  pH o n  DPP IV a c t iv it y
pH R a n g e B uf fer pH A djuster
4 .0 -5 .5 50mM Sodium acetate 5M HCI
5 .5-6 .5 50mM MES 5M NaOH
6 .5 -7 .0 50mM MOPS 5M NaOH
7 .0 -8 .0 50mM HEPES 5M HCI
8.0 -9 .0 50mM Tris 5M HCI
9.0- 10 50mM CHES 5M NaOH
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Purified DPP IV (5ml) was dialysed for 12 hours against 2L ultra-pure water. A 300|il 
volume of dialysate was then further dialysed overnight into each of the buffers listed in 
T a b l e  2.2. (but at 20mM concentration instead of 50mM) with buffer changes at 2 and 6 
hours. A temperature profile was performed as described in section 2.7.1.1.
2.10. A ctive Site T itration
2.10.1. rFasciola hepatica Cathepsin LI (rFheCLl)
This procedure is based on a method by Barrett et al. (1982). ¿raws-epoxysuccinyl-L- 
leucylamido(4-guanidino)-butane (E-64) (ImM initially dissolved in 0.1ml DMSO, 
brought to 10ml final volume) was diluted to a 2 0 |aM working solution using ultra-pure 
water. Lower E-64 concentrations were prepared (0-2.5/xM) by dilution of the working 
solution with ultra-pure water. A titration of activated rFheCLl with E-64 was prepared. 
At each point, 25/zl of activated rFheCLl (diluted 1/5 with 0.1M sodium acetate, pH 5.0) 
was reacted with an equal volume of 0-2.5 (iM E-64 and brought to a total volume of 100(xl 
with 0.1M sodium acetate, pH 5.0, containing 8mM DTT and lOmM EDTA. Samples were 
incubated at 37°C for 15 minutes. Activity was then determined (section 2.4.3.3.). All 
assays were carried out in triplicate. A plot of fluorescence intensity versus E-64 
concentration (fJ-M) was plotted and the operational molarity of rFheCLl determined.
2.9.2. pH Temperature Profile
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2 .11 . C h e m ic a l  M o d if ic a t io n
2.11.1. Cross-linking of rFasciola hepatica Cathepsin LI (rFheCLl) with EG-NHS
The protocol for the ester reaction was based on that of Ryan et al. (1994). Activated 
rFheCLl (2ml) in 0.1M sodium acetate, pH 5.0, containing 8mM DTT and lOmM EDTA 
was dialysed extensively for at least 3 hours against 0.1M potassium phosphate, pH 7.5. 
Ethylene glycol-bis(succinic acid N-hydroxy-succinimide ester) (EG-NHS) (5mg) was 
dissolved in 0.125ml DMSO. Cross-linking was commenced by addition of the EG-NHS 
solution to rFheCLl (2ml) in 0.1M potassium phosphate, pH 7.5. This reaction solution 
was stirred gently at room temperature for 20 minutes after which the reaction was 
terminated by removal of excess reagent as described in section 2.11.2. below. The 
modified enzyme was re-dialysed into 0.1M sodium acetate, pH 5.0, containing 8mM DTT 
and lOmM EDTA. Enzyme activity was determined pre- and post modification.
2.11.2. Sephadex™ G-25 Gel Filtration
The method was based on that of Helmerhorst and Stokes (1980). Sephadex™ G-25 (5g) 
was swollen in 50ml 0.1M potassium phosphate, pH 7.5. This mixture was stirred slowly 
overnight. A slurry of the above mixture (20ml) was poured into a 10ml column and 
capped. The column was then centrifuged at 1800 rpm for 3 minutes in a bench centrifuge 
to remove excess buffer (rotor radius 12cm). Modified enzyme solution (2ml) was applied 
to the semi-dry Sephadex™ G-25 column and re-centrifuged as described above, to remove 
unreacted and excess ethylene glycol-bis(succinic acid N-hydroxy-succinimide ester) (EG- 
NHS).
70
The method was based on that of Fields (1971) using 2,4,6-trinitrobenzenesulphonic acid 
(TNBS) for the estimation of free amino groups in native and modified rFheCLl. A 20mM 
(w/v) Na-acetyl-L-Lysine stock solution was prepared in ultra-pure water. Lower Na- 
acetyl-L-Lysine concentrations were prepared in ultra-pure water to form standard curves in 
the range of 0-20mM. The TNBS assay was performed in test tubes as follows:
• 0.1ml rFheCLl (native/modified)/Na-acetyl-L-Lysine standard
• 0.5ml 0.1M borate buffer, pH 9.6
• 0.4ml ultra-pure water
• The reaction was initiated by addition of 0.02ml 0.5% (v/v) TNBS. Tubes were mixed 
by inversion and reaction proceeded at room temperature in the dark. After 5 minutes, 
the reaction was terminated by the addition of 2ml 0.1M monobasic sodium phosphate 
(Na^PCU) containing 1.5mM sodium sulphite.
Absorbance at 420nm was determined on a Unicam2 UV/Vis spectrophotometer. Blank 
controls were included, substituting buffer for enzyme samples. All solutions were assayed 
in triplicate and their mean absorbance calculated.
2.11.3. Amino Group Estimation - TNBS Assay
71
Denaturing electrophoresis was used to determine the success of purification based on the 
method of Laemmli (1970).
2.12.1. Sample Preparation
Activated rFheCLl and samples collected during DPP IV purification (crude serum, post- 
phenyl-Sepharose DPP IV, and post-Q-Sepharose DPP IV) were combined with 5X sample 
buffer (60mM Tris/HCl pH 6.8, 25% (v/v) glycerol, 2% (w/v) sodium dodecyl sulphate, 5% 
(v/v) 2-mercaptoethanol and 0.1% (w/v) bromophenol blue) i.e. 20|il sample + 5(0.1 sample 
buffer, and denatured by immersion in a boiling water bath for 5 minutes after which 
samples were kept on ice until application onto the gel. For DPP IV and rFheCLl analysis 
Sigmamarker™ high and low molecular weight range markers were used as standards, 
respectively (T a b l e  2.3.).
2.12 . P o l y a c r y l a m id e  G el  E l e c t r o p h o r e s is  (P A G E )
T a b l e  2.3. M o l e c u l a r  W e ig h t  D is t r ib u t io n  o f  S ig m a m a r k e r ™
Proteins mw (Da) High Range Low Range
Myosin 205,000 X
ß-Galactosidase 116,000 X
Phosphorylase b 97,000 X
Fructose-6-phosphate Kinase 84,000 X
Albumin, Bovine Serum (BSA) 66,000 X X
Glutamic Dehydrogenase 55,000 X
Ovalbumin 45,000 X X
Glyceraldehyde-3-phosphate Dehydrogenase 36,000 X X
Carbonic Anhydrase 29,000 X
Trypsinogen 24,000 X
Trypsin Inhibitor 20,000 X
a-Lactalbumin 14,200 X
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T a b l e  2.4. lists the composition of each solution used in the preparation of gels for SDS- 
PAGE electrophoresis. All solutions were prepared in ultra-pure water. Gels were 
prepared from the solutions in Table 2.4. with volumes documented in Table 2.5.
2.12.2. SDS Gel Preparation
T a b l e  2.4. So l u t io n s  a n d  t h e ir  c o m p o s it io n s  u s e d  in  SDS-PAGE
So l u t io n C o m p o s it io n
A c  r  y  l / b 1 s -A c  r y  l a  m  i d e  
A m m o n iu m  p e r s u l f a t e  
So d iu m  d o d e c y l  s u l f a t e  
4 X  R e s o l v in g  g e l  b u f f e r  
10X  R u n n in g  b u f f e r  
4 X  S t a c k in g  g e l  b u f f e r
30% (w/v) Acrylamide, 0.8% (w/v) bis-Acrylamide 
10% (w/v) ammonium persulfate 
10% (w/v) sodium dodecyl sulfate (SDS)
1.5M Tris/HCl, pH 8.8, with 0.4% (w/v) SDS 
0.25M Tris, 1.92M glycine, 1% (w/v) SDS, pH 8.3 
0.5M Tris/HCl, pH 6.8 with 0.4% (w/v) SDS
T a b l e  2.5. SDS-PAGE G e l  P r e p a r a t io n
(TEMED acts as a catalyst for gel polymerization so it is added last.)
St o c k  S o l u t io n R e s o l v in g  G e l R e s o l v in g  G e l St a c k in g  G e l
9%  (v /v ) 12% (v /v ) 4% (v /v )
A c r y l / b is -A c r y l  So l u t io n 3.0ml 4.0ml 1.33ml
A m m o n iu m  p e r s u l f a t e 0.1ml 0.1ml 0.1ml
R e s o l v in g  g e l  b u f f e r 2.5ml 2.5ml
St a c k in g  g e l  b u f f e r 2.5ml
T E M E D 50jj,1 50|il 50^1
U l t r a - pu r e  w a t e r 4.5ml 3.5ml 6.17ml
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Gels were cast in a BioRad Mini Gel set and positioned in an ATTO vertical 
electrophoresis system. The gel box was filled with IX running buffer and 1Ojal of the 
prepared samples and markers were loaded into the wells under buffer head. To avoid edge 
effects, 10|il of 5X sample buffer was loaded into unused wells. Electrophoresis was 
performed at room temperature at a constant voltage of 200V for approximately lhour or 
until the dye front had migrated 5mm from the end of the gel.
2.12.3. Visualisation of Proteins
Polyacrylamide gels were stained using GelCode® Blue stain reagent. Table 2.6. outlines 
the stages performed. An image of each stained gel was recorded using a Plustek OpticPro 
482 lp scanmaker (for DPP IV) and Pharmacia Biotech Imagemaster® Video 
Documentation System for Gel Electrophoresis (for rFheCLl).
T a b l e  2 .6 . G e l C o d e ®  B l u e  S t a in in g  P r o c e d u r e
Step Reagent Volume Time
Rinsing
Staining
Rinsing
Ultra-pure water 
GelCode® Blue Stain 
Ultra-pure water
3 x 100ml
1 x 200ml
2 x 200ml
3 x 1 5  minutes 
1 x 60 minutes 
1 x 60 mi nules
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2.13. E n z y m a t i c  P e p t i d e  S y n t h e s i s
2.13.1. Synthesis of model tripeptide Z-Phe-Arg-SerNH2
The enzymatic synthesis of Z-Phe-Arg-SerNH2 using Z-Phe-Arg-OMe (ester) and SerNH2 
(amine) was performed based on similar methods described by Stehle et al. (1990) and 
Lozano et al. (1992). rFheCLl was activated to a final protein concentration of 0.05mg/ml. 
Z-Phe-Arg-OMe was prepared as a 20mM stock solution in 100% acetonitrile (w/v). The 
nucleophile, SerNH2, was prepared in 0.1M ammonium acetate, pH 9.0, giving a final 
concentration of 50mM. Enzyme, nucleophile and ester were separately pre-incubated in a 
waterbath at 37°C for 15 minutes prior to assay to ensure that solutions had reached thermal 
equilibrium. Into a 5ml volume test tube, 0.25ml of 20mM Z-Phe-Arg-OMe and 0.4ml 
SerNH2 were combined. Reaction volume was adjusted to 2ml with 0.1M ammonium 
acetate, pH 9.0. The reaction was initiated by the addition of 0.25ml rFheCLl (0.05mg/ml) 
and incubated at 37°C with gentle stirring. Aliquots (200j.il) were removed at several time 
intervals from the reaction mixture and mixed with 25pl acetonitrile:water:formic acid 
(50:25:25 v/v/v) to quench the reaction. Analysis was performed by liquid chromatography 
mass spectrometry (LC-MS) (instrument -  Bruker Mass Spectrometer with electrospray 
ionisation and ion-trap detector linked to a Hewlett-Packard Esquire Liquid chromatograph 
1100 with photo diode array detector). The LC isocratic method used a Zorbax SB-C18, 50 
x 2.1 mm, 3.5fim narrow bore column with a mobile phase 25:75:0.1 (v/v/v) 
acetonitrile:water:formic acid at a flow rate of 0.2ml/min. Monitoring was performed using 
a photodiode array detector at 200nm and injection volume 2pl.
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2.14. S e q u e n c e  A l ig n m e n t
2.1.14. Sequence alignment of fluke and recombinant Fasciola hepatica cathepsin LI
Comparative analysis of the amino acid sequences for fluke {Fasciola hepatica) cathepsin 
LI and recombinant Fasciola hepatica cathepsin LI were aligned using ClustalW. The 
amino acid sequence for fluke {Fasciola hepatica) cathepsin LI, accession number 
Q24940, was obtained from Protein Data Bank. Sequence for recombinant Fasciola 
hepatica cathepsin LI (rFheCLl) was obtained from Mr Peter Collins, Parasitology 
Research Group, formerly based at Dublin City University.
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C ha pter  3 
P u r if ic a tio n  of D ipeptid yl  P eptid a se  IV
3.1. In tro d u c tio n
Dipeptidyl peptidase IV (DPP IV) is a serine protease enzyme with exopeptidase activity. 
It is specific for a Pro residue at the Pi position hydrolysing, on the carboxyl side of the Pro 
(Burleigh & Andrews, 1998). The amide substrate, Gly-Pro-AMC when hydrolyzed by 
DPP IV releases AMC, which is monitored fluorimetrically, making this a sensitive and 
suitable substrate. The enzyme was purified from an ample supply of bovine serum, using 
a variety of techniques, based on a method by Buckley et al. (2004). Protein concentration, 
enzyme activity, and yield were determined after each purification stage. The extent of 
purity and subunit molecular weight of the enzyme were determined.
The undertaken studies differed from those of Buckley et al. (2004) who previously 
characterised the enzyme with regards to pH optimum, catalytic classification, substrate 
specificity and inhibition studies. This study focused on investigating the temperature and 
solvent stability of DPP IV. A temperature profile was determined for the enzyme and the 
temperature at half-inactivation (T50) estimated. The effect of organic solvents on DPP IV 
activity was investigated following exposure to a range of organic solvents at various 
concentrations and the half-inactivation concentration (C 5 0 ) determined. The effect of pH 
on DPP IV activity and kinetics was also examined, with two pK  values observed. The 
effect of changing the buffer on DPP IV activity was also investigated.
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3.2. Results -  P urification  of DPP IV
3 .2 .1 . O p tim u m  AMC E x c i t a t i o n  a n d  E m is s io n  W a v e l e n g t h s
Scans intensity of fluorescence versus wavelength were performed on free AMC as 
described in section 2.4.1.3. to determine the optimum excitation and emission wavelengths 
for this compound. F ig u r e  3.2.1.1. shows that the optimum excitation and emission 
wavelengths for AMC are 370nm and 440nm respectively.
F ig u r e  3 .2 .I .I .
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F i g u r e  3 .2 .I .I .  AMC E x c i t a t i o n  a n d  E m is s io n  S c a n
Plot of intensity of fluorescence versus wavelength (nm) for free AMC in solution.
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3 .2 .2 . A M C  S t a n d a r d  C u r v e s  a n d  t h e  I n n e r  F i l t e r  E f f e c t  
AMC standard curves were prepared as outlined in Section 2.4.1.1. Plots of fluorescence 
intensity versus AMC concentration (micromol) were constructed and the slope of the lines 
calculated. F ig u r e  3.2.2.1. represents a typical AMC standard curve at emission slit width 
2.5nm. The inner filter effect was also determined as described in section 2.4.1.2. to assess 
the effect of including crude or post column fractions in the assay mixture on fluorescence 
intensity. FIGURE 3.2.2.2. is a plot of fluorescence intensity versus AMC concentration 
(micromol) each curve and the degree of filtering observed for enzyme samples.
T a b l e  3 .1 . S l o p e s  o f  f il t e r e d  s t a n d a r d  c u r v e s
S a m p l e e ! S l o p e F i l t e r i n g  (%)
B u f f e r 0.99 55.19 0
C r u d e  Se r u m 0.99 32.33 41
P o s t -Q -S e p h a r o s e  DPP IV 0.99 54.07 2
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F ig u r e  3 .2 .2 .I .
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F ig u r e  3 .2 .2 .I . T y p ic a l  AMC S t a n d a r d  C u r v e
Plot of fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus free AMC concentration (micromol). Values represent mean (n=3) 
and standard deviation (± 5%).
F ig u r e  3 .2 .2 .2 .
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F ig u r e  3 .2 .2 .2 . AMC Q u e n c h e d  S t a n d a r d  C u r v e
Plot of fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width, 2.5nm) versus free AMC concentration (micromol) (•). The quenching agents used 
were crude bovine serum (■) and post-Q-Sepharose DPP IV (A). Values represent mean 
(n=3) and standard deviation (± 5%).
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3 .2 .3 . P r o t e in  D e t e r m in a t io n
Bovine serum albumin (BSA) standard curves were prepared as outlined in section 2 .4 .2 . 
Plots of protein absorbance at 560nm versus BSA concentration (mg/ml) are shown in 
f ig u r e s  3 .2 .3 .1 . and 3 .2 .3 .2 . for Biuret and standard BCA assays respectively.
F ig u r e  3 .2 .3 .I .
BSA concentration (mg/ml)
F ig u r e  3 .2 .3 .I .  B iu r e t  P r o t e in  S t a n d a r d  C u r v e
Plot of absorbance at 560nm versus bovine serum albumin (BSA) concentration (mg/ml). 
Values represent mean (n=3) and standard deviation (± 5%).
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F ig u r e  3 .2 .3 .2 .
BSA concentration (mg/m l)
F ig u r e  3.2.3.2. St a n d a r d  BCA P r o t e in  St a n d a r d  C u r v e
Plot of absorbance at 560nm versus bovine serum albumin (BSA) concentration (mg/ml). 
Values represent mean (n=3) and standard deviation (± 5%).
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3.2.4. P u r if ic a t io n  o f  B o v in e  S e r u m  D P P  IV
3.2.4.1. Serum Preparation
12 litres of fresh bovine whole blood was collected and allowed to clot at 4°C as described 
in section 2.3.1.1. This resulted in the formation of 2.5 litres unclotted serum and 
particulate matter. Centrifugation yielded 2 litres of serum.
3.2.4.2. Phenyl Sepharose Hydrophobic Interaction Chromatography
Crude serum containing 1M ammonium sulphate was applied to a phenyl Sepharose 
hydrophobic interaction chromatography column as outlined in section 2.3.1.2. A run- 
through DPP IV activity peak was observed from this column as shown in F ig u r e
3.2.4.2.1. This activity was well separated from a significant proportion of bound protein. 
Fractions containing DPP IV activity were combined to yield a post-phenyl Sepharose DPP 
IV pool. A 1ml aliquot of this pool was retained to determine protein concentration and 
total enzymatic activity as described in section 2.4.2.1. and 2.4.3.1.
3.2.4.3. Sephacryl S-300 High Resolution (HR) Gel Filtration Chromatography
Following concentration of the post-phenyl Sepharose DPP IV pool by osmosis using solid 
polyethylene glycol, the concentrated sample was applied onto a Sephacryl S-300-HR gel 
filtration column as described in section 2.3.1.3. F ig u r e  3.2.4.3.I. shows the molecular 
sieving effect of this column on the enzyme’s purification. Fractions containing DPP IV 
activity were combined to yield a post-Sephacryl-S-300 DPP IV pool. A 1ml aliquot of 
this pool was retained to determine protein concentration and total enzymatic activity as 
described in section 2.4.2.2. and 2.4.3.1.
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3.2.4.4. Quaternary (Q) Sepharose Strong Anion Exchange Chromatography
The post-Sephacryl S-300 DPP IV was concentrated via osmosis using solid polyethylene 
glycol. DPP IV activity was detected in the bound fractions from this column and no run- 
through DPP TV protein was detected. F ig u r e  3 .2 .4 .4 .I .  illustrates the elution profile from 
this column. Post-Q-Sepharose DPP IV fractions were combined, dialysed and stored at - 
20°C until required. A 1ml aliquot of the dialysed pool was retained for protein 
concentration and total enzymatic activity determination as described in section 2.4.2.2. and
2 .4 .3 .1 .
3.2.4.5. Effectiveness of Purification Procedure
A  p u r if ic a t io n  ta b le  (T a b l e  3 .2 .)  w as  c o n s tru c te d  to  d e te rm in e  th e  o v e ra ll e ffe c tiv en e ss  o f  
th e  p u r if ic a tio n  p ro to c o l a s  o u tlin e d  in  se c tio n  2 .3 .
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F i g u r e  3.2.4.2.I.
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F ig u r e  3.2.4.2.I. P h e n y l  S e p h a r o s e  C h r o m a t o g r a p h y  o f  B o v in e  S e r u m  D P P  IV (F r a c t io n s  6-12 P o o l e d ) 
Fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit width, 2.5nm) indicates DPP IV activity.
F ig u r e  3.2.4.3.I.
Fraction Num ber (voliune 5ml)
F ig u r e  3.2.4.3.I. S e p h a c r y l  S-300-HR F i l t r a t i o n  C h r o m a t o g r a p h y  o f  DPP IV (F r a c t io n s  12-21 P o o l e d ) 
Fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit width, 2.5nm) indicates D P P  IV activity.
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F i g u r e  3 .2 .4 .4 .1 . Q - S e p h a r o s e  S t r o n g  A n io n  E x c h a n g e  C h r o m a t o g r a p h y  o f  DPP IV (F r a c t io n s  25-31 P o o l e d ) 
Fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit width, 2.5nm) indicates DPP IV activity.
T a b l e  3.2. P u r if ic a t io n  t a b l e  f o r  b o v in e  s e r u m  DPP IV. Total activity (eu) defined as nanomoles/min/ml.
P u r if ic a t io n  S t a g e T o t a l  P r o t e i n  
(mg)
T o t a l  A c t i v i t y  
(eu)
S p e c i f i c  A c t i v i t y  
(eu/mg)
P u r if ic a t io n
Fa c t o r
Y ie l d
(% )
C r u d e  Se r u m 10195 336 0.03 1 100
P o s t-P S -D P P  IV 386 104 0.27 9 31
P o s t  S-300-HR D P P  IV 66 60 0.91 30 18
P o s t-Q A E -D P P  IV 41 43 1.05 35 13
3 .2 .5 . D e t e r m in a t io n  o f  E n z y m e  P u r it y
3.2.5.1. SDS Polyacrylamide Gel Electrophoresis
SDS polyacrylamide gel electrophoresis was performed as outlined in section 2.12. 
F ig u r e  3.2.5.1.2. represents an image of the GelCode® Blue stained serum DPP IV, 
illustrating high molecular weight markers and the various post-column serum DPP IV 
pools. The single peak of DPP IV activity post-Q-Sepharose (F ig u r e  3.2.4.4.1) showed 
two major bands on SDS-PAGE (Lane 3); one band coincided with the position of 
bovine serum albumin among the molecular weight marker proteins, while the other 
was deemed to be DPP IV, with a subunit relative molecular mass of 77,224 Da 
estimated from a plot of log relative molecular mass versus relative mobility (Rf) 
(F ig u r e  3.2.5.1.1.) standard proteins on the SDS gel.
F i g u r e  3.2.5.I.I.
R f
F i g u r e  3.2.5.I.I. S t a n d a r d  C u r v e  f o r  M o l e c u l a r  W e i g h t  D e t e r m i n a t i o n
Plot of log molecular weight versus Rf
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F ig u r e  3 .2 .5 .I .2 .
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F i g u r e  3 .2 .5 .1 .2 . G e lC o d e ®  S t a in  S D S -P A G E  o f  B o v in e  S e r u m  D P P  IV  
Lane 1: molecular weight markers (from top), myosin (205,000 Da), P-Galactosidase 
(116,000 Da), phosphorylase b (97,000 Da), fructose-6-phosphate kinase (84,000 Da), 
bovine serum albumin (66,000 Da), glutamic dehydrogenase (55,000 Da) and 
ovalbumin (45,000 Da). Lane 3: post-Q-Sepharose anion exchange chromatography 
fraction. Lane 5: post-Sephacryl-S-300 gel filtration fraction. Lane 7: post-phenyl 
Sepharose chromatography fraction. Lane 9: crude serum fraction (1/100 dilution). 
Lanes between the samples and molecular weight markers were left empty.
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3.3. Discussion
Fluorometric assays rely upon the excitation of a fluorophore by electromagnetic 
radiation at a specific wavelength, and the subsequent detection of emitted 
electromagnetic radiation at a higher specific wavelength. The observed fluorescence 
signal generally decreases as the solution becomes increasingly concentrated. This 
phenomenon is known as the inner filter effect and includes all light-attenuating 
processes -  due not only to the fluorophore but also to any other chromophores that may 
be present (Lloyd, 1981). There are other concentration-dependent processes that 
reduce fluorescence intensities: intermolecular processes involving either ground or 
excited states of a fluorophore or both are a common cause. Quenching molecules may 
be present, e.g. oxygen in aerated solvents, or heavy atom perturbers such as residues of 
halogenated solvents (Lloyd, 1981). In crude biological samples, the effect of this 
phenomenon can be quite significant, leading to inaccurate determination of free AMC 
concentrations within a particular reaction mixture.
To determine the extent of this effect and overcome this problem, free AMC standard 
carves were constructed in a manner replicating standard assay conditions as outlined in 
section 2 .4 .1 .1 . Results were recorded in section 3 .2 .2 . A significant difference in 
fluorescence detection was observed when biological samples were added; the effect of 
this on standard curves is clearly demonstrated in FIGURE 3 .2 .2 .2 . Both samples 
contributed to the inner filter effect and 4 1 %  of filtering was observed when crude 
bovine serum was added, yet only 2% filtering was demonstrated after the final step in 
the purification was performed. However, it is important to account for this effect when 
quantifying the enzymatic activity present in a sample and, therefore, the preparation of 
“filtered” standard curves is a useful method to ensure the accuracy of results obtained
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from fluorometric assays and when ascertaining the effectiveness of a purification 
process.
Serum was prepared from freshly obtained whole bovine blood. This was a simple 
technique involving clotting, clot shrinkage and centrifugation. The source of starter 
material is a reliable, commercially available, and cheap source. Serum is also known 
to contain moderate amounts of DPP IV activity (Iwaki-Egawa et al., 1998). 
Hydrophobic interaction chromatography (HIC) depends on the affinity between a 
hydrophobic group on the matrix and regions of hydrophobicity on a protein (Bollag et 
al., 1996a). Surface hydrophobic amino acids are usually arranged in patches, 
interspersed with more hydrophilic domains. The number, size and distribution of these 
non-ionic regions is a characteristic of each protein and can therefore be used as a basis 
for their separation. Salting-out decreases the availability of water molecules in 
solution, and enhances hydrophobic interaction (Roe, 1989). Hydrophobic interactions 
become stronger as the solution salt concentration increases. Hence, most HIC 
protocols call for protein loading at high salt and elution by lowering the salt 
concentration (Bollag et al., 1996a).
Crude bovine serum was salted and applied to a phenyl-Sepharose hydrophobic 
interaction column. The elution profile demonstrates (F ig u r e  3.2.4.2.1.) that two DPP 
IV-like activities were separated, one activity eluting in wash buffer, the second activity 
eluting in elution buffer. These results are comparable to results obtained by Shibuya- 
Saruta et al. (1996) who reported similar findings for human serum DPP IV, suggesting 
the possibility of a DPP IV isozyme. Lambeir et al. (1997) isolated different forms of 
DPP IV from seminal plasma by immobilised adenosine deaminase (ADA) and ion 
exchange chromatography, each form was distinguishable by net charge, and molecular
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weight. They determined that the observed differences were primarily due to differing 
degrees of glycosylation. The elution profiles for ion exchange chromatography also 
differed, with some forms eluting at low salt concentrations, others eluting at high salt 
concentrations. Renal membrane-bound DPP IV of rat shows more that 12 isofoms 
each with different pi values ranging between 4.8 and 5.3 (Reutter et al., 1995). The 
obtained results are also comparable to Buckley et al. (2004) who previously purified 
DPP IV from bovine serum. Further studies would be necessary to clarify if the second 
observed peak (eluting in elution buffer) is indeed a bovine serum DPP IV isozyme. 
This purification step provided a 27-fold reduction in protein, allowing a 9-fold increase 
in purity. Although DPP IV did not bind to the column (fractions eluted in wash 
buffer), a decrease in enzyme activity was observed. Recovery was reduced to 31%. 
Binding of DPP IV could be achieved by optimising the salting-out conditions; 
however, as is evident from the results, the salting-out step may be responsible for this 
loss in enzyme activity. The main object of this step was to separate DPP IV activity 
from PO activity, as both enzymes have similar properties.
Gel filtration chromatography is separation based on size. It is also a useful technique 
for transfering a protein into a different buffer (Bollag et al., 1996b). The resin used for 
this separation, Sephacryl S-300-HR, has a fractionation range of 10-1500 kDa. This 
method is unique in fractionating without requiring protein binding, thus reducing the 
risk of protein loss through irreversible binding or protein inactivation. However, 
although this non-binding column was successful in providing a 6-fold reduction in the 
total protein content, a 42% reduction in enzyme activity was also observed, leading to a 
total yield of 18%. The poor sample recovery and loss of DPP IV activity, indicates that 
this step is possibly deleterious to DPP IV. This loss could be due to a number of
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factors, including protein adsoiption to the matrix as hydrophobic interactions with the 
matrix are possible; however, the elution profile does not fit this theory (Bollag et al., 
1996b).
Ion-exchange chromatography separates proteins on the basis of their charge. The resin 
quaternary ammonium was used for this procedure. This is classed as a strong anion 
exchange resin. F ig u r e  3.2.4.4.I. illustrates the separation of bound from unbound 
protein. There is overlap between the protein peak and activity peak, suggesting that 
this protein peak can be mainly attributed to DPP IV. This is verified by only a slightly 
smaller reduction in total protein content and enzyme activity as compared to the 
previous purification steps. However, this final step resulted in an overall 35-fold 
increase in purity.
The aim of protein purification is to isolate one particular protein from all other proteins 
in the starting material. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) separates proteins based primarily on their molecular weights (Laemmli, 
1 9 7 0 ) and is routinely used for determination of protein purity (Bollag et al., 19 9 6 c). 
F ig u r e  3 .2 .5 .1 .2 . clearly illustrates that most of the contaminating albumin was 
separated from DPP IV activity, however a small amount of albumin was co-purified 
with DPP IV (Lane 3 ). Shibuya-Saruta et al. (1 9 9 6 )  obtained similar results when they 
purified DPP IV from human serum. They successfully separated DPP IV from this 
contaminating albumin using a monoclonal antibody (Tal) affinity chromatography 
column, thus producing a purer enzyme preparation. However, a 6-fold decrease in 
activity was observed suggesting that this co-eluting albumin may have a stabilizing 
effect on the enzyme. Albumin is a major component of serum, representing up to 6 0  to 
7 0 %  of the total serum protein (Ung et al., 2 0 0 4 ) . A number of methods are available
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for depletion of albumin in serum samples. Dye affinity chromatography resins, 
employing chlorotriazine dyes, such as Cibacron Blue have been used for this purpose. 
Cibacron blue has three negatively-charged sulfonic acid groups and is known to bind at 
multiple sites on the surface of albumin. Although this dye can be used for the 
purification of many proteins e.g dehydrogenases and kinases, its most well-known 
application is its interaction with serum albumins (Hermanson et al., 1992). Most 
albumin depletion protocols utilize buffered salt solutions to reduce non-specific 
binding to the resin, which may lead to a loss of the desired protein. However, an 
alternative is the use of immunoaffinity chromatographic methods, which can offer 
extreme specificity. The antibodies used for these columns can be targeted against 
either the albumin (anti-albumin) or the enzyme of interest.
Since dipeptidyl peptidase IV was first discovered by Hopsu-Havu and Glenner in 1966, 
the enzyme has been purified to homogeneity from a variety of tissues including kidney 
(Yoshimoto & Walter, 1977), pancreas (Yoshimoto et al., 1982), human meconium 
(Caporale et al., 1985) and human serum (Duke-Cohan et al., 1995; Shibuya-Saruta et 
al., 1996). Although the standard chromatographic techniques previously discussed 
contributed considerably to the overall purification of DPP IV, it is the affinity resins 
that have reported the greatest purification factors. Seidl and Schaefer (1991) utilised 
the resin Gly-Pro-EAH-Sepharose to successfully achieve a 2964-fold increase in 
purity. This resin exploits, and is based the affinity between the enzyme and its 
corresponding substrate, Gly-Pro-AMC. This group also utilised the lectin affinity resin 
Concanavalin A-Sepharose, which has been widely used for both membrane bound and 
soluble DPP IV (Duke-Cohan et al., 1995).
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DeMeester et al. (1996) utilised immobilized adenosine deaminase (ADA), thus 
manipulating the DPP IV-AD A binding properties to purify DPP IV from human 
seminal plasma, achieving an overall purification factor of 262. However, Shibuya- 
Saruta et al. (1996) achieved an 18,000 fold purification, the highest observed, using a 
monoclonal antibody, Tal, bound to EAH-Sepharose when purifying human serum 
DPP IV, although the resulting yield of 2.2% suggests that active-site binding may 
reduce the lifetime of the enzyme.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) also allowed 
for estimation of the enzyme’s monomeric molecular weight, which was calculated to 
be 77,224 Da. This is in contrast to data obtained for DPP IV isolated from other 
mammalian sources, were subunit molecular weight was lOOkDa or higher (De Meester 
et al., 1996; Shibuya-Saruta et al., 1996). A dimeric structure has generally been 
proposed for this enzyme with reported weights for soluble DPP IV ranging between 
210-290 kDa (Engel et al., 2003). Therefore, bovine serum DPP IV would display a 
native molecular mass at about 150 kDa-160 kDa, this is lower than previously obtained 
for DPP IV isolated from bovine serum (Buckley et al., 2004). However, these results 
are consistent with those of DPP IV isolated from some microorganisms, e.g. DPP IV 
isolated from Flavobacterium meningosepticum is composed of two subunits of 75 kDa 
(Yoshimoto & Tsuru, 1982). A trimeric form of DPP IV has also been isolated from 
porcine seminal plasma with a reported subunit molecular weight of 105 kDa and native 
molecular mass of 310 kDa (Ohkubo et al., 1994). Differences in the molecular weight 
of DPP IV are influenced by the species, tissue and degree of glycosylation of the 
polypeptide chain of this glycoprotein (Sentandreu & Toldra, 2001). The native 
molecular weight for this enzyme was not determined. This can be determined by either
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native polyacrylamide gel electrophoresis or by gel filtration (Bollag et al., 1996b). 
Performing this step would have established whether the enzyme has a dimeric or 
trimeric structure. However the main purpose of SDS-PAGE was to determine the 
purity of the purified enzyme preparation.
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C h a p te r  4  
S tud ies  o n  D ipeptidyl Peptidase IV
4 .1 . R e su l t s  -  A ssa y  a n d  S t a b il it y  S t u d ie s  o n  D P P  IV
All of the upcoming graphs illustrate data points that represent the average of triplicate 
fluorescence intensity or absorbance readings (n=3), minus the blank measurement, 
standard deviation ± 5%. All error bars represent the standard error.
4.1.1. A s s a y  D e v e l o p m e n t
4.1.1.1. Autodigestion Assay
The process of DPP IV autodigestion was examined as described in section 2.5.1. 
F ig u r e  4.1.1.1.1. demonstrates that at 37°C no autodigestion was observed over a 
period of 240 minutes.
4.1.1.2. Linearity of Enzyme Assay with Respect to Time
The stability of DPP IV and its ability to cleave its corresponding substrate Gly-Pro- 
AMC with respect to time was examined as described in section 2.5.2.1. F ig u r e
4.1.1.2.1. demonstrates that serum DPP IV activity is linear (R2: 0.99) over a period of 
120 minutes.
4.1.1.3. Linearity of Assay with Respect to Enzyme Concentration
Linearity of purified DPP IV degrading activity with respect to enzyme concentration 
was determined as outlined in section 2 .5 .3 .1 . F ig u r e  4 .1 .1 .3 .1 . illustrates that th e  
enzyme assay is linear (R2: 0.98) with respect to enzyme concentration.
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F ig u r e  4.1.1.1.1, a u t o d ig e s t io n  o f  DPP IV o v e r  t im e  a t  3 7 °C
Plot of absorbance at 620nm versus time (minutes).
F ig u r e  4 .1 .L 2.1»
Time (minutes)
F ig u r e  4.1.1.2.1. DPP IV l in e a r it y  w it h  r e s p e c t  t o  t im e  a t  3 7 °C
Plot of fluorescence intensity (excitation 370nm, slit width 1 Onm; emission 440nm, slit 
width 2.5nm) versus time (minutes).
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Figure 4.1.L3.1.
D P P  IV C o n c e n tr a t io n  (% )
F ig u r e  4.1.1.3.1. L in e a r it y  o f  a s s a y  t o  DPP IV c o n c e n t r a t io n  a t  37°C  
Plot of fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus enzyme concentration (%). Value at 100% is equal to 43 enzyme 
units (refer: T a b l e  3.2.).
1 0 0
4 .1 .2 . T e m p e r a t u r e  S t u d ie s
4.1.2.1. Temperature Profile
A temperature profile of DPP IV was performed as outlined in section 2.7.1.1. 
Apparent activity increased to a maximum of 134% at 50°C. Activity decreased 
gradually above 58°C; however, activity at 64°C still equalled that at 37°C. The half­
inactivation temperature T50, where observed activity was 50% of 37°C rate after 10 
minutes incubation in a waterbath, was estimated at 71°C ± 1°C. FIGURE 4.1.2.1.1. 
illustrates the effect of temperature on enzyme activity.
F ig u r e  4.1.2.1.1,
F ig u r e  4.I.2.I.I. T e m p e r a t u r e  p r o f il e  o f  DPP IV
Plot of % residual activity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus temperature (°C). Residual activity is represented as a percentage 
of that at 37°C.
1 0 1
A thermoinactivation study was performed at 71 °C (T50) over a 60 minute period as 
outlined in section 2.7.2.1. FIGURE 4.1.2.2.1. illustrates the activity profile of DPP IV at 
71°C over the 60-minute period. Data were fitted to first order exponential decay 
equation (F ig u r e  4.1.2.2.2.). Data up to 28 minutes fitted well to a single exponential 
decay to give a ¿-value of 0.071 ± 0.003 min_1and apparent half-life (t*/2) of 10 minutes 
but, deviated above 30 minutes. After 60 minutes, 95% loss of original activity was 
observed. However, a double exponential decay plot at 71°C indicated that more than 
one molecular event was contributing to loss of activity at this temperature.
F ig u r e  4.I.2.2.I.
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F ig u r e  4.I.2.2.I. T h e r m o in a c t iv a t io n  o f  DPP IV a t  T 50 (71°C)
Plot of % residual activity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus time (minutes). Residual activity is represented as a percentage of 
the t = zero value.
4.I.2.2. Thermoinactivation of DPP IV
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F i g u r e  4.I.2.2.2.
Time (minutes)
F ig u r e  4.1.2.2.2. T h e r m o i n a c t i v a t i o n  D a t a  F it t e d  u p  t o  28 m in u t e s
Data for thermo inactivation at T50 (71°C) fitted to the first order exponential decay 
equation using the Enzfitter programme (Biosoft, Cambridge, UK).
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4 .1 .3 . O r g a n o t o l e r a n c e  S t u d ie s
4.1.3.1. Solvent Stability Studies
The stability of DPP IV in a range of solvents (0-90% (v/v)) was investigated as 
outlined in section 2.8.1.1. Threshold concentrations (C50) at which half-inactivation is 
observed were determined for each solvent (T able 4.1.). F igure 4.1.3.1.1. illustrates 
the effect of solvent concentration on enzyme activity. Activation effects were 
observed in THF (up to 139%; between 10-20% (v/v)) and up to 118% in DMF 
(between 10-30% (v/v)). However, THF was the most potent denaturing solvent 
(observed C50 at 32% (v/v) solvent concentration). In acetonitrile, the enzyme retained 
50% of its original activity at 70% (v/v) solvent concentration.
4.1.3.2. Temperature Profile of DPP IV in Organic Solvents
A temperature profile of DPP IV was examined in a range of solvents each at 50% (v/v) 
concentration as outlined in section 2.7.1.1. F ig u r e  4.1.3.2.1. illustrates the effect of 
solvent on the temperature profile of DPP TV. At 37°C a dramatic loss of DPP TV 
activity was observed in each of the tested solvents (relative to aqueous DPP TV). 
Activation effects were observed in 50% (v/v) DMSO (at 45°C; relative to value at 
37°C); however, activity declined dramatically above this temperature. No enhanced 
thermostability was observed in acetonitrile, DMF or THF, where activity was minimal 
at all temperatures examined.
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A thermoinactivation study was performed at 37°C over a 30 minute period as outlined 
in section 2.7.2.1. F ig u r e  4.1.3.3.1. illustrates the activity profile o f DPP IV in a range 
of organic solvents at 50% (v/v) at 37°C over 30 minutes. At time equals zero only 
DPP IV in acetonitrile had comparable activity to native enzyme, and a steady decline 
in activity Was observed over the 30 minute time period. In contrast, placing DPP IV in 
DMSO resulted in an initial 20% loss in activity. However, 80% activity remained after 
30 minutes. Minimal activity was observed in DMF and THF.
4.1.3.3. Thermoin activation of DPP IV in Organic Solvents
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F i g u r e  4.I.3.I.I.
Solvent Concentration (%)
F ig u r e  4.13.1.1. So l v e n t  s t a b il it y  o f  DPP IV
Plot of % residual activity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus solvent concentration (%). Residual activity is represented as a 
percentage of that in aqueous buffer (C = zero value).
T a b l e  4.1. O b s e r v e d  C50 v a l u e s  f o r  DPP IV in  o r g a n ic  s o l v e n t s
(Assay performed in triplicate)
So l v e n t O b s e r v e d  C50 v a l u e s
Acetonitrile 77% ±0.5%
DMSO 54% ±1%
DMF 47% ±0.5%
THF 33% ±0.5%
1 0 6
F i g u r e  4.I.3.2.I.
Temperature (°C)
F ig u r e  4.I.3.2.I. T e m p e r a t u r e  p r o f il e  in  50% (v/v) o r g a n ic  s o l v e n t  
Plot of fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus temperature (°C).
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F ig u r e  4.I.3.3.I. T h e r m o in a c t iv a t io n  i n  50% (v/v) o r g a n ic  s o l v e n t  a t  37°C 
Plot of fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus time (minutes).
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4 .1 .4 . p H  S t u d ie s
4.1.4.1. Effect of pH on DPP IV Activity
The effect of pH on DPP IV activity was determined as outlined in section 2.9.1. In 
order to determine if  the effects on activity was due to buffer or pH, buffer systems with 
overlapping pH values were compared (T a b l e  4.2.). F ig u r e  4.1.4.1.1. illustrates the 
effect of both buffer and pH on DPP IV activity. T a b l e  4.2. illustrates the direct effect 
of the buffer. Complete inactivation occurred at pH 4.0. At pH 5.5 a 25% decrease in 
enzyme activity was observed when the buffer system was changed from acetate to 
MES. Activity decreases of 65% and 67% were observed at pH 7.0 and 7.5, 
respectively, on changing from MOPS to HEPES. At pH 9.0 the enzyme was more 
active in CHES than in Tris. Optimum pH was observed between 7.5 and 9.0.
4.1.4.2. Effect of pH on DPP IV Kinetics
Michaelis-Menten kinetics were determined at each pH point as described in sections
2.6.1. and 2.9.1. In 50mM HEPES, pH 8.0, DPP IV displayed Michaelis-Menten 
kinetics giving Vmax and Km values of 0.00142 + 0.00014 pM/min"1 and 173 ± 7.6 pM'1, 
respectively. Two pK  values were observed at pH 6.18 ± 0.07 and 9.7 ± 0.5 (Enzfitter 
software; data not shown). Both occurred in plots of log VmdJK m and log l/Km versus 
pH; only the upper value occurred in a plot of log Fmax against pH (F ig u r e s  4.1.4.2.1. 
and 4.1.4.2.2.). F ig u r e  4.1.4.2.1. illustrates the classical bell-shaped curve and the pK  
values derived from the plot of log V/Km versus pH.
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A temperature profile of DPP IV was examined at various pH values in different buffer 
systems as outlined in section 2.9.2. The ha!f-inactivation temperature Tso, was 
calculated for each buffer system at similar pH values (Ta b l e 4.3. and 4.4,). Figures
4.1.4.3.1. and 4.1.4.3.2. illustrate the effect o f pH on the temperature profile of DPP IV. 
At temperatures above 72°C DPP IV demonstrated activity in only the following 
buffers; acetate, pH 5.5 and I-IEPES, pH 8.0; however, activity was minimal. DPP IV 
exhibited higher activity in acetate than MBS buffer at pH 5.5. At pH 6.5, DPP IV was 
up to 70% more active in MES than in MOPS buffer (between 37-60°C). Activity was 
higher in I-IEPES than Tris, at pH 8.0. DPP IV demonstrated similar activity (between 
64-72°C) when placed in either Tris or CHES, pH 9.0.
4.1.4.3. pH Thermostability
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F ig u r e  4.I.4.I.I. E f f e c t  o f  p H /b u f f e r  o n  DPP IV a c t iv it y
Plot of fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus pH.
T a b l e  4.2. C o m p a r is o n  o f  DPP I V  a c t iv it y  in  v a r io u s  b u f f e r  s y s t e m s  a t  
s im il a r  p H . (F I =  F l u o r e s c e n c e  In t e n s it y )
Buffer
*
pH -» 5.5
(FI)
6.5
(FI)
7.0
(FI)
7.5
(FI)
8.0
(FI)
9.0
(FI)
76.5
MES 58.1 207.7
MOPS 173.2 291.7 333.8
HEPES 99.9 108.2 197.5
Tris 159.5 163.4
CHES 300.1
n o
F i g u r e  4.I.4.2.I.
ic
I
o
x
E
>
CD
o
pH
F ig u r e  4.1.4.2.1. E f f e c t  o f  pH o n  t h e  k in e t ic s  o f  DPP IV
Plot o f Log V/Km x 10’7 (min"1) versus pH
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F ig u r e  4.I.4.2.2. E f f e c t  o f  pH DPP IV k in e t ic s
Plot o f Log V(jj,M/min) versus pH and plot of Log l/Km (|iM) versus pH
i l l
F i g u r e  4.I.4.3.I.
Temperature (°C)
F ig u r e  4.L4.3.1. pH T e m p e r a t u r e  p r o f il e  o f  DPP IV (pH 5.5-6.S)
Plot of fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus temperature (°C).
T a b l e  4.3. O b s e r v e d  T50 v a l u e s  in  d if f e r e n t  b u f f e r  s y s t e m s  (pH 5.5-6.5)
(Assay performed in triplicate)
Buffer
*
p H -» 5.5
Tso
6.5
t 50
Sodium acetate 63°C ± 0.5°C
MES 62°C ± 0.5°C 66°C ± 0.5°C
MOPS 65°C±0.5°C
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F i g u r e  4.I.4.3.2.
Temperature (°C)
F ig u r e  4.I.4.3.2. pH T e m p e r a t u r e  p r o f il e  o f  DPP IV (pH 7.0-9.0)
Plot of fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus temperature (°C).
T a b l e  4.4. O b s e r v e d  T50 v a l u e s  in  d if f e r e n t  b u f f e r  s y s t e m s  (pH 7.0-9.0)
(Assay performed in triplicate)
Buffer
*
pH -» 7.0
T50
8.0
T50
9.0
T50
MOPS 66°C ±0.5°C
HEPES 68°C ± 0.5°C 71°C + 0.5°C
Tris 69°C ± 0.5°C 68°C± 1°C
CHES 68°C±0.5°C
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Bickerstaff and Zhou (1993) developed a method to determine directly autolytic 
processes of a protease. This method gives a direct indication of the loss of enzyme 
protein with time and eliminates the need for gel electrophoresis (used to determine 
autolytic products/protein reduction). It employs the Coomassie blue dye reagent and 
enzyme alone, enabling the protein content to be monitored, while providing a direct 
measurement of autolytic activity. No autolysis was observed over the assay period at 
37°C (F ig u r e  4.1.1.1.1.). The resistance of DPP IV to proteolysis has been documented 
(Lambeir et al., 1997).
F ig u r e  4.1.1.2.1. illustrates that bovine serum DPP IV catalysed the linear release of 
AMC over the standard 60-minute assay period and up to 120 minutes, thus allowing 
for longer analysis if  required. This shows that DPP IV is not only stable but also, fully 
active and saturated with sufficient substrate over this longer time.
Under given conditions, two enzyme molecules acting independently in solution will 
transform twice as much substrate in a given time as one molecule, hence, the velocity 
should be proportional to the enzyme concentration. This is found in a majority of cases 
and is the basis of nearly all enzyme assay methods. However, deviations can occur, 
and a linear relationship between velocity and enzyme concentration in the range used 
should be established before any further attempt at kinetics, or before attempts to 
calculate specific activities are made. Departures from linearity are due to an artefact of 
the assay system, but there are cases where such behaviour is a property of the enzyme 
itself (Dixon & Webb, 1979a).
4.2. Discussion
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F ig u r e  4.1.1.3.1. illustrates that fluorescence intensity increases linearly and 
proportionally with the increase in enzyme concentration at 37°C. Hence, the enzyme 
hydrolyses at the same rate depending on the quantity o f enzyme present.
The rate of inactivation of an enzyme in solution increases rapidly with the temperature. 
In most cases, inactivation becomes virtually instantaneous at temperatures well below 
100°C and, in some cases, below 70°C (Dixon & Webb, 1979b). However, there are a 
number o f enzymes that can withstand more extreme temperatures and remain 
catalytically active. The growth optimum of citrate synthase from the thermophilic 
Archaea Pyrococcus furiosus was found at 100°C (Danson & Hough, 1998). An 
extremely thermoresistant serine protease from Staphylothermus marinus maintains 
catalytic activity after 10 minutes at 135°C. A subtilisin-type serine protease detected in 
Pyrococcus furiosus called pyrolysin was found to retain 50% of its activity after a 20- 
minute 105°C challenge (Eichler, 2001).
An enzyme denatures at an elevated temperature due to unfolding of the protein 
backbone. At high temperatures, the enzyme loses its “regular” non-covalent 
interactions that support the native structure at moderate temperatures, and acquires 
high temperature ‘non-native’ non-covalent bonds. As the temperature decreases, these 
“irregular” non-covalent interactions, although thermodynamically unstable, remain and 
the molecular mobility of the polypeptide chain decreases with decreasing temperature. 
Hence, the protein remains denatured and cannot spontaneously reacquire the native 
form at low temperature (Mozhaev & Martinek, 1982). However, it has been shown 
that bonds and interactions at secondary and tertiary structural levels may indeed be 
broken without loss of any activity. Moreover, enzymes may be “stabilized” or 
“protected” against deactivation. Therefore, in these situations, it is important to know
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not only the amount of denaturation required to abolish enzyme activity but also the 
order of denaturation stages, which often plays a significant role. Hence, it is 
reasonable to expect that more than one bond of a particular type or more than one 
“sensitive structure” must be broken before significant changes in conformation leading 
to loss of activity occur (Henley & Sadana, 1985). Bovine serum DPP IV demonstrated 
an increase in catalytic activity up to 62°C (maximal activity observed at 50°C, T50 at 
71°C), showing an apparent activation, as opposed to the expected thermal inactivation. 
This is well above normal mammalian body temperature (37°C). Durinx et al. (2000) 
investigated the thermostability of human serum DPP IV over the range 25-80°C. They 
determined optimum temperature between 50-60°C. Similar results were obtained for 
porcine seminal plasma DPP IV (Ohkubo et al., 1994). Yoshimoto et al. (1978) have 
reported an optimum temperature of 60°C for lamb kidney DPP IV with 50% of activity 
retained up to 72°C. Despite these reports, all routine and kinetic assays were 
performed at physiological temperature, 37°C.
Activity loss with time was investigated at 71°C (T50). Double exponential decay at this 
temperature indicated that more than one molecular event was contributing to loss of 
activity at this temperature; however, data (up to 28 minutes) fitted well to single 
exponential decay, allowing the estimation of an apparent half-life (10 minutes). The 
first step in the inactivation of an oligomeric enzyme is the dissociation into nonactive 
subunits (Trubetskoy & Torchilin, 1985). Kurganov et al. (2000) suggested that 
denaturation proceeds by a dissociative mechanism, as determined by their investigation 
of the thermal denaturation of rabbit skeletal muscle glycogen phosphorylase b. This 
mechanism involves the reversible dissociation of the active dimer into the
corresponding inactive monomers, followed by the irreversible denaturation of the
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monomer. As demonstrated by the inactivation kinetics of DPP IV at 71°C, one 
inactivation process seems to dominate over a short period of time, after which a second 
process is apparent at longer times. This mechanism of dissociative unfolding could 
therefore be applied to explain the inactivation kinetics of dimeric bovine serum DPP 
IV. This unfolding could be monitored by gel electrophoresis, as the unfolded protein 
migrates less rapidly than the compact folded forms (Creighton, 1993c). Structural 
changes could be verified by LC-MS protein characterization analysis. This method 
gives an accurate mass of the intact protein, observing the loss of one or more amino 
acids. Denaturation can also be measured by fluorescence spectroscopy. This process 
causes an abrupt increase in the fluorescence intensity and wavelength of maximal 
emission (^max) as a result of contact between the aromatic chromophores (buried within 
the hydrophobic core of the protein) with the polar (solvent) environment e.g. 
fluorescence intensity increased and /-max shifts from 333nm to 340nm were observed 
upon thermal denaturation of oc-chymotrypsin (Mozhaev et al., 1989).
For enzymes to exhibit their full catalytic properties they must have a strictly defined or 
native conformation. A network of hydrogen bonds, electrostatic and hydrophobic 
interactions, determines this conformation, which is maintained by an essential 
hydration layer of tightly bound water. Replacement of this water shell with an organic 
solvent may affect the nature of biocatalysis in a number of ways, solvents may; (1) 
interact with the essential hydration layer o f the enzyme (2) disrupt the hydrogen bonds, 
ionic or hydrophobic interactions, altering the native conformation by direct interaction 
with the protein (Khmelnitsky et al., 1988; Dordick 1991). The concentration at which 
half inactivation (C50) is observed was determined for each solvent (T a b l e  4.1). THF 
was found to be the most deleterious solvent. This corresponds with it having the
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highest denaturing capacity (DC = 100) correlating with the findings of Mozhaev et al. 
(1989). However, an activation effect was observed up to 20% (v/v) concentration, 
after which activity greatly decreased where little or no activity was exhibited above 
40% (v/v) concentration. This activation effect may be explained in two ways (1) 
changes in the conformation of the enzyme molecule caused by introducing the solvent 
into the system or (2) the solvent participating in the enzymatic reaction by acting as an 
additional nucleophile in the deacylation step (Khmelnitsky et al., 1988). The enzyme 
was most stable in acetonitrile, where at 70% (v/v) the enzyme still retained up to 70% 
initial activity. Enzyme activity in DMSO steady declined to a minimum observed 
between 60-90 % (v/v). As F ig u r e  4 . 1.3.1.1. illustrates, increasing solvent 
concentration (DPP IV in DMF) did not affect the catalytic activity; however, after a 
critical concentration of solvent had been reached, further addition resulted in an abrupt 
decrease in enzyme activity. The effect of solvent on protein conformation in organic 
media can be determined by means of high-resolution x-ray crystallography. This is a 
useful method to elucidate the three-dimensional structure of the enzyme in solvent and 
compare it to that in aqueous solution. Fitzpatrick et al. (1993) used this method to 
determine changes in the structure of subtilisin Carlsberg in anhydrous acetonitrile. 
Their findings concluded that the three-dimensional structure in anhydrous acetonitrile 
was essentially identical to that in water.
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T a b l e  4.5. C h a r a c t e r i s t i c s  o f  O r g a n i c  S o l v e n t s  (Gupta et al. 1997)
S o l v e n t DK.NATI RATION C A P A C I T Y  ( D C )
A ce t on i tr i l e 64.3
DMF 63.3
DMSO 60.3
THF 100
No enhancement of thermostability was observed at any temperature when DPP IV was 
placed in any of the given solvents (50% (v/v)): only minimal activity was present as 
compared to DPP IV in aqueous buffer. Activity in DMSO was higher relative to other 
solvents (up to 47°C) after which a dramatic decrease in activity was observed. Similar 
results were obtained for thermoinactivation studies in 50% (v/v) solvent, at 37°C. DPP 
IV in aqueous buffer remained stable over the duration of the experiment. When DPP 
IV was placed in DMF or THF no appreciable activity was observed after two minutes 
(relative to DPP IV in aqueous buffer). In contrast only a minimal loss in activity was 
observed over the duration, when the enzyme was placed in DMSO. This diminished 
activity is not uncommon in aqueous-organic mixtures and can occur as a result of the 
enzyme being driven to denature by the organic component and being enabled to 
succumb to this denaturation by the aqueous component. Therefore, in such mixtures 
activity may drop below that seen when the enzyme is in pure water (Klibanov, 2001). 
This is possibly the reason why no enhanced stability was observed. 
pH influences the secondary, tertiary and quaternary structure of proteins. Hence, the 
rate of inactivation of an enzyme, like other protein denaturation, is in most cases 
greatly dependent on the pH of the solution. pH inactivation of an enzyme involves
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unfolding of the protein caused by changes in the balance of electrostatic and hydrogen 
bonding. These changes occur due to pH-induced alterations in the ionisation states of 
functional groups on the protein. The effect of pH may vary greatly from one enzyme 
to another. However, in general there is a zone of maximum stability, and the 
inactivation increases on the acid and alkaline side. In most cases a definite optimum 
pH is observed. The effect of pH on enzyme-catalyzed reactions is separated into two 
categories (1) pH influence on binding and catalysis (2) pH influence on enzyme 
stability. (Dixon & Webb, 1979c; Sadana & Henley, 1988).
The effect of pH on the thermostability of DPP IV was investigated. To determine if 
irreversible destruction occurred, enzyme activity was tested after readjustment to the 
standard pH 8.0 in 50mM buffer (having been previously exposed to range of pH values 
in 20mM buffer). The activity of DPP IV between 5.5-6.5 (acetate, MES) decreased 
steadily after 60°C, indicating decreased thermostability at non-neutral pH values. The 
highest activity was observed at pH 6.5 in MES (F ig u r e  4.1.4.3.1.) The T 5o value 
obtained for DPP IV in 20mM Tris, pH 8.0 was only 2°C less than that in 20mM 
HEPES, pH 8.0; therefore, changing the buffer did not greatly influence DPP IV 
thermostability. However, comparison of observed T50 values at each pH indicates that 
DPP IV is more thermostable in the neutral-alkaline pH region, with optimum stability 
observed at pH 8.0 in HEPES buffer. Irreversible destruction was observed in most 
cases at temperatures above 70°C. It should be mentioned that the pH of buffer 
solutions are influenced by changes in temperature e.g. pH 7.0 Tris buffer prepared at 
4°C would have a pH of 5.95 at 37°C, this occurs because of temperature-dependent 
changes in the dissociation constant (pA'a) of ions in solution (Boyer, 2000). Therefore, 
further investigation is required to determine if possible changes in the pH of buffer
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occurred with increasing temperature. These changes maybe assessed and accounted 
for by following theoretical procedures for calculating the practical pK values that apply 
to buffers under chosen experimental conditions and for determining the ionic strength 
of buffers at various pH values (Ellis & Morrison, 1982).
The effect of pH on DPP IV activity was investigated. Sodium acetate, MES, MOPS, 
HEPES, Tris and CHES buffer systems were used. F ig u r e  4.1.4.1.1. illustrates a non- 
classical bell-shaped curve, with neutral pH preferred. These results are comparable to 
Sentandreu and Toldra (2001) and Buckley et al. (2004), who found similar results 
when they studied DPP IV from porcine skeletal muscle and bovine serum, 
respectively. Complete inactivation was noticed at pH 4.0. This is similar to the 
findings of Duke-Cohan et al. (1995), who reported complete inhibition of human 
serum DPP IV at acidic pH 4.5-5.0. F ig u r e  4.1.4.1.1 shows a broad, stable pH range 
7.0-10 at 37°; however, this depends on the buffer system used. The objective of these 
pH studies was to ascertain the direct effect of pH on DPP IV activity. This is achieved 
by altering the pH of the buffer species within the limits of its buffering capacity, i.e.
1.0 pH unit either side of its designated piTa. Hence, the buffer species also changes as 
pH is altered, creating two variables to study, i.e. pH effect and buffer effect. This 
problem can be minimised if overlapping pH values are used between various buffer 
systems. However, some buffers can themselves have a specific effect on enzymatic 
activity regardless of pH, e.g. phosphate inhibits certain enzymes, including kinases, 
phosphatases, and dehydrogenases (Bollag et al., 1996d). T a b l e  4.2. demonstrates the 
direct effect of changing the buffer on DPP IV activity. Activity was higher at pH 8.0 
in HEPES than in Tris and was greatest at pH 7.5 in MOPS buffer. These results are 
similar to Yoshimoto and Walter (1977), who reported a pH optimum of 7.8 for lamb
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kidney DPP IV. However, all routine assays were performed at pH 8.0, in HEPES 
buffer.
The effect of pH on DPP IV kinetics with Gly-Pro-AMC as substrate was investigated. 
Sodium acetate, MES, MOPS, HEPES, Tris and CHES buffer systems were used. To 
determine pK values, a plot of Log V/Km versus pH was constructed, giving the pK  
values for the free enzyme [E] and free substrate [S] (Fersht, 2002a). F ig u r e  4.1.4.2.1. 
illustrates the classical bell-shaped curve, which indicates that at least two ionising 
groups change their state of protonation as the pH is raised from pH 4 to more alkaline 
values. In F ig u r e  4.1.4.2.1. it is clearly demonstrated that the pKB is far above the p 
giving rise to a bell shaped curve with a flat top. Two pK  values are observed at 6.18 
and 9.7. These values occur in plots of Log VKm and log V/Km versus pH as downward 
bends, indicating that they belong to the free enzyme [E] and free substrate [S] (Dixon 
& Webb, 1979c; Fersht, 2002a). The 9.7 value alone occurs as an upward bend in the 
plot Log V versus pH. This represents the value affecting the enzyme-substrate [ES] 
complex. The upper pATa value of 9.7 possibly belongs to the a-amino group of the Gly 
moiety on the substrate Gly-Pro-AMC, as this value is common to plots indicating pK  
values in both the [ES] complex and also in the free [E] and free [S]. The unique 
arrangement of the DPP IV catalytic triad renders this a non-classical serine protease. 
Its catalytic residues are arranged in the unique order Ser-Asp-His (nucleophile-acid- 
base) order, different from that found in classical serine proteases such as the trypsin 
and subtilisin families. The 200 C-terminal residues of DPP IV containing the catalytic 
triad have similarity with several other non-classical serine hydrolases including prolyl 
oligopeptidase (Abbott et al., 1999). A general catalytic triad reported is Ser63o, Asp7o8, 
His74o. However, the exact position of these residues may vary in different species, e.g.
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murine DPP IV -  Ser624, Asp702, and His734, bovine DPP IV -  Ser63o, Asp702, and His734, 
(Niedermeyer et al., 1998; DeMeester et al., 1999; Lee et al, 2002). It is tempting to 
assign a measured pK  value to a particular amino acid side chain, from tables of values 
pertaining to the pK  for free amino acids, but one should bear in mind that the side- 
chain environment within an enzyme may differ from that of the free amino acid 
causing a shift in pK  (Price & Stevens, 1999). With this in mind, the lower pK  value 
(6.18) was attributed to that of His734 in the enzyme active site.
The results presented here reveal that DPP IV from bovine serum does not undergo 
autolysis at 37°C and is catalytically active up 62°C, with T50 determined at 71°C ± 
1°C. Solvent stability studies indicate that the enzyme is most stable in acetonitrile up 
to 70% (v/v). In comparison, activity in DMF and DMSO declines above 40% (v/v) 
and THF is the most deleterious solvent to the enzyme. pH studies show that DPP IV 
displays maximum activity at pH 7.5, and is completely inactive at pH 4.0. The effect 
of pH on the thermostability of DPP IV indicates that the enzyme is most thermostable 
in the neutral-alkaline pH region, with optimum thermostability observed at pH 8.0. 
Kinetic studies indicate that DPP IV activity depends on the ionization of a group with a 
pK  value of 6.18, which has been attributed to the active site histidine residue.
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C h a pter  5
R ec o m b in a n t  F a s c io la  h ep atica  Ca th e p s in  L1 S tudies
Cathepsin L is an endopeptidase. It preferentially cleaves peptide bonds with 
hydrophobic amino acid residues in P2 and P3 (Barrett et al., 1998). The amide 
substrate, Z-Phe-Arg-AMC when hydrolyzed by cathepsin L releases AMC, which is 
monitored fluorometrically, making this a sensitive and suitable substrate. The ester 
substrate Z-Lys-ONp when hydrolyzed by cathepsin L releases ONp and is determined 
colorimetrically.
Recombinant Fasciola hepatica cathepsin LI (rFheCLl) was investigated with regards 
to temperature and solvent stability prior to chemical modification of the enzyme. A 
temperature profile was determined and the apparent half-inactivation temperature (T50) 
estimated. The effect of organic solvents on rFheCLl was investigated following 
exposure to a range of solvents at various concentrations and the half-inactivation 
concentration ( C 50)  determined. The steady state kinetics of native and modified 
(section 6.2.3.) rFheCLl were studied to compare the respective Km and kcat values and 
to observe the effects of modification on rFheCLl -catalyzed aminolysis.
5.1. In t r o d u c t io n
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5.2. Re su l t s  -  A ssa y  a n d  St a b il it y  St u d ie s  o n  rFheCLl
All of the upcoming graphs illustrate data points that represent the average of triplicate 
fluorescence intensity or absorbance readings (n=3), minus the blank measurement; 
standard deviation ± 5%. All error bars represent the standard error.
5 .2 .1 . A M C  S t a n d a r d  C u r v e s  a n d  t h e  I n n e r  F i l t e r  E f f e c t
AMC standard curves were prepared as outlined in Section 2.4.1.1. Plots of 
fluorescence intensity versus AMC concentration (micromol) were constructed (section
3.2.2. F ig u r e  3.2.2.1.) and the slope of the lines calculated. The inner filter effect was 
also performed as described in section 2.4.1.2. to assess the effect on fluorescence of 
including the post column fraction in the assay mixture. F ig u r e  5.2.1.1. is a plot of 
fluorescence intensity versus AMC concentration (micromol) for purified rFheCLl. 
T a b l e  5.1. lists the slopes calculated for each curve and the degree of filtering observed 
for the enzyme sample.
T a b l e  5 .1 . S l o p e s  o f  f il t e r e d  s t a n d a r d  c u r v e s
S a m p l e s i S l o p e F il t e r in g  (% )
B u f f e r 0.99 59.99 0.0
A c t iv a t e d  rFheCLl 0.99 59.74 0.5
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F i g u r e  5 .2 .1 .1 .
AMC (micromol)
F ig u r e  5.2.1.1. AMC Q u e n c h e d  S t a n d a r d  C u r v e
Plot o f fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width, 2.5nm) versus free AMC concentration (micromol) (•). The quenching agent 
used was purified rFheCLl (A).
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5 .2 .2 . P r o t e i n  D e t e r m in a t io n
Bovine Serum Albumin (BSA) standard curves were prepared as outlined in section
2 .4 .2 . Plots of protein absorbance at 560nm versus BSA concentration (mg/ml) were 
constructed (section 3 .2 .3 ; F ig u r e  3 .2 .3 .2 .)  for standard BCA assays.
5 .2 .3 . A s s a y  D e v e l o p m e n t
5 .2 .3 .1 . Autodigestion Assay
The process of native rFheCLl autodigestion was examined as described in section
2.5.1. F ig u r e  5.2.3.1.1. demonstrates that at 37°C no autodigestion was observed over 
a period of 240 minutes.
5 .2 .3 .2 . Linearity of Enzyme Assay with Respect to Time
The stability of rFheCLl and its ability to cleave its corresponding substrate Z-Phe-Arg- 
AMC with respect to time was examined as described in section 2 .5 .2 .2 . FIGURE
5.2.3.2.1. demonstrates that rFheCLl activity is linear (R2: 0.99) over a period of 30 
minutes.
5 .2 .3 .3 . Linearity of Assay with Respect to Enzyme Concentration
Linearity of purified rFheCLl degrading activity with respect to enzyme concentration 
was determined as outlined in section 2.5.3.2. F ig u r e  5.2.3.3.1. illustrates that the 
assay is linear (R2: 0.97) with respect to enzyme concentration.
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FIGURE 5.2.3.1.1.
T im e  (m in u te s)
F ig u r e  5.2.3.I.I. A u t o d ig e s t io n  o f  rFheCLl o v e r  t im e  a t  37°C 
Plot o f absorbance at 620nm versus time (minutes).
F ig u r e  5.2.3.2.I.
Time (minutes)
F i g u r e  5 .2 .3 .2 .L  r F h e C L l L i n e a r i t y  w i t h  r e s p e c t  t o  t i m e  a t  3 7 ° C
Plot o f fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus time (minutes).
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F i g u r e  5.2.3.3.I.
r F h e C H  c o n c e n tr a tio n  (% )
F ig u r e  5.2.3.3.1. L in e a r it y  o f  a s s a y  t o  r F h e C L l c o n c e n t r a t io n  AT 37°C
Plot of fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus rFheCLl concentration (%). Value at 100% is equal to an enzyme 
protein concentration of 2(ig/ml.
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5.2.4. T e m p e r a t u r e  S t u d ie s
5.2.4.1. Temperature Profile
A temperature profile of native rFheCLl was performed as outlined in section 2.7.1.2. 
Apparent activity increased to a maximum of 265% at 65°C, above which activity 
decreased; however, at 70°C activity was still greater than that observed at 37°C. The 
T50, where observed activity was 50% of maximal rate after 10 minutes incubation in a 
waterbath, was estimated as 78°C ± 1°C. F ig u r e  5.2.4.1.1. illustrates the effect of 
temperature on enzyme activity.
5.2.4.2. Thermoinactivation of rFheCLl
A thermoinactivation study was performed at 78°C (T 50)  over a 30 minute period as 
outlined in section 2.7.2.2. F i g u r e  5.2.4.2.1, illustrates the activity profile of rFheCLl. 
Data fitted satisfactorily to a single exponential decay to give a ¿-value of 0.12 ± 0.01 
min"’and apparent half-life (t/2) of 5.4 minutes. After 30 minutes, less than 1% activity 
remained.
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F ig u r e  5 .2 .4 .I .I .
- i --------------- 1----------------1-------------- r
47 52 57 6 2  6 7  72
T e m p e r a t u r e  ( ° Q
F ig u r e  5 .2 .4 .I . I .  T e m p e r a t u r e  p r o f il e  o f  r F h e C L l
Plot of % residual activity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus temperature (°C). Residual activity is represented as a percentage 
of that at 37°C.
F ig u r e  5 .2 .4 .2 .I .
100
i i i i i i i i i i i i i i
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F ig u r e  5 .2 .4 .2 .1 . T h e r m o i n a c t i v a t i o n  D a t a  F it t e d  u p  t o  3 0  m in u t e s
Data for thermoinactivation at T50 (78°C) fitted to the first order exponential decay 
equation using the Enzfitter programme (Biosoft, Cambridge, UK).
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5 .2 .5 . O r g a n o t o l e r a n c e  S t u d ie s
5.2.5.I. Solvent Stability Studies
The organotolerance of rFheCLl was investigated as outlined in section 2.8.1.2. for the 
following organic solvents: acetone, acetonitrile, DMF, DMSO and THF. Graphs of % 
residual activity versus solvent concentration (%) were plotted for each solvent and 
half-inactivation concentrations (C 50)  were determined for each solvent ( T a b l e  5.2.). 
F i g u r e  5.2.5.1.1. illustrates the effect o f solvent concentration on enzyme activity. 
Activation effects were observed in all of the solvents studied with the exception of 
THF, which was found to be the most potent denaturing solvent ( C 50 at 26% (v/v) 
solvent concentration). In 70% (v/v) acetone and acetonitrile, enzyme activity was still 
greater than in the absence of solvent.
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F ig u r e  5 .2 .5 .I .I .
Solvent Concentration (%)
F i g u r e  5.2.5.I.I. S o l v e n t  s t a b i l i t y  o f  rFheCLl
Plot o f % residual activity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus solvent concentration (%). Residual activity is represented as a 
percentage of that in aqueous buffer (C=zero value).
T a b l e  5.2. O b s e r v e d  C50 v a l u e s  f o r  rFheCLl in  o r g a n ic  s o l v e n t s .
(Assay performed in triplicate).
S o l v e n t O b s e r v e d  C 5o v a l u e s
Acetone 79% ±2%
Acetonitrile 78% ±2%
DMF 63% +2%
DM SO 66% ±2%
THF 26% ± 1 %
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Active site protease concentration was determined as described in 2.10.1. F ig u r e
5.2.6.1. illustrates the titration of rFheCLl with E-64. The concentration of active 
enzyme was determined from this plot, where the intercept on the x-axis (best line fit) is 
equal to the concentration of active enzyme. The enzyme was determined to have an 
operational molarity of 0.58p.M, 78.4% of that expected on a protein basis.
5.2.6. A c t i v e  S i t e  T i t r a t i o n  o f  rFheCLl
F ig u r e  5.2.6.I.
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F ig u r e  5.2.6.I. T it r a t io n  o f  r F h e C L l w it h  E-64
Plot of fluorescence intensity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) and activity (micromol/ml/min) versus E-64 concentration (micromol)
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5.2.7. rFheCLl Kinetics
Michaelis-Menten kinetics was determined for native enzyme as described in section
2.6.2. Native rFheCLl displayed Michaelis-Menten kinetics giving ¿cat and Km values of 
0.49 s'1 and 14.6 ± 0.6 (J.M1, respectively. Values of ¿cat were calculated from the 
equation FmaX/[E] = ¿cat, where [E] is the active enzyme concentration (section 5.2.6). 
The ¿cat/Km was determined to be 33,562 s'1 M '1 for the amidase substrate Z-Phe-Arg- 
AMC.
5.2.8. E s t e r a s e  A c t i v i t y
The eslerase activity of rFheCLl was determined as described in section 2.4.3.4. F ig u r e
5.2.8.1. demonstrates that the assay is linear up to 9 minutes (R~ 0.99). Optimum 
enzyme and substrate concentrations were determined at 0.1 mg/ml and 0.5mM 
respectively for this assay. The kcJ K m was determined to be 1648 s '1 M '1 for the ester 
substrate Z-Lys-ONp.
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F i g u r e  S.2.8.1.
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F i g u r e  5.2.8.I. E s t e r a s e  a c t i v i t y  d e t e m i n a t i o n  f o r  rFheCL 1 a t  37°C 
Plot of change in absorbance at 405nm over time (minutes) for rFheCLl using Z-Lys- 
ONp as substrate.
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No autolysis was observed over the assay period at 37°C, pH 5.0 (FIGURE 5.2.3.1.1.). 
These results are comparable with Dowd et al. (2000), who demonstrated that fluke 
(Fasciola hepático) cathepsin LI remained fully active after incubation at 37°C for 20 
hours. However, they performed the assay at pH 7.0. Human liver cathepsin L retained 
at least 70% of its initial activity when incubated for 24 hours at 37°C in the pH range 
4.5-5.0. At pH 7.0, however, 85% of activity was lost after only 15 minutes incubation 
(Mason et al., 1985). F ig u r e  5.2.3.2.1. illustrates that rFheCLl catalysed the linear 
release of AMC over the standard 30-minute assay period and up to 60 minutes, thus 
allowing for longer analysis if required. This demonstrates that rFheCLl is not only 
stable but also is fully active and saturated with sufficient substrate over this longer 
time.
F ig u r e  5.2.3.3.I. illustrates that fluorescence intensity increases linearly and
proportionally with the increase in enzyme concentration at 37°C. Therefore, the
enzyme hydrolyses at the same rate depending on the quantity of enzyme present.
Protein molecules are stable within a certain temperature range. However the subtle
balance between the folded and unfolded state can be disrupted by a number of factors
including temperature. The upper temperature for activity in enzymes appears to be
governed by the limits of protein stability, since, there is no theoretical upper limit for
conformational stability of proteins. It is possible, however, that irreversible reactions
occurring when the protein has unfolded will set this temperature limit. Enzymes exist
with optima above 100°C (previously discussed, section 4.2); indeed, some extremely
thermophilic enzymes are known to have significant half-lives above 120°C (Daniel,
1996; Eichler, 2001). Dowd et al. (2000) investigated the thermostability of Fasciola
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5 .3 . D is c u s s io n
hepatica cathepsin LI over the range 30-90°C. The enzyme retained 95-100% activity 
when incubated between 30-45°C. A 35% loss in activity was observed at 50°C and 
was substantially lost at 55°C or greater. They estimated T5o at 52.5°C however; 
activity assays were performed at pH 7.0. In contrast, rFheCLl demonstrated an 
increase in catalytic activity up to 70°C (maximal activity observed at 65°C), showing 
an apparent activation, as opposed to the expected thermal inactivation. The 
temperature of half-inactivation (T50) was estimated at 78°C. These results are much 
higher than previously reported for cathepsin L from other sources. Carp 
hepatopancreas cathepsin L lost activity above 40°C (Aranishi et al., 1997). Despite 
these findings, all assays in this work were performed at physiological temperature, 
37°C.
Activity loss with time was investigated at 78°C (T50). Data fitted well to single 
exponential decay, allowing the estimation of an apparent half-life (5.4 minutes). This 
indicates that there is only one inactivation process under these assay conditions. 
Arrowtooth flounder muscle cathepsin L rapidly lost activity after incubation at 55°C 
for 2.5 minutes (Visessanguan et al., 2003).
Enzymes and other proteins maintain their structural conformations through
intramolecular interactions e.g. hydrophobic. In aqueous environments, they have both
hydrophilic and hydrophobic regions. The hydrophilic regions form contacts with the
essential layer of water, while hydrophobic regions fold inside the molecule. If the
polarity of the medium surrounding the enzyme is reduced by introduction of an organic
solvent, the hydrophobic core of the protein may disperse, resulting in unfolding of the
molecule. As previously discussed, some solvents may replace the essential water layer
surrounding the enzyme, affecting biocatalysis (Ogino & Ishikawa, 2001). The
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concentration at which half-inactivation (C50) is observed was determined for each 
solvent (T a b l e  5.2). THF was found to be the most deleterious solvent. This 
corresponds with it having the highest denaturing capacity (DC = 100). However, while 
Dowd et al. (2000) reported a substantial loss in activity at concentration of THF greater 
than 15% (v/v) (at pH 7.0), rFheCLl retained up to 30% of its original activity at 60% 
(v/v) solvent. Nevertheless, once this concentration had been reached, further addition 
of solvent resulted in an abrupt decrease in activity. Zaks and Klibanov (1988) 
determined that, at low solvent concentrations, the solvent cannot strip off the essential 
water layer; however, at increasingly higher concentrations, solvent molecules compete 
with water for the protein surface and replace some water molecules. Polar organic 
solvents can replace water in the essential water layer without damaging the protein 
structure. This was demonstrated by Fitzpatrick et al. (1993), who concluded that the 
three dimensional structure of subtilisin Carlsberg in anhydrous acetonitrile was 
essentially identical to that in water. The polarity index (I) is another guide among 
solvent parameters (DC, log P, etc.) for enabling the choice of solvent in which 
enzymes are relatively more stable. This indicates that solvents with polarity indexes of
5.1 and below interact with the protein surface differently from pure water. These 
particular solvents cannot substitute for water molecules in the essential water layer. 
This leads to the enzyme adopting a different conformation with consequential loss of 
biological activity, which is demonstrated by changes in emission spectra for the 
enzyme in solvent when compared to that in buffer (Gupta et al., 1997). This may 
explain why THF (polarity index I = 4.0; T a b l e  5.3) was determined to be the most 
deleterious solvent among those tested. Activation effects were observed in acetone, 
acetonitrile, DMF and DMSO. The enzyme retained up to 150% of its original activity
and was most stable in acetone and acetonitrile. Activation effects may be accounted 
for by conformational changes in the enzyme molecule cause by introducing the organic 
solvent into the system (Khmelnitsky et al., 1 9 8 8 ). The stability of the enzyme in these 
solvents may be accounted for by the ability of these solvents to replace water 
molecules in the enzyme maintaining the structure of the enzyme. However, at higher 
solvent concentrations this replacement may lead to deformation of the conformational 
structure and, hence, to denaturation of the enzyme (Ogino & Ishikawa, 2 0 0 1 ).
T a b l e  5 .3 . O r g a n ic  S o l v e n t  C h a r a c t e r is t ic s  (G u p ta  et al., 1 997)
S o l v e n t P o l a r i t y  I n d e x  (I) D e n a t u r a t io n  C a p a c it y  (DC)
Acetone 5.1 78.2
Acetonitrile 5.8 64.3
DMF 6.4 63.3
DMSO 7 .2 60.3
THF 4.0 100
Organic solvents also affect the binding of the substrate to the active site by altering the 
apparent Km values. rFheCLl prefers non-polar amino acid residues in the P2 and P3 
subsite positions of its substrate e.g. Z-Phe-Arg-. In polar solutions, these compounds 
will partition into the hydrophobic active site; again, this could be a possible reason for 
the activation effects seen when the enzyme in placed in these polar solvents excluding 
THF (Dordick, 1989).
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Many strategies have been pursued to enhance enzyme stability e.g. immobilisation, 
chemical modification and genetic/protein engineering techniques. Site-specific 
mutagenesis allows a protein to be stabilized by substituting amino acid residues at 
specific sites in a protein, which may lead to enhanced stability by replacing chemical, 
thermal or solvent labile residues, or by increasing interior interactions such as 
hydrophobic ones, thereby increasing protein rigidity. A comparison was made 
between the amino acid sequence of fluke and recombinant Fasciola hepatica cathepsin 
LI. A number of differences were observed (F ig u r e  5.3.1.). The Q24940 entry notes a 
lack of consensus at certain sites, some of which will be discussed thus giving a 
plausible explanation as to why the recombinant form of cathepsin appears to have 
enhanced stability when compared to fluke (Fasciola hepatica) cathepsin L I . 
Hydrophobic interactions contribute greatly to the stability of the folded state of the 
protein and may be considered the driving force in protein folding. Investigations of 
structural differences obseived between mesophilic and thermophilic proteins have 
suggested that the latter proteins are substantially more hydrophobic and have more 
surface area buried upon folding. It has also been suggested that higher stability 
observed in thermophilic proteins is due to better packing because of smaller and less 
numerous cavities. All of the substitutions at positions 165 (Gly for Arg), 293 (Thr for 
Leu) and 304 (Ala for Val) may enhance stability by increasing the compactness of the 
molecule, as all of these substitutions involve changing one smaller residue for a larger 
one, thereby decreasing the solvent accessible area. Substituting weakly polar threonine 
(T) at position 293 with the bulky hydrophobic amino acid leucine (L) may also 
strengthen the internal hydrophobicity of the protein. Glycine is a small amino acid, 
which is more destabilising because it has more conformational freedom in the unfolded
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state. Changing this for arginine (with a considerably larger side chain) could possibly 
restrict its conformational freedom by reducing the entropy loss on unfolding and 
increase the rigidity of the protein. The guanidine group of this residue can form salt 
bridges; this formation has been implicated in the thermostability of proteins. 
Exchanging alanine for the more hydrophobic valine may help stabilise the protein. 
Substituting tyrosine for phenylalanine (position 118) with the loss of a hydroxyl group 
may contribute to increasing the hydrophobicity at this site (Nosoh & Sekiguchi, 1990; 
Fersht & Serrano, 1993; Kumar et al., 2000).
Matsuura et al. (1998) demonstrated that the addition of peptide tails with random 
sequences to the C-terminal of the enzymes molecule enhanced thermostability. They 
suggested that peptide addition increases the dimension of the protein sequence space, 
thereby imposing constraints on the enzyme molecule. However, they concluded that a 
peptide tail providing beneficial effects to one enzyme may not provide the same effect 
to another. Eight amino acid residues are present at the C-terminal of rFheCLl these 
include glycine, proline and a 6 histidine tag. The inclusion of this peptide “tail” is for 
purposes of purification; however, it may also be responsible for conferring some 
degree of stability upon the recombinant enzyme. Positively charged amino acid 
residues (such as histidine) at a protein terminus fortify the adjacent peptide bonds 
against acid hydrolysis, as they repel hydronium ions (Wong & Parasrampuria, 1997). 
The substitution and addition of residues may be responsible for the enhanced 
thermostability and organic solvent tolerance demonstrated by this recombinant enzyme 
as compared to the fluke enzyme. However, the folding of an enzyme also dictates how 
an amino acid residue contributes to its stability. A crystal structure for the fluke 
enzyme is not yet available; hence the above reasoning involves assumptions. The
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interesting results obtained for this recombinant enzyme would suggest that further 
studies should be performed to elucidate this phenomenon.
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Q24940 - MRLFiLAVLTVGVLGSNDDLWHQWKRMYNKEYNGADDQHRRNTWEKNVKHIQEHNLRHDLGLVTYTLGLNQFTDMTFEEFKAKYLTHMSR
rFheCLl- EAFAYSNnDT-WHOWKRMYNKFYNGAODOHRRNTWEKNVKHiOF.HNr.RHDl.Gl VTYTLGLNQFTDMTFEEFK.AKYLTEMSR
165 173
Q24940 - ASDlLSHGVPYEANNRAVPDKroWRESGYVTEVKDQGNCGSCWAFSTTGTMEGOYMKNERI SISISEQQI VDCS@P^ §
rFheCLl- ASDDLSHGVPVIANNRAVPDKIDWRESGYVrEVKDQGNCGSCWAFSTTGTMEGQYMKNERTSISFSEQQLVDCS@»WGNNGC@GGl MEN V>
118 236-237
Q24940 - QYLKQFGLEIKSYPYTAVEGQCRYNKOLGVAKV fC^YI VHSGSEVELKNLVGARR^AA MMYRS
rFheCLl- QYLKQFGLEIESSYPY1 \vi:G(X RVNKQLGVAKV rdFTYTVHSGSEVELKNLVGAlEG^AAVAVPVESDFMMYRSGIYOSOl<
 293-294 304
Q24940 - YGTQGGi dyw iVKNS\VC,{n]v 1Km|a]r n r g n m c g IAS1 AS! I'Mv aRFP
rFheCLl-AVGYGTOGGTDVWIVKXSUi [ 1 S YIRM0RNRGNMCGlASi.ASl.PMVARFPGPHHHIIHH
Figure 5.3.1. Amino acid sequence of fluke (Fasciola hepatica) cathepsin LI accession number Q24940 and recombinant Fasciola hepatica 
cathepsin LI (rFheCLl). The active site cysteine is bold and underlined. Differences in sequence appear in blue surrounded 
by border. Underlined sequence at N-terminus is the end of the yeast signal sequence. Underlined sequence at the C-terminal 
is the added 6 x His tag for purification. Sequence for fluke (Fasciola hepatica) cathepsin LI obtained from Protein Data 
Bank, sequence for recombinant Fasciola hepatica cathepsin LI obtained from Mr Peter Collins, Parasitology Research 
Group, formerly based at Dublin City University. Sequences aligned by ClustalW.
Kinetic constants for the hydrolysis of Z-Phe-Arg-AMC were determined for 
recombinant Fasciola hepatica cathepsin LI (rFheCLl). The recombinant enzyme had 
similar affinity toward Z-Phe-Arg-AMC (Km = 14.6 jaM) as fluke (Fasciola hepatica) 
cathepsin LI, which reported a Km value of 14.7(iM (Dowd et al., 1994). However, 
rFheCLl had lower affinity toward Z-Phe-Arg-AMC than cathepsin L from other 
sources, which demonstrated Km values in the range 1.8-8.2p.M (Mason et al., 1985; 
Visessanguan et al., 2003). The kcat value for rFheCLl (0.49 s"1) is lower than values 
reported for cathepsin L from rat liver (26 s '1), human liver (17 s'1), and arrowroot 
flounder (12.2 s’1) (Kirschke et al., 1982; Mason et al., 1985; Visessanguan et al., 
2003). A difference was observed between the kcat value obtained for the recombinant 
as opposed to the fluke (Fasciola hepatica) cathepsin LI (1.08 s'1) (Dowd et al., 1994). 
Thus, resulting in a lower catalytic efficiency value (kcJ K m) for the recombinant 
enzyme (33,562 s '1 M '1) when compared to the fluke enzyme (73,469 s '1 M'1) (Dowd et 
al., 1994). However, these observed differences in the kinetic constants may be 
explained by differences in the pH and temperature of assay conditions e.g. cathepsin L 
from other sources were routinely assayed at pH and temperature values ranging 
between pH 5.5-7.0, and 30°C-37°C, respectively (Bromme et al., 1993; Dowd et al., 
2000; Visessanguan et al., 2003).
The esterase activity of rFheCLl was determined using the substrate Z-Lys-ONp. 
Literature values for esterase activity of cathepsin L are few. However, Kirschke et al. 
(1982) reported a kcJ K m value of 1980 x 103 s'1 M '1 for rat liver cathepsin L hydrolysis 
of Z-Lys-ONp. The result obtained for rFheCLl demonstrated a 1000-fold lower value 
(1648 s'1 M '1) for esterase activity, when compared to this value. A major disadvantage
associated with the use o f this substrate is its rapid spontaneous hydrolysis, especially in
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the presence of thiol compounds e.g. DTT (Kirschke, 1981). While the amount present 
in the overall esterase assay was minimal, it may have been enough to cause some 
autolysis of the substrate, hence leading to erroneous results. Z-Lys-ONp has also been 
used as an active site titrant, inactivating thiol proteases that maybe present in crude 
samples and hence, maybe an unsuitable substrate to determine esterase activity (Shaw 
& Green, 1981). These factors may account for obtaining such a low kcJ K m value. To 
determine the overall esterase/amidase ratio for rFheCLl a more suitable fluorescent 
ester substrate would be necessary i.e. Z-Phe-Arg-7HMC ester. In this case, both 
amidase/esterase measurement parameters would perhaps be more accurate, as both 
activities would be determined with similar Z-Phe-Arg peptides. A peptide synthesis 
company was engaged to synthesise this ester fluorescent substrate; however, they 
encountered numerous problems in this task and no further esterase studies could be 
undertaken.
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C h a pter  6  
C hemical Modification  S tu d ie s
6.1. Introduction
N-Hydroxysuccinimide (NHS) esters are popular cross-linking reagents due to their 
mild reaction conditions, commercial availability and ease of synthesis. The reaction is 
rapid with the most accessible protein amino groups attacked with 10-20 minutes and 
proceeds most efficiently at pH 7-8, over a wide temperature range (4-25°C). A 10-fold 
molar excess of the NHS ester is usually sufficient to acylate amino groups. Their 
limited solubility in aqueous buffers requires that they be initially dissolved in organic 
solvents such as DMSO. The reaction involves the nucleophilic attack of an amine on 
the acid carboxyl of the NHS ester forming an amide and releasing the NHS (F ig u r e
6.1.1.). Therefore, the product of the reaction is an amide with the loss of the positive 
charge from the original amino group. Reactions must proceed in buffers that do not 
contain extraneous amines e.g. Tris or glycine (Ji, 1983).
O
O
N-hydroxysuccinimide ester Amine
 C  N  R
H
O
O
A m id e N-hydroxysuccinimide
F ig u r e  6.1.1. NHS E s t e r  R e a c t io n  S c h e m e
147
Bis-N-hydroxysuccinimide esters are homobifunctional reagents with a reactive group 
at either end of the molecule. These reactive groups can be used to introduce both inter 
and intramolecular bridges into a protein. The N-hydroxysuccinimide (NHS) ester used 
for modification of rFheCLl was an ethylene glycol succinic acid (EG) ester of NHS 
(FIGURE 6.1.2.) (Han et al., 1984). Bis-N-hydroxysuccinimides cross-link the molecule 
and also neutralize the charge on the lysine residue. It has been shown that modification 
o f enzymes with these cross-linking agents enhances thermostability, organic solvent 
tolerance and diminishes autolysis (Miland et al., 1996; Murphy & O’Fagain, 1996b).
N — O— C—  CH2— CH2— C— 0 — CHJ" 
O O
FIGURE 6.1.2. Ethylene glycol-bis(succinic acid N-hydroxy-succinimide ester) 
EG-NHS
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6.1. R e su l t s  -  A ssa y  a n d  S t a b il it y  St u d ie s  o n  EG-rFheCLl
6.2.1. C r o s s - l i n k i n g  o f  rFheCLl
Modification of rFheCLl was performed as described in section 2.11. A minimal loss 
(3%) in activity was observed following modification of the enzyme. TNBS assay 
indicated that approximately 62% of the lysine residues were modified, suggesting that 
approximately 8 of the 13-lysine residues per rFheCLl molecule had been modified.
6.2.2. SDS P o l y a c r y l a m i d e  G e l  E l e c t r o p h o r e s i s
SDS-polyacrylamide gel electrophoresis was performed as described in section 2.12. 
F ig u r e  6.2.1.1. illustrates that modified rFheCLl did not show any higher molecular 
weight species as compared to native rFheCLl, suggesting that no intermolecular cross- 
linking occurred and that the product was free of higher molecular weight aggregates of 
rFheCLl. The band appearing above the native and modified samples corresponds to 
different processed forms of the monomer (Personal communication with Mr Peter 
Collins, Parasitology Research Group, formerly based at Dublin City University).
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F ig u r e  6 .2 .2 .I .
Native— ietti EG-rFheCL1
3 6 9
F ig u r e  6.2.2.I. G e l C o d e ®  B l u e  S t a in e d  S D S -P A G E  o f  r F h e C L l
Lane 3: molecular weight markers (from top), bovine serum albumin (66,000 Da), 
ovalbumin (45,000 Da), glyceraldehyde-3-phosphate dehydrogenase (36,000 Da), 
carbonic anhydrase (29,000 Da), trypsinogen (24,000 Da) and trypsin inhibitor (20,000 
Da). Lane 6 : native-rFheCLl. Lane 9: EG-rFheCLl. Lanes between the samples and 
molecular weight markers were left empty.
6.2.3. E f f e c t  o f  M o d if ic a t io n  o n  rFheCLl K in e t ic s
Michaelis-Menten kinetics was determined for native and EG-rFheCLl as described in 
section 2 .6 .2 .
T a b l e  6 .1. M ic h a e l is -M e n t e n  p a r a m e t e r s  f o r  n a t iv e  a n d  m o d if ie d  rFheCLl
rFheCLl Km (nM’1) ^cat (S ) kcJ K m (s’1 M -1)
Native 14.6 0.49 33,562
Modified 12.5 0.41 32,800
66,000
45.000
36.000
29.000
24.000
20.000 
Dye front
Lane number
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6.2.4. T e m p e r a t u r e  S t u d ie s
6.2.4.1. Temperature Profile
A temperature profile of native and EG-rFheCLl was performed as outlined in section
2.7.1.2. T50, where 50% of initial activity remained after 10 minutes incubation in a
waterbath, was estimated at 87°C ± 1% for EG-rFheCLl, a 9°C increase above that 
determined for native rFheCLl. Enhanced thermostability was demonstrated by EG- 
rFheCLl at all of the investigated temperatures; however its greatest degree of 
thermostability was seen at higher temperatures (between 60-90°C).
6.2.4.2. Thermoinactivation of Native and Modified rFheCLl
A thermoinactivation study was performed at 70°C over a 60 minute period as outlined 
in section 2.7.2.2. F ig u r e  6.2.4.2.I. illustrates the activity profile of native and EG- 
rFheCLl at 70°C over 60 minutes. A 70% decrease in activity was observed for native 
rFheCLl after the 60-minute incubation period. In contrast, EG-rFheCLl retained 
1 0 0 % of its original activity after the same incubation period.
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F i g u r e  6 .2 .4 .2 .I .
T i m e  ( m in u t e s )
— Nat i ve  
M o d .
F ig u r e  6.2.4.2.I. T h e r m o in a c t iv a t io n  o f  n a t iv e  a n d  EG-rFheCLl a t  70°C. 
Plot o f % residual activity (excitation 370nm, slit width lOnm; emission 440nm, slit 
width 2.5nm) versus time (minutes). Residual activity is represented as a percentage of 
the t = zero value.
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6 .2 .5 . O r g a n o t o l e r a n c e  S t u d ie s
6.2.5.1. Solvent Stability Studies
Organotolerance studies on native and EG-rFheCLl were investigated for the following 
solvents: acetone, acetonitrile, DMF, DMSO and THF as outlined in section 2.8.1.2. 
Graphs of % residual activity versus solvent concentration (%) were plotted for each 
solvent. Threshold concentrations (C50) at which half-inactivation was observed were 
determined for native and modified rFheCLl in each solvent (T a b l e  6.2.). Activation 
effects were observed when native (results similar to section: 5.2.5) and modified 
rFheCLl were placed in DMF; modified rFheCLl demonstrating enhanced activity up 
to 60% (v/v) solvent concentration. However, threshold concentrations for native and 
modified rFheCLl in DMF did not differ. Placing the enzyme in acetone and 
acetonitrile resulted in enhanced activity at higher concentrations (between 60-90%) as 
demonstrated by an increase in threshold concentrations. In contrast, THF was the most 
deleterious solvent to both native and modified rFheCLl; however, modified rFheCLl 
demonstrated up to 15% higher activity at solvent concentrations between 70-90%.
6.2.5.2. Thermoinactivation of Native and Modified rFheCLl
A thermoinactivation study was performed at 37°C and 50°C over a 60 minute period as 
outlined in section 2.7.2.2. F ig u r e  6.2.5.2.1. and 6.2.5.2.2. illustrate the activity profile 
of native and EG-rFheCLl in 50% (v/v) organic solvent over 60 minutes. Both native 
and EG-rFheCLl retained 100% of original activity after the 60-minute assay period 
when placed in 50% (v/v) DMF at 37°C. However, native rFheCLl demonstrated 
higher activity in this solvent at 37°C. Similar results were obtained for rFheCLl in
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50% (v/v) acetonitrile at 37°C, with a slight activation effect being observed. Both 
forms of the enzyme demonstrated increased activity in 50% (v/v) acetonitrile as 
opposed to 50% (v/v) DMF. At 50°C the modified enzyme demonstrated higher 
activity in 50% (v/v) DMF than the native form; however, both native and modified 
forms retained up to 97% of original activity after the assay period. Both forms of the 
enzyme were deemed to be more stable in this solvent than in acetonitrile at the same 
concentration, where a steady decline in activity was observed over the assay period. 
However, EG-rFheCLl was more active in this solvent than the native rFheCLl.
T a b l e  6 .2 . C50 v a l u e s  f o r  n a t iv e  a n d  EG-rFheCLl in  o r g a n ic  s o l v e n t s  
(Assay performed in triplicate)
So l v e n t O b s e r v e d  C 5o v a l u e s  
native rFheCLl
O b s e r v e d  C50 v a l u e s  
EC-rFheCLl
Acetone 81% +2% 85%  ± 1 %
Acetonitrile 76% ±2% 88%  ± 2 %
DMF 65% ±2% 65%  ± 1 %
DMSO 68% ±2% 69%  ±  1 %
THF 15% ±0.5% 17% ±  2%
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F i g u r e  6 .2 .5 .2 .I .
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F ig u r e  6.2.5.2.I. T h e r m o in a c t iv a t io n  o f  n a t iv e  a n d  EG-rFheCLl in  50% 
(v/v) ORGANIC s o l v e n t  a t  37°C. Plot of fluorescence intensity (excitation 370nm, slit 
width lOnm; emission 440nm, slit width 2.5nm) versus time (minutes).
F ig u r e  6.2.5.2.2.
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F ig u r e  6.2.5.2.2. T h e r m o in a c t iv a t io n  o f  n a t iv e  a n d  EG-rFheCLl in  50% 
(v/v) ORGANIC s o l v e n t  a t  50°C. Plot of fluorescence intensity (excitation 370nm, slit 
width lOnm; emission 440nm, slit width 2.5nm) versus time (minutes).
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There are a number of reasons for choosing to modify lysine residues. Lysine residues 
are polar and the ^-amino groups of lysine residues are usually among the most 
abundant and most accessible of the potentially reactive groups. Many proteins have 
lysine residues that are not involved in the catalytic site (Guisan, 1987; Means & 
Feeney, 1990).
After chemical cross-linking a partial characterisation of the NHS derivative was 
performed. SDS-PAGE (F ig u r e  6.2.2.1.) indicated no molecular weight differences 
between modified (EG-) and unmodified (native) rFheCLl. Hence, it appears that the 
observed NHS ester stabilization took place without intermolecular cross-linking. 
Approximately 8 lysine residues per rFheCLl molecule were modified. A review of the 
literature did not reveal any reports in terms of chemical modification of rFheCLl.
The kinetics of native and modified rFheCLl were studied to determine the effect of 
modification on rFheCLl-catalysed hydrolysis of its corresponding substrate Z-Phe- 
Arg-AMC and compare their respective Km and kcai values. The tabulated kinetic 
parameters (T a b l e  6.1) show that the Michaelis constants for EG-rFheCLl were 
similar. Although an insignificant difference was obtained between the native and 
modified Km value, this can be explained by experimental variability. Overall, these 
results indicate that the active site of the enzyme has not been affected by cross-linking 
and that stability gain has not been at a cost of poorer catalysis.
EG-rFheCLl showed increased resistance to elevated temperatures. The T50 value for
EG-rFheCLl was 9°C higher than that obtained for native cathepsin LI (87°C and
78°C, respectively). Thermoinactivation of native and modified rFheCLl is illustrated
in F igure 6.2.4.2.I. Modified rFheCLl demonstrated considerably enhanced
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6.3. Discussion
thermostability at 70°C over the duration when compared to native rFheCLl. 
Intramolecular cross-linking stabilises a protein’s tertiary structure. The cross-linking 
agent acts as external braces that prevent unfolding of the tertiary structure. Therefore, 
the degree to which thermostability is observed may be dependant on the degree of 
cross-linking (Han et al., 1984; Sheehan et al., 1990). The positioning of lysine 
residues in the protein plays an important role in stability. The rate and extent of 
deamidation of asparagines residues is influenced by the nature of the carboxyl-flanking 
amino acid. Lysines positioned before asparagine residues in the protein have been 
found to contribute to the lability of asparagines and, therefore, its deamidation. 
Modification of these lysine residues could result in a lower extent of deamidation 
(Daniel, 1996; Khajeh et al., 2001). Of the 13-lysine residues in rFheCLl, 4 are 
positioned immediately before asparagine residues. If these are among the 8 lysine 
residues which have been modified, this may hinder the deamidation reaction, giving a 
possible reason why EG-rFheCLl demonstrated enhanced thermostability when 
compared to the native enzyme. Modification may also stabilise the protein by masking 
the hydrophobic methylene chain of the lysine from unfavourable contact with water, 
enhancing stability (Khaparde & Singhal, 2001). Enhanced stability may also be due to 
a simple cross-link stabilizing the tertiary structure (Han et al., 1984).
The tolerance of EG-rFheCLl in organic solvents (acetone, acetonitrile, DMF, DMSO) 
was enhanced. The C50 values for EG-rFheCLl were higher than those for native 
rFheCLl for all the tested solvents (exception DMF; T a b l e  6.2); however, THF was 
still deemed the most deleterious solvent, with only a 2 % difference between the native 
and modified C50 value. Transferring the enzyme to a solvent can be potentially 
destabilizing by leading to loss of solvation. This arises because the native
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conformation of proteins in water tends to maximise the solvation contribution to the 
stability of charged residues. Therefore, removing the charge on these lysine residues 
should enhance the stability of the folded enzyme in solvents that are less capable than 
water of solvating charges. Removing the charge may also decrease the concentration 
of water required for enzyme activation (Arnold, 1990). Stability of EG-rFheCLl may 
result from this factor and from increased conformational rigidity caused by introducing 
intramolecular cross-link into the enzyme, thereby preventing reversible unfolding of 
the molecule.
Many enzymes inactivate at high temperatures in aqueous environments, due to partial 
unfolding and covalent alterations in the primary structure (Dordick, 1991). Water is 
required as a reactant for a number of deleterious processes such as deamidation and 
peptide hydrolysis (Krishna, 2002). In reduced water environments, intra-molecular 
forces such as hydrogen bonding and ion pair interactions are stronger in organic 
solvents than in water. This leads to decreased flexibility, increased conformational 
rigidity and the absence of nearly all covalent reactions that cause irreversible 
thermoinactivation in water (Gupta, 1992; Klibanov, 2001; Colombo & Carrea, 2002). 
Thermoinactivation of both native and EG-rFheCLl in both 50% (v/v) acetonitrile and 
DMF was examined at 37° and 50°C. Both native and modified forms of the enzyme 
were stable at 37°C in these solvents, although the native enzyme was more active. 
Enhanced thermostability of the EG-rFheCLl was observed in these solvents at 50°C. 
A combination of factors may contribute to this increase in thermostability namely: (1) 
the direct effect of the solvent/reduced water environment, discussed above; (2) 
modification of the lysine residues, reducing deleterious deamidation reactions or (3) 
the direct effect of cross-linking decreasing the flexibility of the enzyme.
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C h a pter  7 
P e p tid e  Sy n th e s is
Over the last decade, proteases have been widely used to form peptide bonds. 
Enzymatic peptide synthesis offers an alternative to chemical methods, with numerous 
advantages (see section 1.3. for more details). The synthesis of the model tripeptide Z- 
Phe-Arg-SerNH2 was performed. As previously discussed (section 1.4.), there are two 
strategies for enzymatic peptide synthesis: kinetically-controlled and equilibrium- 
controlled synthesis. The kinetic method making use of ester substrates was preferred 
due to its lower enzyme requirements and shorter reaction times. The chosen process 
can be summarized as follows:
S c h e m e  7 .1 . K i n e t i c a l l y - c o n t r o l l e d  t r ip e p t id e  s y n t h s is  u s in g  r F h e C L l
7 .1 . In t r o d u c t io n
Synthesis (aminolysis)
Z-Phe-Arg-OMe + SerNlk Z-Phe-Arg-SerNH2
Hydrolysis 1
Z-Phe-Arg-OH
Hydrolysis 2
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7.2. R e s u l t s  -  P e p t id e  Sy n t h e s is  w it h  N a t iv e  rFheCLl
7.2.1. LC Conditions
From the spectra obtained from the photodiode array detector the optimum wavelength 
for analysis was found at 200nm. Mobile phase concentration was adjusted: the most 
suitable concentration was a 25% (v/v) acetonitrile / 75% (v/v) water containing 0.1% 
(v/v) formic acid.
7.2.2. Concentration of Enzyme, Ester and Nucleophile
The enzymatic peptide synthesis of Z-Phe-Arg-SerNH2 was performed as described in 
section 2.13. Initially, enzyme, ester and nucleophile concentrations were 0.5mg/ml, 
25mM and 50mM, respectively, with an ester:nucleophile ratio of 1:2. Although 
formation of the desired tripeptide product was detected by mass spectrometry analysis, 
it was not detected on the LC chromatographs, as a peak pertaining to the ester was 
masking its detection. Therefore, concentrations of each constituent were reduced to 
0.05mg/ml, 2.5mM and lOmM, yielding a 1:4 ester:nucleophile ratio.
7.2.3. Tripeptide Formation
FIGURE 7.2.3.2. (Time = 1 0  minutes) clearly demonstrates the formation of a new peak 
corresponding to the molecular weight of the desired tripeptide Z-Phe-Arg-SerNH2 
(mw: 542) as compared with F ig u r e  7.2.3.1. (Time = 0 minutes). Formation of the new 
tripeptide occurred within ten minutes, while the ester substrate was slowly consumed 
over the sixty-minutes (F ig u r e  7.2.3.4.). However, the formation of hydrolysis 
products, Z-Phe-Arg-OH, was noticed at an unexpectedly early stage of the reaction.
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F ig u r e  7 .2 .3 .I .
Time *  0 minutes
V'"-
—  1 ir  rV M': ■ S rr-;in p .j .;3 1 '< 'jp
—  Z-PheArg OH
Z-Phe -Arg-OMe
16 Turn l m t
1 . 1 . i . * i _ --*--1 1 i
— Z-Phe-Arg-OH
47C
. . .  . / I  . Ï . » I. l
,2 » A'l MS
— Z-Phe-Arg-OMe
; 'f- 305 <5 sir ' * <5C> ' * .TO
F i g u r e  7 .2 .3 .I .  U V  c h r o m a t o g r a m  ( u p p e r )  a n d  m a s s  s p e c t r o m e t r y  
t r a c e s  (l o w e r )  f o r  rFheCLl c a t a l y s e d  p e p t id e  s y n t h e s i s ,  a t  T =  0 m in u t e s .
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F ig u r e  1.2 3 .2.
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F i g u r e  1.2.3.2. U V  c h r o m a t o g r a m  (u p p e r )  a n d  m a s s  s p e c t r o m e t r y
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F ig u r e  7.2.3 .4.
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FIGURE 7.2.3.4. UV CHROMATOGRAM (UPPER) AND MASS SPECTROMETRY 
TRACES (LOWER) FOR rFheCLl CATALYSED PEPTIDE SYNTHESIS, AT T = 60 MINUTES.
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A review of the literature indicated that cathepsin L has a preference for small amino 
acid side chains (Ala, Ser) or for long but non-branched (Asn, Gin, Lys) side chains at 
the P i' position. It also indicated the order of preference among these residues at this 
site i.e. Ser > Ala >Lys > Asn > Gin (Menard et al., 1993). Hence, serine was chosen 
as a suitable nucleophile for this synthesis.
F ig u r e s  7.2.3.1.-7.2.3.4., clearly demonstrate that within ten minutes of reaction 
commencement a tripeptide was formed, while the ester was steadily consumed over the 
60-minute period (although some ester still remained up to this point). However, 
formation of the ester hydrolysis product steadily increased over the reaction duration. 
Minimal optimisation of this reaction has taken place to date. Given time, many 
parameters could be investigated to ascertain the effects of varying enzyme, substrate 
and nucleophile concentrations, pH, temperature and reaction medium on the 
mechanistic features of the process.
Decreasing the water concentration in the reaction medium can minimize competing 
hydrolytic reactions. The behaviour of enzymes in solvent is variable: each enzyme has 
its own level of tolerance. Careful selection of the organic solvent for enzyme-catalysed 
peptide bond synthesis is essential as it affects not only the enzyme stability, but also 
solubility of the substrate and yield of peptide product (Zhou et al., 2003). Synthesis in 
organic solvents prevents substrate ester hydrolysis as well as unwanted proteolysis 
(Jakubke, 1994). rFheCLl demonstrated maximum activity in 50% (v/v) acetonitrile. 
The ester substrate is also soluble in this solvent; hence, this would be a good starting 
point for catalysing synthesis in a suitable organic cosolvent system.
7.3. Discussion
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Kinetically-controlled peptide synthesis has been performed at many temperatures 
ranging from frozen aqueous systems up to 40°C. Therefore, the optimisation of this 
reaction temperature would be worthwhile. Haensler et al. (1999) demonstrated that a- 
chymotrypsin and papain were capable of synthesising various peptides (kinetically- 
controlled synthesis) using unprotected amino acids as acyl acceptors in a frozen 
aqueous system, with yields ranging from 43-95% depending on the acyl acceptor used. 
Freezing is thought to increase the concentration of reactants in the unfrozen liquid 
phase that is in equilibrium with the ice crystals. Decreasing the temperature also 
reduces the extent of hydrolytic side reactions that take place at higher temperatures. 
Optimising the concentration of reactants is an important step to achieve the highest rate 
of product formation. Decreasing the concentration of the reactants (as described in 
section 7.2.2.) enhanced the resolution of the LC chromatographs. This could be further 
optimised. It would be interesting to establish the highest esterinucleophile ratio that 
would still allow product formation and to determine the saturation level where 
maximum tripeptide formation is achieved. Here, peptide synthesis was obtained at a 
1:4 ratio. Lozano et al. (1992) used papain to catalyse the synthesis of a tripeptide using 
an esterinucleophile ratio of 1:6. Varying the nucleophile acceptor would be an 
interesting experiment, to elucidate which nucleophile gives the highest rate of 
tripeptide formation. A comparison of results could be made with Menard et al. (1993), 
who concluded that cathepsin L favoured serine (amongst other amino acids) at the P i' 
position. Neither the rate nor the total amount of product synthesised by rFheCLl was 
established in this reaction.
pH can influence kinetically-controlled synthesis in two ways: the binding of the ester 
substrate to the enzyme, leading to esterase activity and the deacylation of the acyl-
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enzyme by the nucleophile, leading to synthesis. Therefore, investigating the optimum 
pH at which maximum synthetic activity is observed would be instructive (Lozano et 
al., 1992). If not for the constraints of time, full optimisation of this reaction would 
have taken place. However, the results obtained have proved that rFheCLl is capable of 
peptide synthesis.
The preference of DPP IV for proline residues at the Pi position in substrates makes the 
investigation of using the enzyme for peptide synthesis an interesting concept. It is a 
difficult task to perform peptide coupling near a proline residue. The bulky size of the 
5-membered ring may interfere with the coupling process (Tai, 2003). However, as 
previously discussed (section 1.9.), the side chains of residues at the P i' position of DPP 
IV substrates point into the large active site cavity and no specific interactions with DPP 
IV occur. This explains why this enzyme has no specific preference for amino acids in 
substrates at this position. Therefore, peptide synthesis using a variety o f nucleophiles 
should be possible. It had been hoped to investigate the potential of DPP IV in peptide 
synthesis; however, a suitable commercial ester substrate was not available preventing 
realisation of this ambition. A commercial peptide synthesis group was engaged to 
prepare a suitable ester substrate (Gly-Pro-7HMC). However, this has been 
unsuccessful to date, as many problems were encountered during its synthesis. 
Heiduschka et al. (1989) did achieve peptide synthesis using DPP IV, synthesising 
various peptides using unprotected amino acids (Ala, Gly) as acyl acceptors in 50% 
(v/v) glycerol. To date this is the only recorded synthesis using this enzyme.
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C h a pter  8  
C o n c lu sio n
Initially, the stability properties of the serine protease dipeptidyl peptidase IV (DPP IV) 
were explored, the enzyme having been successfully purified from bovine serum with a 
final yield of 12% and an overall 32-fold increase in purity. DPP IV demonstrated no 
autolysis activity and was catalytically active up to 62°C, with a T50 value determined at 
71°C ± 1°C. The apparent half-life (t>/2) determined at 71 °C was ten minutes. 
Organotolerance studies determined that DPP IV was most stable in acetonitrile up to 
70% (v/v); activity declined in both DMF and DMSO above 40% (v/v). THF was 
deemed to be the most deleterious solvent to the enzyme. No enhancement of 
thermostability was observed when the enzyme was placed in acetonitrile, DMF or THF 
(50%) (v/v)). pH investigations revealed complete inactivation of the enzyme at pH 4.0, 
but a broad stable pH range between 7.0-10. These studies also concluded that buffer 
species had an effect on the activity of the enzyme: activity in MOPS buffer at pH 7.0 
was greater than in HEPES at the same pH. Two pK  values were determined at 6.18 
and 9.7, which were attributed to the ionisation of the active site histidine734 and a- 
amino group of the glycine moiety on the substrate Gly-Pro-AMC, respectively. The 
effect of pH on DPP IV thermostability was investigated and revealed that activity 
sharply decreased above 60°C between pH 5.5-6.5. T50 values at each pH indicated that 
the enzyme was most thermostable in the neutral-alkaline pH region, with optimum 
stability observed at pH 8.0.
It had been hoped to use this enzyme for peptide synthesis; however, as discussed 
(section 7.3.) the lack of a suitable ester substrate to act as acyl donor impeded any such 
attempt.
8.0 Conclusion
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The next part of this project involved investigating the stability properties of the 
cysteine protease, recombinant Fasciola hepatica cathepsin LI (rFheCLl). The enzyme 
demonstrated no autolysis activity. rFheCLl was catalytically active up to 70°C, with 
T50 at 78°C ± 1°C. Data fitted well to a single exponential decay and the apparent half- 
life (ty2) at 78°C was 5.4 minutes.
Solvent stability studies determined that little or no loss in activity occurred at lower 
concentrations of the solvents tested. Activity in acetone, acetonitrile, DMF and DMSO 
was actually enhanced. However, a dramatic decrease in activity occurred at a critical 
solvent concentration, which varied with solvent. Again, THF was found to be the most 
deleterious solvent to the enzyme.
Kinetic constants determined for native rFheCLl were quite similar to reported values 
for fluke (Fasciola hepatica) cathepsin LI. Reported values for the esterase activity of 
this enzyme using the substrate Z-Lys-ONp are few. However, the enzyme 
demonstrated a kcJ K m 1000-fold lower value than that obtained by Kirschke et al. 
(1982).
Whether the observed stability associated with this enzyme is due to differences in 
amino acid sequence between the fluke and recombinant enzyme has yet to be 
elucidated.
Modification of rFheCLl with the homobifunctional reagent EG-NHS yielded a 
catalytically active stable derivative probably with intramolecular cross-linked amino 
acid groups. A comparison of the kinetic constants for the native and modified enzyme 
indicated that the active site of the enzyme had not been affected by cross-linking, 
apparently no loss of catalytic performance upon modification. Modification yielded 
notable benefits. The EG-rFheCLl demonstrated increased thermostability, with T50
169
determined at 87°C, 9 degrees higher than that obtained for native rFheCLl. 
Thermoinactivation at 70°C showed that EG-rFheCLl retained 100% activity over a 60- 
minute duration; in contrast, native rFheCLl demonstrated a loss of up to 70% over the 
same period. Organotolerance studies revealed that the activity of EG-rFheCLl in 
solvents (acetone, acetonitrile, DMF, DMSO) was enhanced: C50 values were higher 
than those obtained for the native enzyme. However, cross-linking did not improve the 
stability o f the enzyme in THF. Thermoinactivation of native and EG-rFheCLl in 50% 
(v/v) acetonitrile or DMF at 37°C and 50°C revealed that both forms of the enzyme 
were stable at 37°C, with the modified enzyme demonstrating enhanced thermostability 
at 50°C.
Successful synthesis of the tripeptide Z-Phe-Arg-SerNH2 was achieved with native 
rFheCLl, although this reaction could be further optimised. A review of the literature 
did not reveal any reports in terms of peptide synthesis or chemically modi fying fluke 
(Fasciola hepatica) cathepsin LI or recombinant Fasciola hepatica cathepsin LI, so the 
present findings appear to be novel.
The original research aims of this project have been substantially achieved. 
Investigating the stability properties of both enzymes has revealed some interesting and 
potentially significant results. The thermostability of both mammalian DPP IV and 
rFheCLl proved considerably higher than would be expected for these enzymes, as both 
are normally found existing in environments at the physiological body temperature of 
37°C. Both enzymes exhibited enhanced tolerance in the present of organic solvents, 
proving their possible usefulness as biocatalytic reagents in industry, where most 
reactions are carried out in an organic environment. Enzymes in organic solvents can
readily catalyze many transformations that are impossible in aqueous environments.
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From a biotechnological aspect there are numerous potential advantages in employing 
enzymes in organic as opposed too aqueous media (section 1.5; T a b l e  1.1.). Native 
rFheCLl demonstrated that it could catalyse peptide synthesis, again proving a role for 
the enzyme in the biotechnology industry, where enzymes have been used to catalyse 
the synthesis of some well-known peptides e.g. aspartame. The successful modification 
of rFheCLl and the enhanced thermostability demonstrated by the modified enzyme 
may allow this modified enzyme to be considered for use in detergents, where another 
cysteine protease papain, having also been successfully modified is currently being 
considered for application in detergent formulations (Khaparde & Singhal, 2001).
It is hoped that these results will be of use and interest to other researchers working in 
the field of modification, protein stability and enzymatic peptide synthesis and may in 
future be applied to a variety of biocatalytic applications, as both enzymes would appear 
to have considerable potential as biocatalysts.
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A ppe n d ix
One unit of enzyme activity is defined as the amount of enzyme, which releases 1 
nanomole of AMC per minute at 37°C.
Derivation:
Let AMC released = Xpmoles/litre (assay uses 100|il AMC and 25|il enzyme sample)
= X x 1 O'3 x 0.1 |imoles/min/25[xl 
60
= X x 10~3 x 0.1 x!0+3 nanomoles/min/25^1 
60
= X x 0.1 nanomoles/min/25|il 
60
= X x 0.4 nanomoles/min/1000fj,l 
60
= X x 0.4 nanomoles/min/1 ml 
60
= X nanomoles/min/ml 
15
1 unit of activity is defined as the amount of enzyme, which releases 1 nanomole
AMC/min, therefore = X units/ml
15
AMC released (X) is also defined as observed fluorescence intensity/slope of the 
appropriate filtered AMC standard curve (section 2.4.1.1.-2.4.1.2.), hence:
Unit/ml or unit of activity = fluorescence intensity/ slope of filtered standard curve x 15
Quantitation of enzyme activity:
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